id	sid	tid	token	lemma	pos
ajlm-991	1	1	abstract	abstract	ADJ
ajlm-991	1	2	introduction	introduction	NOUN
ajlm-991	1	3	methods	method	NOUN
ajlm-991	1	4	results	result	VERB
ajlm-991	1	5	discussion	discussion	NOUN
ajlm-991	1	6	acknowledgements	acknowledgement	NOUN
ajlm-991	1	7	references	reference	NOUN
ajlm-991	1	8	about	about	ADP
ajlm-991	1	9	the	the	DET
ajlm-991	1	10	author(s	author(s	NOUN
ajlm-991	1	11	)	)	PUNCT
ajlm-991	1	12	shilpi	shilpi	NOUN
ajlm-991	1	13	gupta	gupta	PROPN
ajlm-991	1	14	department	department	PROPN
ajlm-991	1	15	of	of	ADP
ajlm-991	1	16	microbiology	microbiology	NOUN
ajlm-991	1	17	,	,	PUNCT
ajlm-991	1	18	military	military	ADJ
ajlm-991	1	19	hospital	hospital	NOUN
ajlm-991	1	20	,	,	PUNCT
ajlm-991	1	21	bhopal	bhopal	PROPN
ajlm-991	1	22	,	,	PUNCT
ajlm-991	1	23	india	india	PROPN
ajlm-991	1	24	mahadevan	mahadevan	PROPN
ajlm-991	1	25	kumar	kumar	PROPN
ajlm-991	1	26	department	department	PROPN
ajlm-991	1	27	of	of	ADP
ajlm-991	1	28	microbiology	microbiology	NOUN
ajlm-991	1	29	,	,	PUNCT
ajlm-991	1	30	bharati	bharati	PROPN
ajlm-991	1	31	vidyapeeth	vidyapeeth	PROPN
ajlm-991	1	32	university	university	PROPN
ajlm-991	1	33	medical	medical	PROPN
ajlm-991	1	34	college	college	PROPN
ajlm-991	1	35	,	,	PUNCT
ajlm-991	1	36	pune	pune	PROPN
ajlm-991	1	37	,	,	PUNCT
ajlm-991	1	38	india	india	PROPN
ajlm-991	1	39	shelinder	shelinder	PROPN
ajlm-991	1	40	p.s	p.s	PROPN
ajlm-991	1	41	.	.	PROPN
ajlm-991	1	42	shergill	shergill	PROPN
ajlm-991	1	43	department	department	PROPN
ajlm-991	1	44	of	of	ADP
ajlm-991	1	45	microbiology	microbiology	NOUN
ajlm-991	1	46	,	,	PUNCT
ajlm-991	1	47	armed	armed	ADJ
ajlm-991	1	48	forces	force	NOUN
ajlm-991	1	49	medical	medical	ADJ
ajlm-991	1	50	college	college	NOUN
ajlm-991	1	51	,	,	PUNCT
ajlm-991	1	52	pune	pune	PROPN
ajlm-991	1	53	,	,	PUNCT
ajlm-991	1	54	india	india	PROPN
ajlm-991	1	55	kundan	kundan	PROPN
ajlm-991	1	56	tandel	tandel	PROPN
ajlm-991	1	57	department	department	PROPN
ajlm-991	1	58	of	of	ADP
ajlm-991	1	59	microbiology	microbiology	NOUN
ajlm-991	1	60	,	,	PUNCT
ajlm-991	1	61	command	command	NOUN
ajlm-991	1	62	hospital	hospital	NOUN
ajlm-991	1	63	(	(	PUNCT
ajlm-991	1	64	central	central	ADJ
ajlm-991	1	65	command	command	NOUN
ajlm-991	1	66	)	)	PUNCT
ajlm-991	1	67	,	,	PUNCT
ajlm-991	1	68	lucknow	lucknow	PROPN
ajlm-991	1	69	,	,	PUNCT
ajlm-991	1	70	india	india	PROPN
ajlm-991	1	71	citation	citation	PROPN
ajlm-991	1	72	gupta	gupta	PROPN
ajlm-991	1	73	s	s	PROPN
ajlm-991	1	74	,	,	PUNCT
ajlm-991	1	75	kumar	kumar	PROPN
ajlm-991	1	76	m	m	PROPN
ajlm-991	1	77	,	,	PUNCT
ajlm-991	1	78	shergill	shergill	PROPN
ajlm-991	1	79	sps	sps	PROPN
ajlm-991	1	80	,	,	PUNCT
ajlm-991	1	81	tandel	tandel	PROPN
ajlm-991	1	82	k.	k.	PROPN
ajlm-991	1	83	evaluation	evaluation	NOUN
ajlm-991	1	84	of	of	ADP
ajlm-991	1	85	ceftriaxone	ceftriaxone	NOUN
ajlm-991	1	86	-	-	PUNCT
ajlm-991	1	87	sulbactam	sulbactam	NOUN
ajlm-991	1	88	-	-	PUNCT
ajlm-991	1	89	disodium	disodium	NOUN
ajlm-991	1	90	edetate	edetate	NOUN
ajlm-991	1	91	adjuvant	adjuvant	ADJ
ajlm-991	1	92	combination	combination	NOUN
ajlm-991	1	93	against	against	ADP
ajlm-991	1	94	multi	multi	ADJ
ajlm-991	1	95	-	-	ADJ
ajlm-991	1	96	drug	drug	ADJ
ajlm-991	1	97	resistant	resistant	ADJ
ajlm-991	1	98	gram	gram	NOUN
ajlm-991	1	99	-	-	PUNCT
ajlm-991	1	100	negative	negative	ADJ
ajlm-991	1	101	organisms	organism	NOUN
ajlm-991	1	102	.	.	PUNCT
ajlm-991	2	1	afr	afr	PROPN
ajlm-991	2	2	j	j	PROPN
ajlm-991	2	3	lab	lab	PROPN
ajlm-991	2	4	med	me	VERB
ajlm-991	2	5	.	.	PUNCT
ajlm-991	2	6	2020;9(1	2020;9(1	NUM
ajlm-991	2	7	)	)	PUNCT
ajlm-991	2	8	,	,	PUNCT
ajlm-991	2	9	a991	a991	PROPN
ajlm-991	2	10	.	.	PUNCT
ajlm-991	3	1	https://doi.org/10.4102/ajlm.v9i1.991	https://doi.org/10.4102/ajlm.v9i1.991	PROPN
ajlm-991	3	2	original	original	ADJ
ajlm-991	3	3	research	research	NOUN
ajlm-991	3	4	evaluation	evaluation	NOUN
ajlm-991	3	5	of	of	ADP
ajlm-991	3	6	ceftriaxone	ceftriaxone	NOUN
ajlm-991	3	7	-	-	PUNCT
ajlm-991	3	8	sulbactam	sulbactam	NOUN
ajlm-991	3	9	-	-	PUNCT
ajlm-991	3	10	disodium	disodium	NOUN
ajlm-991	3	11	edetate	edetate	NOUN
ajlm-991	3	12	adjuvant	adjuvant	ADJ
ajlm-991	3	13	combination	combination	NOUN
ajlm-991	3	14	against	against	ADP
ajlm-991	3	15	multi	multi	ADJ
ajlm-991	3	16	-	-	ADJ
ajlm-991	3	17	drug	drug	ADJ
ajlm-991	3	18	resistant	resistant	ADJ
ajlm-991	3	19	gram	gram	NOUN
ajlm-991	3	20	-	-	PUNCT
ajlm-991	3	21	negative	negative	ADJ
ajlm-991	3	22	organisms	organism	NOUN
ajlm-991	3	23	shilpi	shilpi	NOUN
ajlm-991	3	24	gupta	gupta	PROPN
ajlm-991	3	25	,	,	PUNCT
ajlm-991	3	26	mahadevan	mahadevan	PROPN
ajlm-991	3	27	kumar	kumar	PROPN
ajlm-991	3	28	,	,	PUNCT
ajlm-991	3	29	shelinder	shelinder	NOUN
ajlm-991	3	30	p.s	p.s	PROPN
ajlm-991	3	31	.	.	PROPN
ajlm-991	3	32	shergill	shergill	PROPN
ajlm-991	3	33	,	,	PUNCT
ajlm-991	3	34	kundan	kundan	PROPN
ajlm-991	3	35	tandel	tandel	PROPN
ajlm-991	3	36	received	receive	VERB
ajlm-991	3	37	:	:	PUNCT
ajlm-991	3	38	04	04	NUM
ajlm-991	3	39	feb	feb	X
ajlm-991	3	40	.	.	PROPN
ajlm-991	3	41	2019	2019	NUM
ajlm-991	3	42	;	;	PUNCT
ajlm-991	3	43	accepted	accept	VERB
ajlm-991	3	44	:	:	PUNCT
ajlm-991	3	45	27	27	NUM
ajlm-991	3	46	aug	aug	NOUN
ajlm-991	3	47	.	.	PROPN
ajlm-991	3	48	2020	2020	NUM
ajlm-991	3	49	;	;	PUNCT
ajlm-991	3	50	published	publish	VERB
ajlm-991	3	51	:	:	PUNCT
ajlm-991	3	52	10	10	NUM
ajlm-991	3	53	dec	dec	PROPN
ajlm-991	3	54	.	.	PROPN
ajlm-991	3	55	2020	2020	NUM
ajlm-991	4	1	copyright	copyright	NOUN
ajlm-991	4	2	:	:	PUNCT
ajlm-991	4	3	©	©	PROPN
ajlm-991	4	4	2020	2020	NUM
ajlm-991	4	5	.	.	PUNCT
ajlm-991	5	1	the	the	DET
ajlm-991	5	2	author(s	author(s	PROPN
ajlm-991	5	3	)	)	PUNCT
ajlm-991	5	4	.	.	PUNCT
ajlm-991	6	1	licensee	licensee	NOUN
ajlm-991	6	2	:	:	PUNCT
ajlm-991	6	3	aosis	aosis	NOUN
ajlm-991	6	4	.	.	PUNCT
ajlm-991	7	1	this	this	PRON
ajlm-991	7	2	is	be	AUX
ajlm-991	7	3	an	an	DET
ajlm-991	7	4	open	open	ADJ
ajlm-991	7	5	access	access	NOUN
ajlm-991	7	6	article	article	NOUN
ajlm-991	7	7	distributed	distribute	VERB
ajlm-991	7	8	under	under	ADP
ajlm-991	7	9	the	the	DET
ajlm-991	7	10	terms	term	NOUN
ajlm-991	7	11	of	of	ADP
ajlm-991	7	12	the	the	DET
ajlm-991	7	13	creative	creative	ADJ
ajlm-991	7	14	commons	common	NOUN
ajlm-991	7	15	attribution	attribution	NOUN
ajlm-991	7	16	license	license	NOUN
ajlm-991	7	17	,	,	PUNCT
ajlm-991	7	18	which	which	PRON
ajlm-991	7	19	permits	permit	VERB
ajlm-991	7	20	unrestricted	unrestricted	ADJ
ajlm-991	7	21	use	use	NOUN
ajlm-991	7	22	,	,	PUNCT
ajlm-991	7	23	distribution	distribution	NOUN
ajlm-991	7	24	,	,	PUNCT
ajlm-991	7	25	and	and	CCONJ
ajlm-991	7	26	reproduction	reproduction	NOUN
ajlm-991	7	27	in	in	ADP
ajlm-991	7	28	any	any	DET
ajlm-991	7	29	medium	medium	NOUN
ajlm-991	7	30	,	,	PUNCT
ajlm-991	7	31	provided	provide	VERB
ajlm-991	7	32	the	the	DET
ajlm-991	7	33	original	original	ADJ
ajlm-991	7	34	work	work	NOUN
ajlm-991	7	35	is	be	AUX
ajlm-991	7	36	properly	properly	ADV
ajlm-991	7	37	cited	cite	VERB
ajlm-991	7	38	.	.	PUNCT
ajlm-991	8	1	abstract	abstract	ADJ
ajlm-991	8	2	background	background	NOUN
ajlm-991	8	3	:	:	PUNCT
ajlm-991	8	4	multi	multi	ADJ
ajlm-991	8	5	-	-	ADJ
ajlm-991	8	6	drug	drug	ADJ
ajlm-991	8	7	resistant	resistant	ADJ
ajlm-991	8	8	(	(	PUNCT
ajlm-991	8	9	mdr	mdr	NOUN
ajlm-991	8	10	)	)	PUNCT
ajlm-991	8	11	gram	gram	PROPN
ajlm-991	8	12	-	-	PUNCT
ajlm-991	8	13	negative	negative	ADJ
ajlm-991	8	14	bacteria	bacteria	NOUN
ajlm-991	8	15	are	be	AUX
ajlm-991	8	16	an	an	DET
ajlm-991	8	17	emerging	emerge	VERB
ajlm-991	8	18	threat	threat	NOUN
ajlm-991	8	19	,	,	PUNCT
ajlm-991	8	20	both	both	CCONJ
ajlm-991	8	21	in	in	ADP
ajlm-991	8	22	hospital	hospital	NOUN
ajlm-991	8	23	and	and	CCONJ
ajlm-991	8	24	community	community	NOUN
ajlm-991	8	25	settings	setting	NOUN
ajlm-991	8	26	.	.	PUNCT
ajlm-991	9	1	as	as	SCONJ
ajlm-991	9	2	very	very	ADV
ajlm-991	9	3	few	few	ADJ
ajlm-991	9	4	antibiotics	antibiotic	NOUN
ajlm-991	9	5	are	be	AUX
ajlm-991	9	6	effective	effective	ADJ
ajlm-991	9	7	against	against	ADP
ajlm-991	9	8	such	such	ADJ
ajlm-991	9	9	infections	infection	NOUN
ajlm-991	9	10	,	,	PUNCT
ajlm-991	9	11	the	the	DET
ajlm-991	9	12	need	need	NOUN
ajlm-991	9	13	of	of	ADP
ajlm-991	9	14	the	the	DET
ajlm-991	9	15	hour	hour	NOUN
ajlm-991	9	16	is	be	AUX
ajlm-991	9	17	a	a	DET
ajlm-991	9	18	new	new	ADJ
ajlm-991	9	19	antibiotic	antibiotic	ADJ
ajlm-991	9	20	or	or	CCONJ
ajlm-991	9	21	drug	drug	NOUN
ajlm-991	9	22	combination	combination	NOUN
ajlm-991	9	23	which	which	PRON
ajlm-991	9	24	can	can	AUX
ajlm-991	9	25	overcome	overcome	VERB
ajlm-991	9	26	the	the	DET
ajlm-991	9	27	effect	effect	NOUN
ajlm-991	9	28	of	of	ADP
ajlm-991	9	29	extended	extend	VERB
ajlm-991	9	30	-	-	PUNCT
ajlm-991	9	31	spectrum	spectrum	NOUN
ajlm-991	9	32	β	β	NOUN
ajlm-991	9	33	-	-	NOUN
ajlm-991	9	34	lactamases	lactamase	NOUN
ajlm-991	9	35	(	(	PUNCT
ajlm-991	9	36	esbl	esbl	NOUN
ajlm-991	9	37	)	)	PUNCT
ajlm-991	9	38	and	and	CCONJ
ajlm-991	9	39	metallo	metallo	ADJ
ajlm-991	9	40	β	β	NOUN
ajlm-991	9	41	-	-	NOUN
ajlm-991	9	42	lactamases	lactamases	PROPN
ajlm-991	9	43	(	(	PUNCT
ajlm-991	9	44	mbl	mbl	NOUN
ajlm-991	9	45	)	)	PUNCT
ajlm-991	9	46	.	.	PUNCT
ajlm-991	10	1	a	a	DET
ajlm-991	10	2	new	new	ADJ
ajlm-991	10	3	antibiotic	antibiotic	ADJ
ajlm-991	10	4	combination	combination	NOUN
ajlm-991	10	5	of	of	ADP
ajlm-991	10	6	ceftriaxone	ceftriaxone	NOUN
ajlm-991	10	7	,	,	PUNCT
ajlm-991	10	8	sulbactam	sulbactam	NOUN
ajlm-991	10	9	and	and	CCONJ
ajlm-991	10	10	disodium	disodium	NOUN
ajlm-991	10	11	edetate	edetate	NOUN
ajlm-991	10	12	(	(	PUNCT
ajlm-991	10	13	cse	cse	NOUN
ajlm-991	10	14	)	)	PUNCT
ajlm-991	10	15	has	have	AUX
ajlm-991	10	16	recently	recently	ADV
ajlm-991	10	17	been	be	AUX
ajlm-991	10	18	proposed	propose	VERB
ajlm-991	10	19	to	to	PART
ajlm-991	10	20	tackle	tackle	VERB
ajlm-991	10	21	the	the	DET
ajlm-991	10	22	mdr	mdr	PROPN
ajlm-991	10	23	organisms	organism	NOUN
ajlm-991	10	24	.	.	PUNCT
ajlm-991	11	1	objective	objective	NOUN
ajlm-991	11	2	:	:	PUNCT
ajlm-991	11	3	our	our	PRON
ajlm-991	11	4	study	study	NOUN
ajlm-991	11	5	was	be	AUX
ajlm-991	11	6	carried	carry	VERB
ajlm-991	11	7	out	out	ADP
ajlm-991	11	8	to	to	PART
ajlm-991	11	9	assess	assess	VERB
ajlm-991	11	10	the	the	DET
ajlm-991	11	11	susceptibility	susceptibility	NOUN
ajlm-991	11	12	of	of	ADP
ajlm-991	11	13	esbland	esbland	NOUN
ajlm-991	11	14	mbl	mbl	NOUN
ajlm-991	11	15	-	-	PUNCT
ajlm-991	11	16	producing	produce	VERB
ajlm-991	11	17	gram	gram	NOUN
ajlm-991	11	18	-	-	PUNCT
ajlm-991	11	19	negative	negative	ADJ
ajlm-991	11	20	organisms	organism	NOUN
ajlm-991	11	21	to	to	ADP
ajlm-991	11	22	cse	cse	PROPN
ajlm-991	11	23	.	.	PUNCT
ajlm-991	12	1	methods	method	NOUN
ajlm-991	12	2	:	:	PUNCT
ajlm-991	12	3	the	the	DET
ajlm-991	12	4	study	study	NOUN
ajlm-991	12	5	was	be	AUX
ajlm-991	12	6	conducted	conduct	VERB
ajlm-991	12	7	in	in	ADP
ajlm-991	12	8	a	a	DET
ajlm-991	12	9	tertiary	tertiary	ADJ
ajlm-991	12	10	-	-	PUNCT
ajlm-991	12	11	care	care	NOUN
ajlm-991	12	12	hospital	hospital	NOUN
ajlm-991	12	13	in	in	ADP
ajlm-991	12	14	delhi	delhi	PROPN
ajlm-991	12	15	,	,	PUNCT
ajlm-991	12	16	india	india	PROPN
ajlm-991	12	17	,	,	PUNCT
ajlm-991	12	18	from	from	ADP
ajlm-991	12	19	february	february	PROPN
ajlm-991	12	20	2017	2017	NUM
ajlm-991	12	21	to	to	ADP
ajlm-991	12	22	june	june	PROPN
ajlm-991	12	23	2017	2017	NUM
ajlm-991	12	24	.	.	PUNCT
ajlm-991	13	1	a	a	DET
ajlm-991	13	2	total	total	NOUN
ajlm-991	13	3	of	of	ADP
ajlm-991	13	4	179	179	NUM
ajlm-991	13	5	mdr	mdr	X
ajlm-991	13	6	(	(	PUNCT
ajlm-991	13	7	85	85	NUM
ajlm-991	13	8	esbl	esbl	NOUN
ajlm-991	13	9	+	+	CCONJ
ajlm-991	13	10	94	94	NUM
ajlm-991	13	11	mbl	mbl	NOUN
ajlm-991	13	12	)	)	PUNCT
ajlm-991	13	13	gram	gram	NOUN
ajlm-991	13	14	-	-	PUNCT
ajlm-991	13	15	negative	negative	ADJ
ajlm-991	13	16	isolates	isolate	NOUN
ajlm-991	13	17	from	from	ADP
ajlm-991	13	18	various	various	ADJ
ajlm-991	13	19	clinical	clinical	ADJ
ajlm-991	13	20	samples	sample	NOUN
ajlm-991	13	21	,	,	PUNCT
ajlm-991	13	22	identified	identify	VERB
ajlm-991	13	23	by	by	ADP
ajlm-991	13	24	an	an	DET
ajlm-991	13	25	automated	automate	VERB
ajlm-991	13	26	system	system	NOUN
ajlm-991	13	27	(	(	PUNCT
ajlm-991	13	28	vitek	vitek	NOUN
ajlm-991	13	29	2	2	NUM
ajlm-991	13	30	)	)	PUNCT
ajlm-991	13	31	were	be	AUX
ajlm-991	13	32	tested	test	VERB
ajlm-991	13	33	against	against	ADP
ajlm-991	13	34	cse	cse	NOUN
ajlm-991	13	35	using	use	VERB
ajlm-991	13	36	the	the	DET
ajlm-991	13	37	kirby	kirby	PROPN
ajlm-991	13	38	-	-	PUNCT
ajlm-991	13	39	bauer	bauer	PROPN
ajlm-991	13	40	disc	disc	NOUN
ajlm-991	13	41	diffusion	diffusion	NOUN
ajlm-991	13	42	method	method	NOUN
ajlm-991	13	43	.	.	PUNCT
ajlm-991	14	1	susceptibility	susceptibility	NOUN
ajlm-991	14	2	to	to	ADP
ajlm-991	14	3	cse	cse	PROPN
ajlm-991	14	4	was	be	AUX
ajlm-991	14	5	recorded	record	VERB
ajlm-991	14	6	based	base	VERB
ajlm-991	14	7	on	on	ADP
ajlm-991	14	8	interpretative	interpretative	ADJ
ajlm-991	14	9	zone	zone	NOUN
ajlm-991	14	10	sizes	size	NOUN
ajlm-991	14	11	of	of	ADP
ajlm-991	14	12	ceftriaxone	ceftriaxone	NOUN
ajlm-991	14	13	as	as	ADP
ajlm-991	14	14	per	per	ADP
ajlm-991	14	15	2017	2017	NUM
ajlm-991	14	16	clinical	clinical	ADJ
ajlm-991	14	17	and	and	CCONJ
ajlm-991	14	18	laboratory	laboratory	NOUN
ajlm-991	14	19	standards	standard	NOUN
ajlm-991	14	20	institute	institute	PROPN
ajlm-991	14	21	guidelines	guideline	NOUN
ajlm-991	14	22	.	.	PUNCT
ajlm-991	15	1	results	result	NOUN
ajlm-991	15	2	:	:	PUNCT
ajlm-991	15	3	the	the	DET
ajlm-991	15	4	most	most	ADV
ajlm-991	15	5	common	common	ADJ
ajlm-991	15	6	isolate	isolate	NOUN
ajlm-991	15	7	was	be	AUX
ajlm-991	15	8	escherichia	escherichia	NOUN
ajlm-991	15	9	coli	coli	NOUN
ajlm-991	15	10	(	(	PUNCT
ajlm-991	15	11	76/179	76/179	NUM
ajlm-991	15	12	;	;	PUNCT
ajlm-991	15	13	42.4	42.4	NUM
ajlm-991	15	14	%	%	NOUN
ajlm-991	15	15	)	)	PUNCT
ajlm-991	15	16	followed	follow	VERB
ajlm-991	15	17	by	by	ADP
ajlm-991	15	18	klebsiella	klebsiella	NOUN
ajlm-991	15	19	pneumoniae	pneumoniae	ADJ
ajlm-991	15	20	(	(	PUNCT
ajlm-991	15	21	53/179	53/179	NUM
ajlm-991	15	22	;	;	PUNCT
ajlm-991	15	23	29.6	29.6	NUM
ajlm-991	15	24	%	%	NOUN
ajlm-991	15	25	)	)	PUNCT
ajlm-991	15	26	and	and	CCONJ
ajlm-991	15	27	acinetobacter	acinetobacter	ADV
ajlm-991	15	28	baumanii	baumanii	NOUN
ajlm-991	15	29	(	(	PUNCT
ajlm-991	15	30	27/179	27/179	NUM
ajlm-991	15	31	;	;	PUNCT
ajlm-991	15	32	15.1	15.1	NUM
ajlm-991	15	33	%	%	NOUN
ajlm-991	15	34	)	)	PUNCT
ajlm-991	15	35	.	.	PUNCT
ajlm-991	16	1	the	the	DET
ajlm-991	16	2	in	in	ADV
ajlm-991	16	3	vitro	vitro	X
ajlm-991	16	4	susceptibility	susceptibility	NOUN
ajlm-991	16	5	of	of	ADP
ajlm-991	16	6	esbland	esbland	NOUN
ajlm-991	16	7	mbl	mbl	NOUN
ajlm-991	16	8	-	-	PUNCT
ajlm-991	16	9	producing	produce	VERB
ajlm-991	16	10	gram	gram	NOUN
ajlm-991	16	11	-	-	PUNCT
ajlm-991	16	12	negative	negative	ADJ
ajlm-991	16	13	isolates	isolate	NOUN
ajlm-991	16	14	to	to	ADP
ajlm-991	16	15	cse	cse	PROPN
ajlm-991	16	16	was	be	AUX
ajlm-991	16	17	found	find	VERB
ajlm-991	16	18	to	to	PART
ajlm-991	16	19	be	be	AUX
ajlm-991	16	20	58/85	58/85	NUM
ajlm-991	16	21	(	(	PUNCT
ajlm-991	16	22	68.2	68.2	NUM
ajlm-991	16	23	%	%	NOUN
ajlm-991	16	24	)	)	PUNCT
ajlm-991	16	25	for	for	ADP
ajlm-991	16	26	esbl	esbl	NOUN
ajlm-991	16	27	and	and	CCONJ
ajlm-991	16	28	37/94	37/94	NUM
ajlm-991	16	29	(	(	PUNCT
ajlm-991	16	30	39.4	39.4	NUM
ajlm-991	16	31	%	%	NOUN
ajlm-991	16	32	)	)	PUNCT
ajlm-991	16	33	for	for	ADP
ajlm-991	16	34	mbl	mbl	NOUN
ajlm-991	16	35	.	.	PUNCT
ajlm-991	17	1	conclusion	conclusion	NOUN
ajlm-991	17	2	:	:	PUNCT
ajlm-991	17	3	the	the	DET
ajlm-991	17	4	in	in	ADP
ajlm-991	17	5	vitro	vitro	X
ajlm-991	17	6	susceptibility	susceptibility	NOUN
ajlm-991	17	7	results	result	NOUN
ajlm-991	17	8	obtained	obtain	VERB
ajlm-991	17	9	for	for	ADP
ajlm-991	17	10	cse	cse	NOUN
ajlm-991	17	11	against	against	ADP
ajlm-991	17	12	esbl	esbl	NOUN
ajlm-991	17	13	-	-	PUNCT
ajlm-991	17	14	producing	produce	VERB
ajlm-991	17	15	organisms	organism	NOUN
ajlm-991	17	16	is	be	AUX
ajlm-991	17	17	promising	promise	VERB
ajlm-991	17	18	.	.	PUNCT
ajlm-991	18	1	it	it	PRON
ajlm-991	18	2	has	have	VERB
ajlm-991	18	3	the	the	DET
ajlm-991	18	4	potential	potential	NOUN
ajlm-991	18	5	to	to	PART
ajlm-991	18	6	emerge	emerge	VERB
ajlm-991	18	7	as	as	ADP
ajlm-991	18	8	a	a	DET
ajlm-991	18	9	carbapenem	carbapenem	NOUN
ajlm-991	18	10	-	-	PUNCT
ajlm-991	18	11	sparing	spare	VERB
ajlm-991	18	12	antibiotic	antibiotic	NOUN
ajlm-991	18	13	,	,	PUNCT
ajlm-991	18	14	active	active	ADJ
ajlm-991	18	15	against	against	ADP
ajlm-991	18	16	esbl	esbl	NOUN
ajlm-991	18	17	-	-	PUNCT
ajlm-991	18	18	producing	produce	VERB
ajlm-991	18	19	strains	strain	NOUN
ajlm-991	18	20	.	.	PUNCT
ajlm-991	19	1	further	further	ADJ
ajlm-991	19	2	clinical	clinical	ADJ
ajlm-991	19	3	studies	study	NOUN
ajlm-991	19	4	are	be	AUX
ajlm-991	19	5	required	require	VERB
ajlm-991	19	6	to	to	PART
ajlm-991	19	7	establish	establish	VERB
ajlm-991	19	8	the	the	DET
ajlm-991	19	9	clinical	clinical	ADJ
ajlm-991	19	10	efficacy	efficacy	NOUN
ajlm-991	19	11	of	of	ADP
ajlm-991	19	12	cse	cse	PROPN
ajlm-991	19	13	against	against	ADP
ajlm-991	19	14	mdr	mdr	PROPN
ajlm-991	19	15	pathogens	pathogen	NOUN
ajlm-991	19	16	.	.	PUNCT
ajlm-991	20	1	keywords	keyword	NOUN
ajlm-991	20	2	:	:	PUNCT
ajlm-991	20	3	ceftriaxone	ceftriaxone	NOUN
ajlm-991	20	4	sulbactam	sulbactam	NOUN
ajlm-991	20	5	,	,	PUNCT
ajlm-991	20	6	disodium	disodium	NOUN
ajlm-991	20	7	edetate	edetate	NOUN
ajlm-991	20	8	;	;	PUNCT
ajlm-991	20	9	multi	multi	ADJ
ajlm-991	20	10	-	-	ADJ
ajlm-991	20	11	drug	drug	ADJ
ajlm-991	20	12	resistance	resistance	NOUN
ajlm-991	20	13	;	;	PUNCT
ajlm-991	20	14	carbapenem	carbapenem	NOUN
ajlm-991	20	15	-	-	PUNCT
ajlm-991	20	16	sparing	sparing	NOUN
ajlm-991	20	17	.	.	PUNCT
ajlm-991	21	1	introduction	introduction	NOUN
ajlm-991	21	2	increased	increase	VERB
ajlm-991	21	3	antimicrobial	antimicrobial	ADJ
ajlm-991	21	4	resistance	resistance	NOUN
ajlm-991	21	5	of	of	ADP
ajlm-991	21	6	gram	gram	NOUN
ajlm-991	21	7	-	-	PUNCT
ajlm-991	21	8	negative	negative	ADJ
ajlm-991	21	9	bacteria	bacteria	NOUN
ajlm-991	21	10	(	(	PUNCT
ajlm-991	21	11	gnb	gnb	PROPN
ajlm-991	21	12	)	)	PUNCT
ajlm-991	21	13	,	,	PUNCT
ajlm-991	21	14	both	both	DET
ajlm-991	21	15	hospitaland	hospitaland	NOUN
ajlm-991	21	16	community	community	NOUN
ajlm-991	21	17	-	-	PUNCT
ajlm-991	21	18	acquired	acquire	VERB
ajlm-991	21	19	,	,	PUNCT
ajlm-991	21	20	is	be	AUX
ajlm-991	21	21	of	of	ADP
ajlm-991	21	22	great	great	ADJ
ajlm-991	21	23	concern	concern	NOUN
ajlm-991	21	24	worldwide.1	worldwide.1	ADP
ajlm-991	21	25	according	accord	VERB
ajlm-991	21	26	to	to	ADP
ajlm-991	21	27	the	the	DET
ajlm-991	21	28	report	report	NOUN
ajlm-991	21	29	of	of	ADP
ajlm-991	21	30	global	global	ADJ
ajlm-991	21	31	antibiotic	antibiotic	ADJ
ajlm-991	21	32	resistance	resistance	NOUN
ajlm-991	21	33	partnership	partnership	NOUN
ajlm-991	21	34	–	–	PUNCT
ajlm-991	21	35	india	india	PROPN
ajlm-991	21	36	working	working	PROPN
ajlm-991	21	37	group	group	NOUN
ajlm-991	21	38	,	,	PUNCT
ajlm-991	21	39	the	the	DET
ajlm-991	21	40	irrational	irrational	ADJ
ajlm-991	21	41	and	and	CCONJ
ajlm-991	21	42	increased	increase	VERB
ajlm-991	21	43	use	use	NOUN
ajlm-991	21	44	of	of	ADP
ajlm-991	21	45	antibiotics	antibiotic	NOUN
ajlm-991	21	46	,	,	PUNCT
ajlm-991	21	47	especially	especially	ADV
ajlm-991	21	48	cephalosporins	cephalosporin	NOUN
ajlm-991	21	49	,	,	PUNCT
ajlm-991	21	50	in	in	ADP
ajlm-991	21	51	india	india	PROPN
ajlm-991	21	52	has	have	AUX
ajlm-991	21	53	resulted	result	VERB
ajlm-991	21	54	in	in	ADP
ajlm-991	21	55	the	the	DET
ajlm-991	21	56	emergence	emergence	NOUN
ajlm-991	21	57	of	of	ADP
ajlm-991	21	58	multi	multi	ADJ
ajlm-991	21	59	-	-	ADJ
ajlm-991	21	60	drug	drug	ADJ
ajlm-991	21	61	resistant	resistant	ADJ
ajlm-991	21	62	(	(	PUNCT
ajlm-991	21	63	mdr	mdr	NOUN
ajlm-991	21	64	)	)	PUNCT
ajlm-991	21	65	bacteria	bacteria	NOUN
ajlm-991	21	66	which	which	PRON
ajlm-991	21	67	were	be	AUX
ajlm-991	21	68	earlier	early	ADV
ajlm-991	21	69	known	know	VERB
ajlm-991	21	70	to	to	PART
ajlm-991	21	71	be	be	AUX
ajlm-991	21	72	susceptible.2	susceptible.2	PROPN
ajlm-991	21	73	the	the	DET
ajlm-991	21	74	menace	menace	NOUN
ajlm-991	21	75	of	of	ADP
ajlm-991	21	76	the	the	DET
ajlm-991	21	77	emerging	emerge	VERB
ajlm-991	21	78	threat	threat	NOUN
ajlm-991	21	79	has	have	AUX
ajlm-991	21	80	been	be	AUX
ajlm-991	21	81	realised	realise	VERB
ajlm-991	21	82	by	by	ADP
ajlm-991	21	83	the	the	DET
ajlm-991	21	84	indian	indian	ADJ
ajlm-991	21	85	government	government	NOUN
ajlm-991	21	86	,	,	PUNCT
ajlm-991	21	87	hence	hence	ADV
ajlm-991	21	88	it	it	PRON
ajlm-991	21	89	has	have	AUX
ajlm-991	21	90	called	call	VERB
ajlm-991	21	91	for	for	ADP
ajlm-991	21	92	effective	effective	ADJ
ajlm-991	21	93	action	action	NOUN
ajlm-991	21	94	to	to	PART
ajlm-991	21	95	address	address	VERB
ajlm-991	21	96	the	the	DET
ajlm-991	21	97	increasing	increase	VERB
ajlm-991	21	98	antimicrobial	antimicrobial	ADJ
ajlm-991	21	99	resistance	resistance	NOUN
ajlm-991	21	100	.	.	PUNCT
ajlm-991	22	1	the	the	DET
ajlm-991	22	2	indian	indian	PROPN
ajlm-991	22	3	ministry	ministry	PROPN
ajlm-991	22	4	of	of	ADP
ajlm-991	22	5	health	health	PROPN
ajlm-991	22	6	and	and	CCONJ
ajlm-991	22	7	family	family	NOUN
ajlm-991	22	8	welfare	welfare	NOUN
ajlm-991	22	9	,	,	PUNCT
ajlm-991	22	10	in	in	ADP
ajlm-991	22	11	collaboration	collaboration	NOUN
ajlm-991	22	12	with	with	ADP
ajlm-991	22	13	the	the	DET
ajlm-991	22	14	world	world	PROPN
ajlm-991	22	15	health	health	PROPN
ajlm-991	22	16	organization	organization	NOUN
ajlm-991	22	17	,	,	PUNCT
ajlm-991	22	18	formulated	formulate	VERB
ajlm-991	22	19	the	the	DET
ajlm-991	22	20	national	national	ADJ
ajlm-991	22	21	health	health	PROPN
ajlm-991	22	22	policy	policy	NOUN
ajlm-991	22	23	2017	2017	NUM
ajlm-991	22	24	,	,	PUNCT
ajlm-991	22	25	which	which	PRON
ajlm-991	22	26	calls	call	VERB
ajlm-991	22	27	for	for	ADP
ajlm-991	22	28	an	an	DET
ajlm-991	22	29	urgent	urgent	ADJ
ajlm-991	22	30	need	need	NOUN
ajlm-991	22	31	for	for	ADP
ajlm-991	22	32	standardisation	standardisation	NOUN
ajlm-991	22	33	of	of	ADP
ajlm-991	22	34	antibiotic	antibiotic	ADJ
ajlm-991	22	35	usage	usage	NOUN
ajlm-991	22	36	guidelines	guideline	NOUN
ajlm-991	22	37	to	to	PART
ajlm-991	22	38	minimise	minimise	VERB
ajlm-991	22	39	the	the	DET
ajlm-991	22	40	emergence	emergence	NOUN
ajlm-991	22	41	of	of	ADP
ajlm-991	22	42	antimicrobial	antimicrobial	ADJ
ajlm-991	22	43	resistance	resistance	NOUN
ajlm-991	22	44	.	.	PUNCT
ajlm-991	23	1	thus	thus	ADV
ajlm-991	23	2	,	,	PUNCT
ajlm-991	23	3	both	both	DET
ajlm-991	23	4	organisations	organisation	NOUN
ajlm-991	23	5	decided	decide	VERB
ajlm-991	23	6	to	to	PART
ajlm-991	23	7	tackle	tackle	VERB
ajlm-991	23	8	the	the	DET
ajlm-991	23	9	issue	issue	NOUN
ajlm-991	23	10	as	as	ADP
ajlm-991	23	11	a	a	DET
ajlm-991	23	12	priority	priority	NOUN
ajlm-991	23	13	collaborative	collaborative	ADJ
ajlm-991	23	14	work	work	NOUN
ajlm-991	23	15	in	in	ADP
ajlm-991	23	16	2018–2019.3	2018–2019.3	NUM
ajlm-991	23	17	despite	despite	SCONJ
ajlm-991	23	18	increasing	increase	VERB
ajlm-991	23	19	antibiotic	antibiotic	ADJ
ajlm-991	23	20	resistance	resistance	NOUN
ajlm-991	23	21	,	,	PUNCT
ajlm-991	23	22	the	the	DET
ajlm-991	23	23	common	common	ADJ
ajlm-991	23	24	therapy	therapy	NOUN
ajlm-991	23	25	for	for	ADP
ajlm-991	23	26	treatment	treatment	NOUN
ajlm-991	23	27	of	of	ADP
ajlm-991	23	28	gnb	gnb	PROPN
ajlm-991	23	29	infections	infection	NOUN
ajlm-991	23	30	includes	include	VERB
ajlm-991	23	31	use	use	NOUN
ajlm-991	23	32	of	of	ADP
ajlm-991	23	33	β	β	NOUN
ajlm-991	23	34	-	-	NOUN
ajlm-991	23	35	lactams	lactam	NOUN
ajlm-991	23	36	with	with	ADP
ajlm-991	23	37	β	β	NOUN
ajlm-991	23	38	-	-	ADJ
ajlm-991	23	39	lactamase	lactamase	ADJ
ajlm-991	23	40	inhibitors	inhibitor	NOUN
ajlm-991	23	41	,	,	PUNCT
ajlm-991	23	42	third	third	ADJ
ajlm-991	23	43	and	and	CCONJ
ajlm-991	23	44	fourth	fourth	ADJ
ajlm-991	23	45	generation	generation	NOUN
ajlm-991	23	46	cephalosporins	cephalosporin	NOUN
ajlm-991	23	47	and	and	CCONJ
ajlm-991	23	48	carbapenems.4	carbapenems.4	PROPN
ajlm-991	23	49	production	production	NOUN
ajlm-991	23	50	of	of	ADP
ajlm-991	23	51	β	β	NOUN
ajlm-991	23	52	-	-	PUNCT
ajlm-991	23	53	lactamase	lactamase	ADJ
ajlm-991	23	54	enzymes	enzyme	NOUN
ajlm-991	23	55	is	be	AUX
ajlm-991	23	56	the	the	DET
ajlm-991	23	57	most	most	ADV
ajlm-991	23	58	widespread	widespread	ADJ
ajlm-991	23	59	mechanism	mechanism	NOUN
ajlm-991	23	60	of	of	ADP
ajlm-991	23	61	resistance	resistance	NOUN
ajlm-991	23	62	adopted	adopt	VERB
ajlm-991	23	63	by	by	ADP
ajlm-991	23	64	gnb	gnb	PROPN
ajlm-991	23	65	to	to	PART
ajlm-991	23	66	counteract	counteract	VERB
ajlm-991	23	67	the	the	DET
ajlm-991	23	68	effect	effect	NOUN
ajlm-991	23	69	of	of	ADP
ajlm-991	23	70	β	β	NOUN
ajlm-991	23	71	-	-	NOUN
ajlm-991	23	72	lactam	lactam	NOUN
ajlm-991	23	73	antibiotics.5,6	antibiotics.5,6	NOUN
ajlm-991	23	74	extended	extend	VERB
ajlm-991	23	75	-	-	PUNCT
ajlm-991	23	76	spectrum	spectrum	NOUN
ajlm-991	23	77	β	β	NOUN
ajlm-991	23	78	-	-	NOUN
ajlm-991	23	79	lactamases	lactamase	NOUN
ajlm-991	23	80	(	(	PUNCT
ajlm-991	23	81	esbls	esbls	PROPN
ajlm-991	23	82	)	)	PUNCT
ajlm-991	23	83	are	be	AUX
ajlm-991	23	84	usually	usually	ADV
ajlm-991	23	85	plasmid	plasmid	NOUN
ajlm-991	23	86	-	-	PUNCT
ajlm-991	23	87	mediated	mediate	VERB
ajlm-991	23	88	β	β	NOUN
ajlm-991	23	89	-	-	NOUN
ajlm-991	23	90	lactamases	lactamase	NOUN
ajlm-991	23	91	and	and	CCONJ
ajlm-991	23	92	hydrolyse	hydrolyse	NOUN
ajlm-991	23	93	oxyimino	oxyimino	PROPN
ajlm-991	23	94	group	group	NOUN
ajlm-991	23	95	-	-	PUNCT
ajlm-991	23	96	containing	contain	VERB
ajlm-991	23	97	β	β	NOUN
ajlm-991	23	98	-	-	NOUN
ajlm-991	23	99	lactam	lactam	NOUN
ajlm-991	23	100	antibiotics.7	antibiotics.7	NOUN
ajlm-991	23	101	metallo	metallo	ADJ
ajlm-991	23	102	β	β	NOUN
ajlm-991	23	103	-	-	NOUN
ajlm-991	23	104	lactamases	lactamase	NOUN
ajlm-991	23	105	(	(	PUNCT
ajlm-991	23	106	mbls	mbls	NOUN
ajlm-991	23	107	)	)	PUNCT
ajlm-991	23	108	are	be	AUX
ajlm-991	23	109	a	a	DET
ajlm-991	23	110	class	class	NOUN
ajlm-991	23	111	of	of	ADP
ajlm-991	23	112	broad	broad	ADJ
ajlm-991	23	113	-	-	PUNCT
ajlm-991	23	114	substrate	substrate	NOUN
ajlm-991	23	115	spectrum	spectrum	NOUN
ajlm-991	23	116	enzymes	enzyme	NOUN
ajlm-991	23	117	that	that	PRON
ajlm-991	23	118	also	also	ADV
ajlm-991	23	119	hydrolyse	hydrolyse	VERB
ajlm-991	23	120	most	most	ADJ
ajlm-991	23	121	β	β	NOUN
ajlm-991	23	122	-	-	ADJ
ajlm-991	23	123	lactam	lactam	NOUN
ajlm-991	23	124	antibiotics	antibiotic	NOUN
ajlm-991	23	125	,	,	PUNCT
ajlm-991	23	126	except	except	SCONJ
ajlm-991	23	127	monobactams.8	monobactams.8	PROPN
ajlm-991	23	128	other	other	ADJ
ajlm-991	23	129	mechanisms	mechanism	NOUN
ajlm-991	23	130	that	that	PRON
ajlm-991	23	131	contribute	contribute	VERB
ajlm-991	23	132	to	to	ADP
ajlm-991	23	133	resistance	resistance	NOUN
ajlm-991	23	134	are	be	AUX
ajlm-991	23	135	drug	drug	NOUN
ajlm-991	23	136	efflux	efflux	NOUN
ajlm-991	23	137	systems	system	NOUN
ajlm-991	23	138	,	,	PUNCT
ajlm-991	23	139	outer	outer	ADJ
ajlm-991	23	140	membrane	membrane	NOUN
ajlm-991	23	141	protein	protein	NOUN
ajlm-991	23	142	changes	change	NOUN
ajlm-991	23	143	,	,	PUNCT
ajlm-991	23	144	antibiotic	antibiotic	NOUN
ajlm-991	23	145	-	-	PUNCT
ajlm-991	23	146	modifying	modify	VERB
ajlm-991	23	147	enzymes	enzyme	NOUN
ajlm-991	23	148	and	and	CCONJ
ajlm-991	23	149	antibiotic	antibiotic	ADJ
ajlm-991	23	150	-	-	PUNCT
ajlm-991	23	151	target	target	NOUN
ajlm-991	23	152	modification.9	modification.9	NOUN
ajlm-991	23	153	carbapenems	carbapenem	NOUN
ajlm-991	23	154	are	be	AUX
ajlm-991	23	155	used	use	VERB
ajlm-991	23	156	against	against	ADP
ajlm-991	23	157	the	the	DET
ajlm-991	23	158	esbl	esbl	NOUN
ajlm-991	23	159	-	-	PUNCT
ajlm-991	23	160	producing	produce	VERB
ajlm-991	23	161	organisms	organism	NOUN
ajlm-991	23	162	because	because	SCONJ
ajlm-991	23	163	of	of	ADP
ajlm-991	23	164	their	their	PRON
ajlm-991	23	165	stability	stability	NOUN
ajlm-991	23	166	against	against	ADP
ajlm-991	23	167	hydrolysis	hydrolysis	NOUN
ajlm-991	23	168	by	by	ADP
ajlm-991	23	169	esbls	esbls	NOUN
ajlm-991	23	170	and	and	CCONJ
ajlm-991	23	171	broad	broad	ADJ
ajlm-991	23	172	-	-	PUNCT
ajlm-991	23	173	spectrum	spectrum	NOUN
ajlm-991	23	174	activity.10	activity.10	NOUN
ajlm-991	23	175	however	however	ADV
ajlm-991	23	176	,	,	PUNCT
ajlm-991	23	177	with	with	ADP
ajlm-991	23	178	the	the	DET
ajlm-991	23	179	emergence	emergence	NOUN
ajlm-991	23	180	of	of	ADP
ajlm-991	23	181	carbapenem	carbapenem	NOUN
ajlm-991	23	182	-	-	PUNCT
ajlm-991	23	183	hydrolysing	hydrolyse	VERB
ajlm-991	23	184	enzymes	enzyme	NOUN
ajlm-991	23	185	,	,	PUNCT
ajlm-991	23	186	overexpression	overexpression	NOUN
ajlm-991	23	187	of	of	ADP
ajlm-991	23	188	efflux	efflux	NOUN
ajlm-991	23	189	pumps	pump	NOUN
ajlm-991	23	190	and	and	CCONJ
ajlm-991	23	191	changes	change	NOUN
ajlm-991	23	192	in	in	ADP
ajlm-991	23	193	outer	outer	ADJ
ajlm-991	23	194	membrane	membrane	NOUN
ajlm-991	23	195	proteins	protein	NOUN
ajlm-991	23	196	,	,	PUNCT
ajlm-991	23	197	increases	increase	NOUN
ajlm-991	23	198	in	in	ADP
ajlm-991	23	199	carbapenem	carbapenem	PROPN
ajlm-991	23	200	resistance	resistance	NOUN
ajlm-991	23	201	have	have	AUX
ajlm-991	23	202	been	be	AUX
ajlm-991	23	203	reported	report	VERB
ajlm-991	23	204	among	among	ADP
ajlm-991	23	205	the	the	DET
ajlm-991	23	206	members	member	NOUN
ajlm-991	23	207	of	of	ADP
ajlm-991	23	208	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-991	23	209	and	and	CCONJ
ajlm-991	23	210	non	non	ADJ
ajlm-991	23	211	-	-	ADJ
ajlm-991	23	212	fermenter	fermenter	ADJ
ajlm-991	23	213	gnb	gnb	PROPN
ajlm-991	23	214	,	,	PUNCT
ajlm-991	23	215	such	such	ADJ
ajlm-991	23	216	as	as	ADP
ajlm-991	23	217	the	the	DET
ajlm-991	23	218	acinetobacter	acinetobacter	ADJ
ajlm-991	23	219	and	and	CCONJ
ajlm-991	23	220	pseudomonas	pseudomona	NOUN
ajlm-991	23	221	group	group	NOUN
ajlm-991	23	222	of	of	ADP
ajlm-991	23	223	pathogens.11,12	pathogens.11,12	NOUN
ajlm-991	23	224	in	in	ADP
ajlm-991	23	225	india	india	PROPN
ajlm-991	23	226	,	,	PUNCT
ajlm-991	23	227	the	the	DET
ajlm-991	23	228	prevalence	prevalence	NOUN
ajlm-991	23	229	of	of	ADP
ajlm-991	23	230	esbl	esbl	PROPN
ajlm-991	23	231	and	and	CCONJ
ajlm-991	23	232	mbl	mbl	NOUN
ajlm-991	23	233	producers	producer	NOUN
ajlm-991	23	234	among	among	ADP
ajlm-991	23	235	gram	gram	NOUN
ajlm-991	23	236	-	-	PUNCT
ajlm-991	23	237	negative	negative	ADJ
ajlm-991	23	238	organisms	organism	NOUN
ajlm-991	23	239	range	range	VERB
ajlm-991	23	240	between	between	ADP
ajlm-991	23	241	28	28	NUM
ajlm-991	23	242	%	%	NOUN
ajlm-991	23	243	–	–	PUNCT
ajlm-991	23	244	84	84	NUM
ajlm-991	23	245	%	%	NOUN
ajlm-991	23	246	and	and	CCONJ
ajlm-991	23	247	7.5	7.5	NUM
ajlm-991	23	248	%	%	NOUN
ajlm-991	23	249	–	–	PUNCT
ajlm-991	23	250	71	71	NUM
ajlm-991	23	251	%	%	NOUN
ajlm-991	23	252	,	,	PUNCT
ajlm-991	23	253	respectively.13,14	respectively.13,14	NOUN
ajlm-991	23	254	the	the	DET
ajlm-991	23	255	increasing	increase	VERB
ajlm-991	23	256	resistance	resistance	NOUN
ajlm-991	23	257	towards	towards	ADP
ajlm-991	23	258	available	available	ADJ
ajlm-991	23	259	antibiotics	antibiotic	NOUN
ajlm-991	23	260	,	,	PUNCT
ajlm-991	23	261	as	as	ADV
ajlm-991	23	262	well	well	ADV
ajlm-991	23	263	as	as	ADP
ajlm-991	23	264	the	the	DET
ajlm-991	23	265	lack	lack	NOUN
ajlm-991	23	266	of	of	ADP
ajlm-991	23	267	development	development	NOUN
ajlm-991	23	268	of	of	ADP
ajlm-991	23	269	new	new	ADJ
ajlm-991	23	270	antibiotics	antibiotic	NOUN
ajlm-991	23	271	against	against	ADP
ajlm-991	23	272	gnb	gnb	PROPN
ajlm-991	23	273	,	,	PUNCT
ajlm-991	23	274	could	could	AUX
ajlm-991	23	275	soon	soon	ADV
ajlm-991	23	276	lead	lead	VERB
ajlm-991	23	277	to	to	ADP
ajlm-991	23	278	the	the	DET
ajlm-991	23	279	world	world	NOUN
ajlm-991	23	280	experiencing	experience	VERB
ajlm-991	23	281	the	the	DET
ajlm-991	23	282	tough	tough	ADJ
ajlm-991	23	283	situations	situation	NOUN
ajlm-991	23	284	of	of	ADP
ajlm-991	23	285	the	the	DET
ajlm-991	23	286	pre	pre	ADJ
ajlm-991	23	287	-	-	ADJ
ajlm-991	23	288	antibiotic	antibiotic	ADJ
ajlm-991	23	289	era	era	NOUN
ajlm-991	23	290	with	with	ADP
ajlm-991	23	291	an	an	DET
ajlm-991	23	292	increase	increase	NOUN
ajlm-991	23	293	in	in	ADP
ajlm-991	23	294	cases	case	NOUN
ajlm-991	23	295	with	with	ADP
ajlm-991	23	296	untreatable	untreatable	ADJ
ajlm-991	23	297	infections	infection	NOUN
ajlm-991	23	298	.	.	PUNCT
ajlm-991	24	1	a	a	DET
ajlm-991	24	2	newer	new	ADJ
ajlm-991	24	3	approach	approach	NOUN
ajlm-991	24	4	to	to	ADP
ajlm-991	24	5	improving	improve	VERB
ajlm-991	24	6	the	the	DET
ajlm-991	24	7	efficiency	efficiency	NOUN
ajlm-991	24	8	of	of	ADP
ajlm-991	24	9	the	the	DET
ajlm-991	24	10	existing	exist	VERB
ajlm-991	24	11	antimicrobials	antimicrobial	NOUN
ajlm-991	24	12	is	be	AUX
ajlm-991	24	13	the	the	DET
ajlm-991	24	14	use	use	NOUN
ajlm-991	24	15	of	of	ADP
ajlm-991	24	16	antibiotic	antibiotic	ADJ
ajlm-991	24	17	adjuvants	adjuvant	NOUN
ajlm-991	24	18	.	.	PUNCT
ajlm-991	25	1	a	a	DET
ajlm-991	25	2	novel	novel	ADJ
ajlm-991	25	3	antibiotic	antibiotic	ADJ
ajlm-991	25	4	adjuvant	adjuvant	ADJ
ajlm-991	25	5	entity	entity	NOUN
ajlm-991	25	6	of	of	ADP
ajlm-991	25	7	ceftriaxone	ceftriaxone	PROPN
ajlm-991	25	8	,	,	PUNCT
ajlm-991	25	9	sulbactam	sulbactam	NOUN
ajlm-991	25	10	with	with	ADP
ajlm-991	25	11	adjuvant	adjuvant	ADJ
ajlm-991	25	12	disodium	disodium	NOUN
ajlm-991	25	13	edetate	edetate	NOUN
ajlm-991	25	14	(	(	PUNCT
ajlm-991	25	15	cse	cse	NOUN
ajlm-991	25	16	)	)	PUNCT
ajlm-991	25	17	is	be	AUX
ajlm-991	25	18	being	be	AUX
ajlm-991	25	19	used	use	VERB
ajlm-991	25	20	in	in	ADP
ajlm-991	25	21	indian	indian	ADJ
ajlm-991	25	22	hospitals	hospital	NOUN
ajlm-991	25	23	against	against	ADP
ajlm-991	25	24	mdr	mdr	PROPN
ajlm-991	25	25	infections.15,16	infections.15,16	NOUN
ajlm-991	25	26	the	the	DET
ajlm-991	25	27	antibiotic	antibiotic	ADJ
ajlm-991	25	28	adjuvant	adjuvant	ADJ
ajlm-991	25	29	entity	entity	NOUN
ajlm-991	25	30	is	be	AUX
ajlm-991	25	31	a	a	DET
ajlm-991	25	32	combination	combination	NOUN
ajlm-991	25	33	of	of	ADP
ajlm-991	25	34	ceftriaxone	ceftriaxone	NOUN
ajlm-991	25	35	plus	plus	CCONJ
ajlm-991	25	36	sulbactam	sulbactam	NOUN
ajlm-991	25	37	with	with	ADP
ajlm-991	25	38	disodium	disodium	NOUN
ajlm-991	25	39	edetate	edetate	NOUN
ajlm-991	25	40	and	and	CCONJ
ajlm-991	25	41	has	have	AUX
ajlm-991	25	42	undergone	undergo	VERB
ajlm-991	25	43	phase	phase	NOUN
ajlm-991	25	44	iii	iii	NUM
ajlm-991	25	45	clinical	clinical	ADJ
ajlm-991	25	46	trials	trial	NOUN
ajlm-991	25	47	under	under	ADP
ajlm-991	25	48	the	the	DET
ajlm-991	25	49	aegis	aegis	NOUN
ajlm-991	25	50	of	of	ADP
ajlm-991	25	51	the	the	DET
ajlm-991	25	52	central	central	ADJ
ajlm-991	25	53	drugs	drug	NOUN
ajlm-991	25	54	standard	standard	PROPN
ajlm-991	25	55	control	control	PROPN
ajlm-991	25	56	organisation	organisation	NOUN
ajlm-991	25	57	,	,	PUNCT
ajlm-991	25	58	india.17	india.17	NOUN
ajlm-991	25	59	this	this	DET
ajlm-991	25	60	study	study	NOUN
ajlm-991	25	61	aimed	aim	VERB
ajlm-991	25	62	to	to	PART
ajlm-991	25	63	study	study	VERB
ajlm-991	25	64	the	the	DET
ajlm-991	25	65	in	in	ADV
ajlm-991	25	66	vitro	vitro	X
ajlm-991	25	67	susceptibility	susceptibility	NOUN
ajlm-991	25	68	to	to	ADP
ajlm-991	25	69	cse	cse	PROPN
ajlm-991	25	70	of	of	ADP
ajlm-991	25	71	mdr	mdr	PROPN
ajlm-991	25	72	gram	gram	PROPN
ajlm-991	25	73	-	-	PUNCT
ajlm-991	25	74	negative	negative	ADJ
ajlm-991	25	75	organisms	organism	NOUN
ajlm-991	25	76	isolated	isolate	VERB
ajlm-991	25	77	in	in	ADP
ajlm-991	25	78	our	our	PRON
ajlm-991	25	79	centre	centre	NOUN
ajlm-991	25	80	.	.	PUNCT
ajlm-991	26	1	thus	thus	ADV
ajlm-991	26	2	,	,	PUNCT
ajlm-991	26	3	the	the	DET
ajlm-991	26	4	present	present	ADJ
ajlm-991	26	5	study	study	NOUN
ajlm-991	26	6	aimed	aim	VERB
ajlm-991	26	7	to	to	PART
ajlm-991	26	8	study	study	VERB
ajlm-991	26	9	the	the	DET
ajlm-991	26	10	in	in	ADV
ajlm-991	26	11	vitro	vitro	X
ajlm-991	26	12	susceptibility	susceptibility	NOUN
ajlm-991	26	13	of	of	ADP
ajlm-991	26	14	esbland	esbland	NOUN
ajlm-991	26	15	mbl	mbl	NOUN
ajlm-991	26	16	-	-	PUNCT
ajlm-991	26	17	producing	produce	VERB
ajlm-991	26	18	gnb	gnb	NOUN
ajlm-991	26	19	to	to	ADP
ajlm-991	26	20	cse	cse	PROPN
ajlm-991	26	21	and	and	CCONJ
ajlm-991	26	22	to	to	PART
ajlm-991	26	23	explore	explore	VERB
ajlm-991	26	24	whether	whether	SCONJ
ajlm-991	26	25	it	it	PRON
ajlm-991	26	26	could	could	AUX
ajlm-991	26	27	be	be	AUX
ajlm-991	26	28	utilised	utilise	VERB
ajlm-991	26	29	as	as	ADP
ajlm-991	26	30	a	a	DET
ajlm-991	26	31	carbapenem	carbapenem	NOUN
ajlm-991	26	32	-	-	PUNCT
ajlm-991	26	33	sparing	spare	VERB
ajlm-991	26	34	drug	drug	NOUN
ajlm-991	26	35	.	.	PUNCT
ajlm-991	27	1	methods	method	NOUN
ajlm-991	27	2	ethical	ethical	ADJ
ajlm-991	27	3	considerations	consideration	NOUN
ajlm-991	27	4	ethical	ethical	ADJ
ajlm-991	27	5	clearance	clearance	NOUN
ajlm-991	27	6	was	be	AUX
ajlm-991	27	7	obtained	obtain	VERB
ajlm-991	27	8	from	from	ADP
ajlm-991	27	9	the	the	DET
ajlm-991	27	10	institutional	institutional	ADJ
ajlm-991	27	11	ethics	ethic	NOUN
ajlm-991	27	12	committee	committee	PROPN
ajlm-991	27	13	,	,	PUNCT
ajlm-991	27	14	army	army	NOUN
ajlm-991	27	15	hospital	hospital	NOUN
ajlm-991	27	16	(	(	PUNCT
ajlm-991	27	17	research	research	NOUN
ajlm-991	27	18	and	and	CCONJ
ajlm-991	27	19	referral	referral	NOUN
ajlm-991	27	20	)	)	PUNCT
ajlm-991	27	21	,	,	PUNCT
ajlm-991	27	22	new	new	PROPN
ajlm-991	27	23	delhi	delhi	PROPN
ajlm-991	27	24	,	,	PUNCT
ajlm-991	27	25	india	india	PROPN
ajlm-991	27	26	(	(	PUNCT
ajlm-991	27	27	92/2016	92/2016	NUM
ajlm-991	27	28	)	)	PUNCT
ajlm-991	27	29	.	.	PUNCT
ajlm-991	28	1	study	study	NOUN
ajlm-991	28	2	design	design	NOUN
ajlm-991	28	3	and	and	CCONJ
ajlm-991	28	4	setting	set	VERB
ajlm-991	28	5	this	this	DET
ajlm-991	28	6	cross	cross	ADJ
ajlm-991	28	7	-	-	ADJ
ajlm-991	28	8	sectional	sectional	ADJ
ajlm-991	28	9	study	study	NOUN
ajlm-991	28	10	was	be	AUX
ajlm-991	28	11	conducted	conduct	VERB
ajlm-991	28	12	in	in	ADP
ajlm-991	28	13	the	the	DET
ajlm-991	28	14	department	department	NOUN
ajlm-991	28	15	of	of	ADP
ajlm-991	28	16	microbiology	microbiology	NOUN
ajlm-991	28	17	of	of	ADP
ajlm-991	28	18	a	a	DET
ajlm-991	28	19	900	900	NUM
ajlm-991	28	20	-	-	PUNCT
ajlm-991	28	21	bed	bed	NOUN
ajlm-991	28	22	,	,	PUNCT
ajlm-991	28	23	tertiary	tertiary	ADJ
ajlm-991	28	24	-	-	PUNCT
ajlm-991	28	25	care	care	NOUN
ajlm-991	28	26	,	,	PUNCT
ajlm-991	28	27	super	super	ADJ
ajlm-991	28	28	-	-	ADJ
ajlm-991	28	29	speciality	speciality	ADJ
ajlm-991	28	30	army	army	NOUN
ajlm-991	28	31	hospital	hospital	NOUN
ajlm-991	28	32	(	(	PUNCT
ajlm-991	28	33	research	research	NOUN
ajlm-991	28	34	and	and	CCONJ
ajlm-991	28	35	referral	referral	NOUN
ajlm-991	28	36	)	)	PUNCT
ajlm-991	28	37	,	,	PUNCT
ajlm-991	28	38	new	new	PROPN
ajlm-991	28	39	delhi	delhi	PROPN
ajlm-991	28	40	,	,	PUNCT
ajlm-991	28	41	india	india	PROPN
ajlm-991	28	42	from	from	ADP
ajlm-991	28	43	february	february	PROPN
ajlm-991	28	44	2017	2017	NUM
ajlm-991	28	45	to	to	ADP
ajlm-991	28	46	june	june	PROPN
ajlm-991	28	47	2017	2017	NUM
ajlm-991	28	48	.	.	PUNCT
ajlm-991	29	1	isolates	isolate	NOUN
ajlm-991	29	2	were	be	AUX
ajlm-991	29	3	obtained	obtain	VERB
ajlm-991	29	4	from	from	ADP
ajlm-991	29	5	various	various	ADJ
ajlm-991	29	6	clinical	clinical	ADJ
ajlm-991	29	7	samples	sample	NOUN
ajlm-991	29	8	from	from	ADP
ajlm-991	29	9	both	both	DET
ajlm-991	29	10	outand	outand	NOUN
ajlm-991	29	11	inpatients	inpatient	NOUN
ajlm-991	29	12	received	receive	VERB
ajlm-991	29	13	in	in	ADP
ajlm-991	29	14	the	the	DET
ajlm-991	29	15	laboratory	laboratory	NOUN
ajlm-991	29	16	for	for	ADP
ajlm-991	29	17	bacterial	bacterial	ADJ
ajlm-991	29	18	culture	culture	NOUN
ajlm-991	29	19	from	from	ADP
ajlm-991	29	20	different	different	ADJ
ajlm-991	29	21	clinical	clinical	ADJ
ajlm-991	29	22	departments	department	NOUN
ajlm-991	29	23	.	.	PUNCT
ajlm-991	30	1	sample	sample	NOUN
ajlm-991	30	2	types	type	NOUN
ajlm-991	30	3	included	include	VERB
ajlm-991	30	4	:	:	PUNCT
ajlm-991	30	5	urine	urine	NOUN
ajlm-991	30	6	,	,	PUNCT
ajlm-991	30	7	pus	pus	NOUN
ajlm-991	30	8	,	,	PUNCT
ajlm-991	30	9	cerebrospinal	cerebrospinal	ADJ
ajlm-991	30	10	fluid	fluid	NOUN
ajlm-991	30	11	,	,	PUNCT
ajlm-991	30	12	sputum	sputum	NOUN
ajlm-991	30	13	,	,	PUNCT
ajlm-991	30	14	tissue	tissue	NOUN
ajlm-991	30	15	from	from	ADP
ajlm-991	30	16	burn	burn	NOUN
ajlm-991	30	17	wound	wound	NOUN
ajlm-991	30	18	sites	site	NOUN
ajlm-991	30	19	,	,	PUNCT
ajlm-991	30	20	endotracheal	endotracheal	NOUN
ajlm-991	30	21	aspirate	aspirate	NOUN
ajlm-991	30	22	,	,	PUNCT
ajlm-991	30	23	semen	semen	NOUN
ajlm-991	30	24	,	,	PUNCT
ajlm-991	30	25	high	high	ADJ
ajlm-991	30	26	vaginal	vaginal	ADJ
ajlm-991	30	27	swab	swab	NOUN
ajlm-991	30	28	and	and	CCONJ
ajlm-991	30	29	drains	drain	VERB
ajlm-991	30	30	fluid	fluid	NOUN
ajlm-991	30	31	.	.	PUNCT
ajlm-991	31	1	microbiological	microbiological	ADJ
ajlm-991	31	2	processing	processing	NOUN
ajlm-991	31	3	samples	sample	NOUN
ajlm-991	31	4	were	be	AUX
ajlm-991	31	5	processed	process	VERB
ajlm-991	31	6	using	use	VERB
ajlm-991	31	7	conventional	conventional	ADJ
ajlm-991	31	8	methods	method	NOUN
ajlm-991	31	9	.	.	PUNCT
ajlm-991	32	1	blood	blood	NOUN
ajlm-991	32	2	culture	culture	NOUN
ajlm-991	32	3	bottles	bottle	NOUN
ajlm-991	32	4	were	be	AUX
ajlm-991	32	5	incubated	incubate	VERB
ajlm-991	32	6	in	in	ADP
ajlm-991	32	7	a	a	DET
ajlm-991	32	8	fully	fully	ADV
ajlm-991	32	9	automated	automate	VERB
ajlm-991	32	10	blood	blood	NOUN
ajlm-991	32	11	culture	culture	NOUN
ajlm-991	32	12	system	system	NOUN
ajlm-991	32	13	,	,	PUNCT
ajlm-991	32	14	the	the	DET
ajlm-991	32	15	bact	bact	NOUN
ajlm-991	32	16	/	/	SYM
ajlm-991	32	17	alert	alert	NOUN
ajlm-991	32	18	3d	3d	NOUN
ajlm-991	32	19	(	(	PUNCT
ajlm-991	32	20	biomérieux	biomérieux	PROPN
ajlm-991	32	21	sa	sa	PROPN
ajlm-991	32	22	,	,	PUNCT
ajlm-991	32	23	marcy	marcy	NOUN
ajlm-991	32	24	-	-	PUNCT
ajlm-991	32	25	l’étoile	l’étoile	PROPN
ajlm-991	32	26	,	,	PUNCT
ajlm-991	32	27	france	france	PROPN
ajlm-991	32	28	)	)	PUNCT
ajlm-991	32	29	.	.	PUNCT
ajlm-991	33	1	after	after	ADP
ajlm-991	33	2	obtaining	obtain	VERB
ajlm-991	33	3	a	a	DET
ajlm-991	33	4	pure	pure	ADJ
ajlm-991	33	5	bacterial	bacterial	ADJ
ajlm-991	33	6	growth	growth	NOUN
ajlm-991	33	7	,	,	PUNCT
ajlm-991	33	8	isolate	isolate	VERB
ajlm-991	33	9	identification	identification	NOUN
ajlm-991	33	10	and	and	CCONJ
ajlm-991	33	11	antibiotic	antibiotic	ADJ
ajlm-991	33	12	sensitivity	sensitivity	NOUN
ajlm-991	33	13	testing	testing	NOUN
ajlm-991	33	14	were	be	AUX
ajlm-991	33	15	carried	carry	VERB
ajlm-991	33	16	out	out	ADP
ajlm-991	33	17	on	on	ADP
ajlm-991	33	18	a	a	DET
ajlm-991	33	19	vitek	vitek	NOUN
ajlm-991	33	20	2	2	NUM
ajlm-991	33	21	compact	compact	NOUN
ajlm-991	33	22	(	(	PUNCT
ajlm-991	33	23	biomérieux	biomérieux	PROPN
ajlm-991	33	24	sa	sa	PROPN
ajlm-991	33	25	,	,	PUNCT
ajlm-991	33	26	marcy	marcy	NOUN
ajlm-991	33	27	-	-	PUNCT
ajlm-991	33	28	l’étoile	l’étoile	PROPN
ajlm-991	33	29	,	,	PUNCT
ajlm-991	33	30	france	france	PROPN
ajlm-991	33	31	)	)	PUNCT
ajlm-991	33	32	.	.	PUNCT
ajlm-991	34	1	an	an	DET
ajlm-991	34	2	mdr	mdr	PROPN
ajlm-991	34	3	isolate	isolate	NOUN
ajlm-991	34	4	was	be	AUX
ajlm-991	34	5	defined	define	VERB
ajlm-991	34	6	as	as	ADP
ajlm-991	34	7	a	a	DET
ajlm-991	34	8	gnb	gnb	PROPN
ajlm-991	34	9	strain	strain	NOUN
ajlm-991	34	10	that	that	PRON
ajlm-991	34	11	showed	show	VERB
ajlm-991	34	12	resistance	resistance	NOUN
ajlm-991	34	13	to	to	ADP
ajlm-991	34	14	at	at	ADV
ajlm-991	34	15	least	least	ADV
ajlm-991	34	16	three	three	NUM
ajlm-991	34	17	different	different	ADJ
ajlm-991	34	18	categories	category	NOUN
ajlm-991	34	19	of	of	ADP
ajlm-991	34	20	antibiotics.18	antibiotics.18	PROPN
ajlm-991	34	21	a	a	DET
ajlm-991	34	22	total	total	NOUN
ajlm-991	34	23	of	of	ADP
ajlm-991	34	24	85	85	NUM
ajlm-991	34	25	esbland	esbland	NOUN
ajlm-991	34	26	94	94	NUM
ajlm-991	34	27	mbl	mbl	NOUN
ajlm-991	34	28	-	-	PUNCT
ajlm-991	34	29	producing	produce	VERB
ajlm-991	34	30	gnb	gnb	PROPN
ajlm-991	34	31	were	be	AUX
ajlm-991	34	32	identified	identify	VERB
ajlm-991	34	33	by	by	ADP
ajlm-991	34	34	phenotypic	phenotypic	ADJ
ajlm-991	34	35	tests	test	NOUN
ajlm-991	34	36	and	and	CCONJ
ajlm-991	34	37	confirmed	confirm	VERB
ajlm-991	34	38	by	by	ADP
ajlm-991	34	39	the	the	DET
ajlm-991	34	40	vitek	vitek	PROPN
ajlm-991	34	41	2	2	NUM
ajlm-991	34	42	system	system	NOUN
ajlm-991	34	43	for	for	ADP
ajlm-991	34	44	inclusion	inclusion	NOUN
ajlm-991	34	45	in	in	ADP
ajlm-991	34	46	the	the	DET
ajlm-991	34	47	study	study	NOUN
ajlm-991	34	48	.	.	PUNCT
ajlm-991	35	1	the	the	DET
ajlm-991	35	2	confirmatory	confirmatory	NOUN
ajlm-991	35	3	test	test	NOUN
ajlm-991	35	4	for	for	ADP
ajlm-991	35	5	esbl	esbl	NOUN
ajlm-991	35	6	production	production	NOUN
ajlm-991	35	7	was	be	AUX
ajlm-991	35	8	carried	carry	VERB
ajlm-991	35	9	out	out	ADP
ajlm-991	35	10	using	use	VERB
ajlm-991	35	11	discs	disc	NOUN
ajlm-991	35	12	containing	contain	VERB
ajlm-991	35	13	ceftazidime	ceftazidime	NOUN
ajlm-991	35	14	(	(	PUNCT
ajlm-991	35	15	30	30	NUM
ajlm-991	35	16	µg	µg	NOUN
ajlm-991	35	17	)	)	PUNCT
ajlm-991	35	18	alone	alone	ADV
ajlm-991	35	19	,	,	PUNCT
ajlm-991	35	20	along	along	ADP
ajlm-991	35	21	with	with	ADP
ajlm-991	35	22	ceftazidime	ceftazidime	NOUN
ajlm-991	35	23	/	/	SYM
ajlm-991	35	24	clavulanic	clavulanic	NOUN
ajlm-991	35	25	acid	acid	NOUN
ajlm-991	35	26	(	(	PUNCT
ajlm-991	35	27	30/10	30/10	NUM
ajlm-991	35	28	µg	µg	NOUN
ajlm-991	35	29	)	)	PUNCT
ajlm-991	35	30	discs	disc	NOUN
ajlm-991	35	31	.	.	PUNCT
ajlm-991	36	1	similarly	similarly	ADV
ajlm-991	36	2	,	,	PUNCT
ajlm-991	36	3	cefotaxime	cefotaxime	NOUN
ajlm-991	36	4	(	(	PUNCT
ajlm-991	36	5	30	30	NUM
ajlm-991	36	6	µg	µg	NOUN
ajlm-991	36	7	)	)	PUNCT
ajlm-991	36	8	and	and	CCONJ
ajlm-991	36	9	cefotaxime	cefotaxime	NOUN
ajlm-991	36	10	/	/	SYM
ajlm-991	36	11	clavulanic	clavulanic	ADJ
ajlm-991	36	12	acid	acid	NOUN
ajlm-991	36	13	discs	disc	NOUN
ajlm-991	36	14	(	(	PUNCT
ajlm-991	36	15	30/10	30/10	NUM
ajlm-991	36	16	µg	µg	NOUN
ajlm-991	36	17	)	)	PUNCT
ajlm-991	36	18	were	be	AUX
ajlm-991	36	19	also	also	ADV
ajlm-991	36	20	used	use	VERB
ajlm-991	36	21	.	.	PUNCT
ajlm-991	37	1	an	an	DET
ajlm-991	37	2	increase	increase	NOUN
ajlm-991	37	3	in	in	ADP
ajlm-991	37	4	zone	zone	NOUN
ajlm-991	37	5	diameter	diameter	NOUN
ajlm-991	37	6	of	of	ADP
ajlm-991	37	7	≥	≥	NUM
ajlm-991	37	8	5	5	NUM
ajlm-991	37	9	mm	mm	NOUN
ajlm-991	37	10	around	around	ADP
ajlm-991	37	11	the	the	DET
ajlm-991	37	12	clavulanate	clavulanate	NOUN
ajlm-991	37	13	disk	disk	NOUN
ajlm-991	37	14	compared	compare	VERB
ajlm-991	37	15	to	to	ADP
ajlm-991	37	16	the	the	DET
ajlm-991	37	17	zone	zone	NOUN
ajlm-991	37	18	of	of	ADP
ajlm-991	37	19	inhibition	inhibition	NOUN
ajlm-991	37	20	for	for	ADP
ajlm-991	37	21	the	the	DET
ajlm-991	37	22	ceftazidime	ceftazidime	NOUN
ajlm-991	37	23	and	and	CCONJ
ajlm-991	37	24	cefotaxime	cefotaxime	NOUN
ajlm-991	37	25	disk	disk	NOUN
ajlm-991	37	26	alone	alone	ADV
ajlm-991	37	27	was	be	AUX
ajlm-991	37	28	used	use	VERB
ajlm-991	37	29	to	to	PART
ajlm-991	37	30	confirm	confirm	VERB
ajlm-991	37	31	and	and	CCONJ
ajlm-991	37	32	isolate	isolate	VERB
ajlm-991	37	33	as	as	ADV
ajlm-991	37	34	positive	positive	ADJ
ajlm-991	37	35	for	for	ADP
ajlm-991	37	36	esbl	esbl	NOUN
ajlm-991	37	37	production	production	NOUN
ajlm-991	37	38	as	as	SCONJ
ajlm-991	37	39	per	per	ADP
ajlm-991	37	40	clinical	clinical	ADJ
ajlm-991	37	41	and	and	CCONJ
ajlm-991	37	42	laboratory	laboratory	NOUN
ajlm-991	37	43	standards	standard	NOUN
ajlm-991	37	44	institute	institute	PROPN
ajlm-991	37	45	guidelines.19	guidelines.19	PROPN
ajlm-991	37	46	the	the	DET
ajlm-991	37	47	modified	modified	PROPN
ajlm-991	37	48	hodge	hodge	PROPN
ajlm-991	37	49	test19	test19	PROPN
ajlm-991	37	50	was	be	AUX
ajlm-991	37	51	used	use	VERB
ajlm-991	37	52	for	for	ADP
ajlm-991	37	53	isolates	isolate	NOUN
ajlm-991	37	54	identified	identify	VERB
ajlm-991	37	55	as	as	ADP
ajlm-991	37	56	carbapenemase	carbapenemase	NOUN
ajlm-991	37	57	-	-	PUNCT
ajlm-991	37	58	producing	produce	VERB
ajlm-991	37	59	gnb	gnb	NOUN
ajlm-991	37	60	strains	strain	VERB
ajlm-991	37	61	.	.	PUNCT
ajlm-991	38	1	a	a	DET
ajlm-991	38	2	10	10	NUM
ajlm-991	38	3	µg	µg	ADV
ajlm-991	38	4	meropenem	meropenem	NOUN
ajlm-991	38	5	disc	disc	NOUN
ajlm-991	38	6	was	be	AUX
ajlm-991	38	7	placed	place	VERB
ajlm-991	38	8	on	on	ADP
ajlm-991	38	9	a	a	DET
ajlm-991	38	10	mueller	mueller	PROPN
ajlm-991	38	11	-	-	PUNCT
ajlm-991	38	12	hinton	hinton	PROPN
ajlm-991	38	13	agar	agar	NOUN
ajlm-991	38	14	plate	plate	NOUN
ajlm-991	38	15	previously	previously	ADV
ajlm-991	38	16	inoculated	inoculate	VERB
ajlm-991	38	17	with	with	ADP
ajlm-991	38	18	escherichia	escherichia	NOUN
ajlm-991	38	19	coli	coli	NOUN
ajlm-991	38	20	american	american	ADJ
ajlm-991	38	21	type	type	NOUN
ajlm-991	38	22	culture	culture	NOUN
ajlm-991	38	23	collection	collection	NOUN
ajlm-991	38	24	25922	25922	NUM
ajlm-991	38	25	(	(	PUNCT
ajlm-991	38	26	the	the	DET
ajlm-991	38	27	indicator	indicator	NOUN
ajlm-991	38	28	organism	organism	NOUN
ajlm-991	38	29	)	)	PUNCT
ajlm-991	38	30	.	.	PUNCT
ajlm-991	39	1	afterwards	afterwards	ADV
ajlm-991	39	2	,	,	PUNCT
ajlm-991	39	3	the	the	DET
ajlm-991	39	4	test	test	NOUN
ajlm-991	39	5	organisms	organism	NOUN
ajlm-991	39	6	were	be	AUX
ajlm-991	39	7	streaked	streak	VERB
ajlm-991	39	8	out	out	ADP
ajlm-991	39	9	in	in	ADP
ajlm-991	39	10	a	a	DET
ajlm-991	39	11	straight	straight	ADJ
ajlm-991	39	12	line	line	NOUN
ajlm-991	39	13	,	,	PUNCT
ajlm-991	39	14	starting	start	VERB
ajlm-991	39	15	from	from	ADP
ajlm-991	39	16	the	the	DET
ajlm-991	39	17	edge	edge	NOUN
ajlm-991	39	18	of	of	ADP
ajlm-991	39	19	the	the	DET
ajlm-991	39	20	meropenem	meropenem	PROPN
ajlm-991	39	21	disc	disc	NOUN
ajlm-991	39	22	,	,	PUNCT
ajlm-991	39	23	for	for	ADP
ajlm-991	39	24	at	at	ADV
ajlm-991	39	25	least	least	ADV
ajlm-991	39	26	20	20	NUM
ajlm-991	39	27	mm	mm	NOUN
ajlm-991	39	28	–	–	PUNCT
ajlm-991	39	29	25	25	NUM
ajlm-991	39	30	mm	mm	NUM
ajlm-991	39	31	length	length	NOUN
ajlm-991	39	32	.	.	PUNCT
ajlm-991	40	1	the	the	DET
ajlm-991	40	2	enhancement	enhancement	NOUN
ajlm-991	40	3	of	of	ADP
ajlm-991	40	4	growth	growth	NOUN
ajlm-991	40	5	of	of	ADP
ajlm-991	40	6	the	the	DET
ajlm-991	40	7	indicator	indicator	NOUN
ajlm-991	40	8	organism	organism	NOUN
ajlm-991	40	9	along	along	ADP
ajlm-991	40	10	the	the	DET
ajlm-991	40	11	test	test	NOUN
ajlm-991	40	12	organism	organism	NOUN
ajlm-991	40	13	’s	’s	PART
ajlm-991	40	14	streak	streak	NOUN
ajlm-991	40	15	line	line	NOUN
ajlm-991	40	16	and	and	CCONJ
ajlm-991	40	17	zone	zone	NOUN
ajlm-991	40	18	of	of	ADP
ajlm-991	40	19	inhibition	inhibition	NOUN
ajlm-991	40	20	of	of	ADP
ajlm-991	40	21	the	the	DET
ajlm-991	40	22	disk	disk	NOUN
ajlm-991	40	23	to	to	PART
ajlm-991	40	24	form	form	VERB
ajlm-991	40	25	a	a	DET
ajlm-991	40	26	cloverleaf	cloverleaf	NOUN
ajlm-991	40	27	appearance	appearance	NOUN
ajlm-991	40	28	was	be	AUX
ajlm-991	40	29	considered	consider	VERB
ajlm-991	40	30	as	as	ADP
ajlm-991	40	31	a	a	DET
ajlm-991	40	32	positive	positive	ADJ
ajlm-991	40	33	indicator	indicator	NOUN
ajlm-991	40	34	for	for	ADP
ajlm-991	40	35	carbapenemase	carbapenemase	NOUN
ajlm-991	40	36	production	production	NOUN
ajlm-991	40	37	as	as	ADP
ajlm-991	40	38	per	per	ADP
ajlm-991	40	39	clinical	clinical	ADJ
ajlm-991	40	40	and	and	CCONJ
ajlm-991	40	41	laboratory	laboratory	NOUN
ajlm-991	40	42	standards	standard	NOUN
ajlm-991	40	43	institute	institute	PROPN
ajlm-991	40	44	guidelines.19	guidelines.19	PROPN
ajlm-991	40	45	for	for	ADP
ajlm-991	40	46	detection	detection	NOUN
ajlm-991	40	47	of	of	ADP
ajlm-991	40	48	class	class	NOUN
ajlm-991	40	49	b	b	PROPN
ajlm-991	40	50	carbapenemases	carbapenemase	NOUN
ajlm-991	40	51	(	(	PUNCT
ajlm-991	40	52	mbl	mbl	NOUN
ajlm-991	40	53	)	)	PUNCT
ajlm-991	40	54	,	,	PUNCT
ajlm-991	40	55	the	the	DET
ajlm-991	40	56	double	double	ADJ
ajlm-991	40	57	-	-	PUNCT
ajlm-991	40	58	disc	disc	NOUN
ajlm-991	40	59	synergy	synergy	NOUN
ajlm-991	40	60	test	test	NOUN
ajlm-991	40	61	using	use	VERB
ajlm-991	40	62	imipenem	imipenem	PROPN
ajlm-991	40	63	and	and	CCONJ
ajlm-991	40	64	imipenem	imipenem	PROPN
ajlm-991	40	65	plus	plus	CCONJ
ajlm-991	40	66	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-991	40	67	acid	acid	NOUN
ajlm-991	40	68	disc	disc	NOUN
ajlm-991	40	69	was	be	AUX
ajlm-991	40	70	done	do	VERB
ajlm-991	40	71	.	.	PUNCT
ajlm-991	41	1	an	an	DET
ajlm-991	41	2	organism	organism	NOUN
ajlm-991	41	3	with	with	ADP
ajlm-991	41	4	a	a	DET
ajlm-991	41	5	zone	zone	NOUN
ajlm-991	41	6	size	size	NOUN
ajlm-991	41	7	difference	difference	NOUN
ajlm-991	41	8	of	of	ADP
ajlm-991	41	9	7	7	NUM
ajlm-991	41	10	mm	mm	NOUN
ajlm-991	41	11	between	between	ADP
ajlm-991	41	12	imipenem	imipenem	PROPN
ajlm-991	41	13	and	and	CCONJ
ajlm-991	41	14	imipenem	imipenem	PROPN
ajlm-991	41	15	plus	plus	CCONJ
ajlm-991	41	16	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-991	41	17	acid	acid	NOUN
ajlm-991	41	18	discs	disc	NOUN
ajlm-991	41	19	was	be	AUX
ajlm-991	41	20	considered	consider	VERB
ajlm-991	41	21	to	to	PART
ajlm-991	41	22	be	be	AUX
ajlm-991	41	23	an	an	DET
ajlm-991	41	24	mbl	mbl	NOUN
ajlm-991	41	25	-	-	PUNCT
ajlm-991	41	26	producing	produce	VERB
ajlm-991	41	27	strain.20	strain.20	NOUN
ajlm-991	41	28	all	all	DET
ajlm-991	41	29	179	179	NUM
ajlm-991	41	30	isolates	isolate	NOUN
ajlm-991	41	31	were	be	AUX
ajlm-991	41	32	then	then	ADV
ajlm-991	41	33	further	far	ADV
ajlm-991	41	34	tested	test	VERB
ajlm-991	41	35	for	for	ADP
ajlm-991	41	36	antimicrobial	antimicrobial	ADJ
ajlm-991	41	37	susceptibility	susceptibility	NOUN
ajlm-991	41	38	against	against	ADP
ajlm-991	41	39	cse	cse	PROPN
ajlm-991	41	40	(	(	PUNCT
ajlm-991	41	41	venus	venus	PROPN
ajlm-991	41	42	medicine	medicine	NOUN
ajlm-991	41	43	research	research	NOUN
ajlm-991	41	44	centre	centre	NOUN
ajlm-991	41	45	,	,	PUNCT
ajlm-991	41	46	baddi	baddi	PROPN
ajlm-991	41	47	,	,	PUNCT
ajlm-991	41	48	himachal	himachal	PROPN
ajlm-991	41	49	pradesh	pradesh	PROPN
ajlm-991	41	50	,	,	PUNCT
ajlm-991	41	51	india	india	PROPN
ajlm-991	41	52	)	)	PUNCT
ajlm-991	41	53	by	by	ADP
ajlm-991	41	54	the	the	DET
ajlm-991	41	55	kirby	kirby	PROPN
ajlm-991	41	56	-	-	PUNCT
ajlm-991	41	57	bauer	bauer	PROPN
ajlm-991	41	58	disc	disc	NOUN
ajlm-991	41	59	diffusion	diffusion	NOUN
ajlm-991	41	60	method	method	NOUN
ajlm-991	41	61	on	on	ADP
ajlm-991	41	62	a	a	DET
ajlm-991	41	63	mueller	mueller	PROPN
ajlm-991	41	64	-	-	PUNCT
ajlm-991	41	65	hinton	hinton	PROPN
ajlm-991	41	66	agar	agar	NOUN
ajlm-991	41	67	kept	keep	VERB
ajlm-991	41	68	at	at	ADP
ajlm-991	41	69	37	37	NUM
ajlm-991	41	70	°	°	NOUN
ajlm-991	41	71	c	c	NOUN
ajlm-991	41	72	for	for	ADP
ajlm-991	41	73	16	16	NUM
ajlm-991	41	74	h	h	NOUN
ajlm-991	41	75	–	–	PUNCT
ajlm-991	41	76	18	18	NUM
ajlm-991	41	77	h	h	NOUN
ajlm-991	41	78	(	(	PUNCT
ajlm-991	41	79	figure	figure	NOUN
ajlm-991	41	80	1	1	NUM
ajlm-991	41	81	)	)	PUNCT
ajlm-991	41	82	.	.	PUNCT
ajlm-991	42	1	quality	quality	NOUN
ajlm-991	42	2	control	control	NOUN
ajlm-991	42	3	of	of	ADP
ajlm-991	42	4	cse	cse	PROPN
ajlm-991	42	5	antibiotic	antibiotic	ADJ
ajlm-991	42	6	discs	disc	NOUN
ajlm-991	42	7	was	be	AUX
ajlm-991	42	8	done	do	VERB
ajlm-991	42	9	using	use	VERB
ajlm-991	42	10	e.	e.	PROPN
ajlm-991	42	11	coli	coli	PROPN
ajlm-991	42	12	american	american	ADJ
ajlm-991	42	13	type	type	NOUN
ajlm-991	42	14	culture	culture	NOUN
ajlm-991	42	15	collection	collection	NOUN
ajlm-991	42	16	25922	25922	NUM
ajlm-991	42	17	and	and	CCONJ
ajlm-991	42	18	a	a	DET
ajlm-991	42	19	laboratory	laboratory	NOUN
ajlm-991	42	20	-	-	PUNCT
ajlm-991	42	21	characterised	characterise	VERB
ajlm-991	42	22	sensitive	sensitive	ADJ
ajlm-991	42	23	isolate	isolate	NOUN
ajlm-991	42	24	of	of	ADP
ajlm-991	42	25	acinetobacter	acinetobacter	ADJ
ajlm-991	42	26	baumanii	baumanii	NOUN
ajlm-991	42	27	(	(	PUNCT
ajlm-991	42	28	strain	strain	VERB
ajlm-991	42	29	no	no	INTJ
ajlm-991	42	30	.	.	NOUN
ajlm-991	43	1	ahrr1205/2017	ahrr1205/2017	NOUN
ajlm-991	43	2	)	)	PUNCT
ajlm-991	43	3	.	.	PUNCT
ajlm-991	44	1	susceptibility	susceptibility	NOUN
ajlm-991	44	2	of	of	ADP
ajlm-991	44	3	the	the	DET
ajlm-991	44	4	tested	test	VERB
ajlm-991	44	5	organisms	organism	NOUN
ajlm-991	44	6	against	against	ADP
ajlm-991	44	7	this	this	DET
ajlm-991	44	8	combination	combination	NOUN
ajlm-991	44	9	was	be	AUX
ajlm-991	44	10	reported	report	VERB
ajlm-991	44	11	as	as	ADP
ajlm-991	44	12	sensitive	sensitive	ADJ
ajlm-991	44	13	,	,	PUNCT
ajlm-991	44	14	intermediate	intermediate	ADJ
ajlm-991	44	15	or	or	CCONJ
ajlm-991	44	16	resistant	resistant	ADJ
ajlm-991	44	17	based	base	VERB
ajlm-991	44	18	on	on	ADP
ajlm-991	44	19	the	the	DET
ajlm-991	44	20	zone	zone	NOUN
ajlm-991	44	21	of	of	ADP
ajlm-991	44	22	inhibition	inhibition	NOUN
ajlm-991	44	23	mentioned	mention	VERB
ajlm-991	44	24	for	for	ADP
ajlm-991	44	25	ceftriaxone	ceftriaxone	NOUN
ajlm-991	44	26	as	as	ADP
ajlm-991	44	27	per	per	ADP
ajlm-991	44	28	clinical	clinical	ADJ
ajlm-991	44	29	and	and	CCONJ
ajlm-991	44	30	laboratory	laboratory	NOUN
ajlm-991	44	31	standards	standard	NOUN
ajlm-991	44	32	institute	institute	PROPN
ajlm-991	44	33	guideline	guideline	NOUN
ajlm-991	44	34	m100s27	m100s27	NOUN
ajlm-991	44	35	:	:	PUNCT
ajlm-991	44	36	performance	performance	NOUN
ajlm-991	44	37	standards	standard	NOUN
ajlm-991	44	38	for	for	ADP
ajlm-991	44	39	antimicrobial	antimicrobial	ADJ
ajlm-991	44	40	sensitivity	sensitivity	NOUN
ajlm-991	44	41	testing	testing	NOUN
ajlm-991	44	42	,	,	PUNCT
ajlm-991	44	43	2017.19	2017.19	NUM
ajlm-991	44	44	the	the	DET
ajlm-991	44	45	zone	zone	NOUN
ajlm-991	44	46	of	of	ADP
ajlm-991	44	47	inhibition	inhibition	NOUN
ajlm-991	44	48	around	around	ADP
ajlm-991	44	49	the	the	DET
ajlm-991	44	50	disc	disc	NOUN
ajlm-991	44	51	was	be	AUX
ajlm-991	44	52	measured	measure	VERB
ajlm-991	44	53	,	,	PUNCT
ajlm-991	44	54	and	and	CCONJ
ajlm-991	44	55	the	the	DET
ajlm-991	44	56	organism	organism	NOUN
ajlm-991	44	57	was	be	AUX
ajlm-991	44	58	labelled	label	VERB
ajlm-991	44	59	as	as	ADP
ajlm-991	44	60	sensitive	sensitive	ADJ
ajlm-991	44	61	if	if	SCONJ
ajlm-991	44	62	the	the	DET
ajlm-991	44	63	zone	zone	NOUN
ajlm-991	44	64	measured	measure	VERB
ajlm-991	44	65	>	>	X
ajlm-991	44	66	23	23	NUM
ajlm-991	44	67	mm	mm	NOUN
ajlm-991	44	68	for	for	ADP
ajlm-991	44	69	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-991	44	70	or	or	CCONJ
ajlm-991	44	71	>	>	ADP
ajlm-991	44	72	21	21	NUM
ajlm-991	44	73	mm	mm	NOUN
ajlm-991	44	74	for	for	ADP
ajlm-991	44	75	acinetobacter	acinetobacter	NOUN
ajlm-991	44	76	,	,	PUNCT
ajlm-991	44	77	intermediate	intermediate	ADJ
ajlm-991	44	78	if	if	SCONJ
ajlm-991	44	79	20	20	NUM
ajlm-991	44	80	mm	mm	NOUN
ajlm-991	44	81	–	–	PUNCT
ajlm-991	44	82	22	22	NUM
ajlm-991	44	83	mm	mm	INTJ
ajlm-991	44	84	(	(	PUNCT
ajlm-991	44	85	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-991	44	86	)	)	PUNCT
ajlm-991	44	87	or	or	CCONJ
ajlm-991	44	88	14	14	NUM
ajlm-991	44	89	mm	mm	NUM
ajlm-991	44	90	–	–	PUNCT
ajlm-991	44	91	20	20	NUM
ajlm-991	44	92	mm	mm	NOUN
ajlm-991	44	93	(	(	PUNCT
ajlm-991	44	94	acinetobacter	acinetobacter	NOUN
ajlm-991	44	95	)	)	PUNCT
ajlm-991	44	96	,	,	PUNCT
ajlm-991	44	97	or	or	CCONJ
ajlm-991	44	98	resistant	resistant	ADJ
ajlm-991	44	99	if	if	SCONJ
ajlm-991	44	100	<	<	X
ajlm-991	44	101	19	19	NUM
ajlm-991	44	102	mm	mm	NOUN
ajlm-991	44	103	for	for	ADP
ajlm-991	44	104	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-991	44	105	or	or	CCONJ
ajlm-991	44	106	<	<	X
ajlm-991	44	107	13	13	NUM
ajlm-991	44	108	mm	mm	NOUN
ajlm-991	44	109	for	for	ADP
ajlm-991	44	110	acinetobacter.19	acinetobacter.19	NOUN
ajlm-991	44	111	non	non	ADJ
ajlm-991	44	112	-	-	NOUN
ajlm-991	44	113	fermenters	fermenter	NOUN
ajlm-991	44	114	such	such	ADJ
ajlm-991	44	115	as	as	ADP
ajlm-991	44	116	pseudomonas	pseudomona	NOUN
ajlm-991	44	117	aeruginosa	aeruginosa	NOUN
ajlm-991	44	118	and	and	CCONJ
ajlm-991	44	119	burkholderia	burkholderia	NOUN
ajlm-991	44	120	cepacia	cepacia	PROPN
ajlm-991	44	121	were	be	AUX
ajlm-991	44	122	not	not	PART
ajlm-991	44	123	tested	test	VERB
ajlm-991	44	124	against	against	ADP
ajlm-991	44	125	cse	cse	NOUN
ajlm-991	44	126	as	as	SCONJ
ajlm-991	44	127	these	these	PRON
ajlm-991	44	128	are	be	AUX
ajlm-991	44	129	known	know	VERB
ajlm-991	44	130	to	to	PART
ajlm-991	44	131	be	be	AUX
ajlm-991	44	132	inherently	inherently	ADV
ajlm-991	44	133	resistant	resistant	ADJ
ajlm-991	44	134	to	to	ADP
ajlm-991	44	135	ceftriaxone	ceftriaxone	NOUN
ajlm-991	44	136	and	and	CCONJ
ajlm-991	44	137	there	there	PRON
ajlm-991	44	138	are	be	VERB
ajlm-991	44	139	no	no	DET
ajlm-991	44	140	testing	testing	NOUN
ajlm-991	44	141	standards	standard	NOUN
ajlm-991	44	142	mentioned	mention	VERB
ajlm-991	44	143	in	in	ADP
ajlm-991	44	144	clinical	clinical	ADJ
ajlm-991	44	145	and	and	CCONJ
ajlm-991	44	146	laboratory	laboratory	NOUN
ajlm-991	44	147	standards	standard	NOUN
ajlm-991	44	148	institute	institute	PROPN
ajlm-991	44	149	guidelines.19	guidelines.19	PROPN
ajlm-991	44	150	figure	figure	VERB
ajlm-991	44	151	1	1	NUM
ajlm-991	44	152	:	:	PUNCT
ajlm-991	44	153	zone	zone	NOUN
ajlm-991	44	154	of	of	ADP
ajlm-991	44	155	inhibition	inhibition	NOUN
ajlm-991	44	156	around	around	ADP
ajlm-991	44	157	the	the	DET
ajlm-991	44	158	ceftriaxone	ceftriaxone	NOUN
ajlm-991	44	159	-	-	PUNCT
ajlm-991	44	160	sulbactam	sulbactam	NOUN
ajlm-991	44	161	-	-	PUNCT
ajlm-991	44	162	disodium	disodium	NOUN
ajlm-991	44	163	edetate	edetate	NOUN
ajlm-991	44	164	disc	disc	NOUN
ajlm-991	44	165	,	,	PUNCT
ajlm-991	44	166	delhi	delhi	PROPN
ajlm-991	44	167	,	,	PUNCT
ajlm-991	44	168	india	india	PROPN
ajlm-991	44	169	,	,	PUNCT
ajlm-991	44	170	february	february	PROPN
ajlm-991	44	171	2017	2017	NUM
ajlm-991	44	172	to	to	ADP
ajlm-991	44	173	june	june	PROPN
ajlm-991	44	174	2017	2017	NUM
ajlm-991	44	175	.	.	PUNCT
ajlm-991	45	1	data	datum	NOUN
ajlm-991	45	2	analysis	analysis	NOUN
ajlm-991	45	3	statistical	statistical	ADJ
ajlm-991	45	4	analysis	analysis	NOUN
ajlm-991	45	5	was	be	AUX
ajlm-991	45	6	done	do	VERB
ajlm-991	45	7	using	use	VERB
ajlm-991	45	8	graph	graph	NOUN
ajlm-991	45	9	pad	pad	NOUN
ajlm-991	45	10	,	,	PUNCT
ajlm-991	45	11	a	a	DET
ajlm-991	45	12	free	free	ADJ
ajlm-991	45	13	online	online	ADJ
ajlm-991	45	14	software	software	NOUN
ajlm-991	45	15	offering	offering	NOUN
ajlm-991	45	16	by	by	ADP
ajlm-991	45	17	founder	founder	PROPN
ajlm-991	45	18	dr	dr	PROPN
ajlm-991	45	19	harvey	harvey	PROPN
ajlm-991	45	20	motulsky	motulsky	PROPN
ajlm-991	45	21	(	(	PUNCT
ajlm-991	45	22	graphpad	graphpad	NOUN
ajlm-991	45	23	software	software	NOUN
ajlm-991	45	24	,	,	PUNCT
ajlm-991	45	25	san	san	PROPN
ajlm-991	45	26	diego	diego	PROPN
ajlm-991	45	27	,	,	PUNCT
ajlm-991	45	28	california	california	PROPN
ajlm-991	45	29	,	,	PUNCT
ajlm-991	45	30	united	united	PROPN
ajlm-991	45	31	states	states	PROPN
ajlm-991	45	32	)	)	PUNCT
ajlm-991	45	33	.	.	PUNCT
ajlm-991	46	1	associations	association	NOUN
ajlm-991	46	2	between	between	ADP
ajlm-991	46	3	two	two	NUM
ajlm-991	46	4	factors	factor	NOUN
ajlm-991	46	5	were	be	AUX
ajlm-991	46	6	drawn	draw	VERB
ajlm-991	46	7	through	through	ADP
ajlm-991	46	8	univariate	univariate	ADJ
ajlm-991	46	9	logistic	logistic	ADJ
ajlm-991	46	10	regression	regression	NOUN
ajlm-991	46	11	using	use	VERB
ajlm-991	46	12	the	the	DET
ajlm-991	46	13	fischer	fischer	PROPN
ajlm-991	46	14	exact	exact	ADJ
ajlm-991	46	15	test	test	NOUN
ajlm-991	46	16	.	.	PUNCT
ajlm-991	47	1	p	p	X
ajlm-991	47	2	-	-	PUNCT
ajlm-991	47	3	values	value	NOUN
ajlm-991	47	4	of	of	ADP
ajlm-991	47	5	less	less	ADJ
ajlm-991	47	6	than	than	ADP
ajlm-991	47	7	0.05	0.05	NUM
ajlm-991	47	8	were	be	AUX
ajlm-991	47	9	considered	consider	VERB
ajlm-991	47	10	statistically	statistically	ADV
ajlm-991	47	11	significant	significant	ADJ
ajlm-991	47	12	.	.	PUNCT
ajlm-991	48	1	results	result	VERB
ajlm-991	48	2	a	a	DET
ajlm-991	48	3	total	total	NOUN
ajlm-991	48	4	of	of	ADP
ajlm-991	48	5	179	179	NUM
ajlm-991	48	6	clinical	clinical	ADJ
ajlm-991	48	7	isolates	isolate	NOUN
ajlm-991	48	8	from	from	ADP
ajlm-991	48	9	168	168	NUM
ajlm-991	48	10	clinical	clinical	ADJ
ajlm-991	48	11	cases	case	NOUN
ajlm-991	48	12	(	(	PUNCT
ajlm-991	48	13	117	117	NUM
ajlm-991	48	14	male	male	ADJ
ajlm-991	48	15	patients	patient	NOUN
ajlm-991	48	16	and	and	CCONJ
ajlm-991	48	17	51	51	NUM
ajlm-991	48	18	female	female	ADJ
ajlm-991	48	19	patients	patient	NOUN
ajlm-991	48	20	)	)	PUNCT
ajlm-991	48	21	were	be	AUX
ajlm-991	48	22	included	include	VERB
ajlm-991	48	23	in	in	ADP
ajlm-991	48	24	the	the	DET
ajlm-991	48	25	study	study	NOUN
ajlm-991	48	26	,	,	PUNCT
ajlm-991	48	27	with	with	ADP
ajlm-991	48	28	a	a	DET
ajlm-991	48	29	mean	mean	ADJ
ajlm-991	48	30	patient	patient	ADJ
ajlm-991	48	31	age	age	NOUN
ajlm-991	48	32	of	of	ADP
ajlm-991	48	33	43.22	43.22	NUM
ajlm-991	48	34	years	year	NOUN
ajlm-991	48	35	(	(	PUNCT
ajlm-991	48	36	range	range	NOUN
ajlm-991	48	37	:	:	PUNCT
ajlm-991	48	38	4–85	4–85	NOUN
ajlm-991	48	39	years	year	NOUN
ajlm-991	48	40	)	)	PUNCT
ajlm-991	48	41	.	.	PUNCT
ajlm-991	49	1	most	most	ADJ
ajlm-991	49	2	isolates	isolate	NOUN
ajlm-991	49	3	were	be	AUX
ajlm-991	49	4	from	from	ADP
ajlm-991	49	5	urine	urine	NOUN
ajlm-991	49	6	,	,	PUNCT
ajlm-991	49	7	followed	follow	VERB
ajlm-991	49	8	by	by	ADP
ajlm-991	49	9	pus	pus	NOUN
ajlm-991	49	10	and	and	CCONJ
ajlm-991	49	11	blood	blood	NOUN
ajlm-991	49	12	specimens	specimen	NOUN
ajlm-991	49	13	,	,	PUNCT
ajlm-991	49	14	and	and	CCONJ
ajlm-991	49	15	these	these	PRON
ajlm-991	49	16	accounted	account	VERB
ajlm-991	49	17	for	for	ADP
ajlm-991	49	18	136	136	NUM
ajlm-991	49	19	(	(	PUNCT
ajlm-991	49	20	75.9	75.9	NUM
ajlm-991	49	21	%	%	NOUN
ajlm-991	49	22	)	)	PUNCT
ajlm-991	49	23	of	of	ADP
ajlm-991	49	24	the	the	DET
ajlm-991	49	25	total	total	ADJ
ajlm-991	49	26	isolates	isolate	NOUN
ajlm-991	49	27	(	(	PUNCT
ajlm-991	49	28	table	table	NOUN
ajlm-991	49	29	1	1	NUM
ajlm-991	49	30	)	)	PUNCT
ajlm-991	49	31	.	.	PUNCT
ajlm-991	50	1	of	of	ADP
ajlm-991	50	2	the	the	DET
ajlm-991	50	3	included	include	VERB
ajlm-991	50	4	pathogens	pathogen	NOUN
ajlm-991	50	5	,	,	PUNCT
ajlm-991	50	6	127	127	NUM
ajlm-991	50	7	(	(	PUNCT
ajlm-991	50	8	70.9	70.9	NUM
ajlm-991	50	9	%	%	NOUN
ajlm-991	50	10	)	)	PUNCT
ajlm-991	50	11	were	be	AUX
ajlm-991	50	12	isolated	isolate	VERB
ajlm-991	50	13	from	from	ADP
ajlm-991	50	14	inpatients	inpatient	NOUN
ajlm-991	50	15	,	,	PUNCT
ajlm-991	50	16	and	and	CCONJ
ajlm-991	50	17	29	29	NUM
ajlm-991	50	18	(	(	PUNCT
ajlm-991	50	19	16.2	16.2	NUM
ajlm-991	50	20	%	%	NOUN
ajlm-991	50	21	)	)	PUNCT
ajlm-991	50	22	were	be	AUX
ajlm-991	50	23	isolated	isolate	VERB
ajlm-991	50	24	from	from	ADP
ajlm-991	50	25	patients	patient	NOUN
ajlm-991	50	26	in	in	ADP
ajlm-991	50	27	intensive	intensive	ADJ
ajlm-991	50	28	care	care	NOUN
ajlm-991	50	29	units	unit	NOUN
ajlm-991	50	30	(	(	PUNCT
ajlm-991	50	31	figure	figure	NOUN
ajlm-991	50	32	2	2	NUM
ajlm-991	50	33	)	)	PUNCT
ajlm-991	50	34	.	.	PUNCT
ajlm-991	51	1	figure	figure	NOUN
ajlm-991	51	2	2	2	NUM
ajlm-991	51	3	:	:	PUNCT
ajlm-991	51	4	ward	ward	NOUN
ajlm-991	51	5	distribution	distribution	NOUN
ajlm-991	51	6	of	of	ADP
ajlm-991	51	7	samples	sample	NOUN
ajlm-991	51	8	included	include	VERB
ajlm-991	51	9	in	in	ADP
ajlm-991	51	10	the	the	DET
ajlm-991	51	11	study	study	NOUN
ajlm-991	51	12	at	at	ADP
ajlm-991	51	13	a	a	DET
ajlm-991	51	14	hospital	hospital	NOUN
ajlm-991	51	15	in	in	ADP
ajlm-991	51	16	delhi	delhi	PROPN
ajlm-991	51	17	,	,	PUNCT
ajlm-991	51	18	india	india	PROPN
ajlm-991	51	19	,	,	PUNCT
ajlm-991	51	20	february	february	PROPN
ajlm-991	51	21	2017	2017	NUM
ajlm-991	51	22	to	to	ADP
ajlm-991	51	23	june	june	PROPN
ajlm-991	51	24	2017	2017	NUM
ajlm-991	51	25	.	.	PUNCT
ajlm-991	52	1	table	table	NOUN
ajlm-991	52	2	1	1	NUM
ajlm-991	52	3	:	:	PUNCT
ajlm-991	52	4	 	 	SPACE
ajlm-991	52	5	prevalence	prevalence	NOUN
ajlm-991	52	6	of	of	ADP
ajlm-991	52	7	individual	individual	ADJ
ajlm-991	52	8	pathogens	pathogen	NOUN
ajlm-991	52	9	in	in	ADP
ajlm-991	52	10	various	various	ADJ
ajlm-991	52	11	samples	sample	NOUN
ajlm-991	52	12	at	at	ADP
ajlm-991	52	13	a	a	DET
ajlm-991	52	14	hospital	hospital	NOUN
ajlm-991	52	15	in	in	ADP
ajlm-991	52	16	delhi	delhi	PROPN
ajlm-991	52	17	,	,	PUNCT
ajlm-991	52	18	india	india	PROPN
ajlm-991	52	19	,	,	PUNCT
ajlm-991	52	20	february	february	PROPN
ajlm-991	52	21	2017	2017	NUM
ajlm-991	52	22	to	to	ADP
ajlm-991	52	23	june	june	PROPN
ajlm-991	52	24	2017	2017	NUM
ajlm-991	52	25	.	.	PUNCT
ajlm-991	53	1	among	among	ADP
ajlm-991	53	2	the	the	DET
ajlm-991	53	3	isolated	isolate	VERB
ajlm-991	53	4	pathogens	pathogen	NOUN
ajlm-991	53	5	,	,	PUNCT
ajlm-991	53	6	e.	e.	PROPN
ajlm-991	53	7	coli	coli	PROPN
ajlm-991	53	8	(	(	PUNCT
ajlm-991	53	9	n	n	NOUN
ajlm-991	53	10	=	=	SYM
ajlm-991	53	11	76	76	NUM
ajlm-991	53	12	;	;	PUNCT
ajlm-991	53	13	42.4	42.4	NUM
ajlm-991	53	14	%	%	NOUN
ajlm-991	53	15	)	)	PUNCT
ajlm-991	53	16	was	be	AUX
ajlm-991	53	17	the	the	DET
ajlm-991	53	18	most	most	ADV
ajlm-991	53	19	predominant	predominant	NOUN
ajlm-991	53	20	followed	follow	VERB
ajlm-991	53	21	by	by	ADP
ajlm-991	53	22	klebsiella	klebsiella	NOUN
ajlm-991	53	23	pneumoniae	pneumoniae	ADJ
ajlm-991	53	24	(	(	PUNCT
ajlm-991	53	25	n	n	NOUN
ajlm-991	53	26	=	=	SYM
ajlm-991	53	27	53	53	NUM
ajlm-991	53	28	;	;	PUNCT
ajlm-991	53	29	29.6	29.6	NUM
ajlm-991	53	30	%	%	NOUN
ajlm-991	53	31	)	)	PUNCT
ajlm-991	53	32	and	and	CCONJ
ajlm-991	53	33	a.	a.	NOUN
ajlm-991	53	34	baumanii	baumanii	PROPN
ajlm-991	53	35	(	(	PUNCT
ajlm-991	53	36	n	n	NOUN
ajlm-991	53	37	=	=	SYM
ajlm-991	53	38	27	27	NUM
ajlm-991	53	39	;	;	PUNCT
ajlm-991	53	40	15	15	NUM
ajlm-991	53	41	%	%	NOUN
ajlm-991	53	42	)	)	PUNCT
ajlm-991	53	43	(	(	PUNCT
ajlm-991	53	44	table	table	NOUN
ajlm-991	53	45	1	1	NUM
ajlm-991	53	46	)	)	PUNCT
ajlm-991	53	47	.	.	PUNCT
ajlm-991	54	1	eighty	eighty	NUM
ajlm-991	54	2	-	-	PUNCT
ajlm-991	54	3	five	five	NUM
ajlm-991	54	4	(	(	PUNCT
ajlm-991	54	5	47.5	47.5	NUM
ajlm-991	54	6	%	%	NOUN
ajlm-991	54	7	)	)	PUNCT
ajlm-991	54	8	of	of	ADP
ajlm-991	54	9	the	the	DET
ajlm-991	54	10	tested	test	VERB
ajlm-991	54	11	isolates	isolate	NOUN
ajlm-991	54	12	were	be	AUX
ajlm-991	54	13	esbl	esbl	NOUN
ajlm-991	54	14	producers	producer	NOUN
ajlm-991	54	15	and	and	CCONJ
ajlm-991	54	16	94	94	NUM
ajlm-991	54	17	(	(	PUNCT
ajlm-991	54	18	52.5	52.5	NUM
ajlm-991	54	19	%	%	NOUN
ajlm-991	54	20	)	)	PUNCT
ajlm-991	54	21	were	be	AUX
ajlm-991	54	22	mbl	mbl	NOUN
ajlm-991	54	23	producers	producer	NOUN
ajlm-991	54	24	.	.	PUNCT
ajlm-991	55	1	fifty	fifty	NUM
ajlm-991	55	2	-	-	PUNCT
ajlm-991	55	3	eight	eight	NUM
ajlm-991	55	4	(	(	PUNCT
ajlm-991	55	5	68.23	68.23	NUM
ajlm-991	55	6	%	%	NOUN
ajlm-991	55	7	)	)	PUNCT
ajlm-991	55	8	of	of	ADP
ajlm-991	55	9	the	the	DET
ajlm-991	55	10	esbl	esbl	NOUN
ajlm-991	55	11	producers	producer	NOUN
ajlm-991	55	12	(	(	PUNCT
ajlm-991	55	13	table	table	NOUN
ajlm-991	55	14	2	2	NUM
ajlm-991	55	15	)	)	PUNCT
ajlm-991	55	16	and	and	CCONJ
ajlm-991	55	17	37	37	NUM
ajlm-991	55	18	(	(	PUNCT
ajlm-991	55	19	39.36	39.36	NUM
ajlm-991	55	20	%	%	NOUN
ajlm-991	55	21	)	)	PUNCT
ajlm-991	55	22	mbl	mbl	NOUN
ajlm-991	55	23	producers	producer	NOUN
ajlm-991	55	24	(	(	PUNCT
ajlm-991	55	25	table	table	NOUN
ajlm-991	55	26	3	3	NUM
ajlm-991	55	27	)	)	PUNCT
ajlm-991	55	28	showed	show	VERB
ajlm-991	55	29	in	in	ADP
ajlm-991	55	30	vitro	vitro	X
ajlm-991	55	31	sensitivity	sensitivity	NOUN
ajlm-991	55	32	towards	towards	ADP
ajlm-991	55	33	cse	cse	PROPN
ajlm-991	55	34	.	.	PUNCT
ajlm-991	55	35	table	table	NOUN
ajlm-991	56	1	2	2	NUM
ajlm-991	56	2	:	:	PUNCT
ajlm-991	56	3	 	 	SPACE
ajlm-991	56	4	antibiogram	antibiogram	PROPN
ajlm-991	56	5	for	for	ADP
ajlm-991	56	6	ceftriaxone	ceftriaxone	NOUN
ajlm-991	56	7	-	-	PUNCT
ajlm-991	56	8	sulbactam	sulbactam	NOUN
ajlm-991	56	9	-	-	PUNCT
ajlm-991	56	10	disodium	disodium	NOUN
ajlm-991	56	11	edetate	edetate	NOUN
ajlm-991	56	12	against	against	ADP
ajlm-991	56	13	extended	extend	VERB
ajlm-991	56	14	-	-	PUNCT
ajlm-991	56	15	spectrum	spectrum	NOUN
ajlm-991	56	16	β	β	NOUN
ajlm-991	56	17	-	-	NOUN
ajlm-991	56	18	lactamases	lactamase	NOUN
ajlm-991	56	19	producing	produce	VERB
ajlm-991	56	20	gram	gram	NOUN
ajlm-991	56	21	-	-	PUNCT
ajlm-991	56	22	negative	negative	ADJ
ajlm-991	56	23	isolates	isolate	NOUN
ajlm-991	56	24	at	at	ADP
ajlm-991	56	25	a	a	DET
ajlm-991	56	26	hospital	hospital	NOUN
ajlm-991	56	27	in	in	ADP
ajlm-991	56	28	delhi	delhi	PROPN
ajlm-991	56	29	,	,	PUNCT
ajlm-991	56	30	india	india	PROPN
ajlm-991	56	31	,	,	PUNCT
ajlm-991	56	32	february	february	PROPN
ajlm-991	56	33	2017	2017	NUM
ajlm-991	56	34	to	to	ADP
ajlm-991	56	35	june	june	PROPN
ajlm-991	56	36	2017	2017	NUM
ajlm-991	56	37	.	.	PUNCT
ajlm-991	57	1	table	table	NOUN
ajlm-991	57	2	3	3	NUM
ajlm-991	57	3	:	:	PUNCT
ajlm-991	57	4	 	 	SPACE
ajlm-991	57	5	antibiogram	antibiogram	PROPN
ajlm-991	57	6	for	for	ADP
ajlm-991	57	7	ceftriaxone	ceftriaxone	NOUN
ajlm-991	57	8	-	-	PUNCT
ajlm-991	57	9	sulbactam	sulbactam	NOUN
ajlm-991	57	10	-	-	PUNCT
ajlm-991	57	11	disodium	disodium	NOUN
ajlm-991	57	12	edetate	edetate	NOUN
ajlm-991	57	13	against	against	ADP
ajlm-991	57	14	metallo	metallo	PROPN
ajlm-991	57	15	β	β	NOUN
ajlm-991	57	16	-	-	NOUN
ajlm-991	57	17	lactamases	lactamase	NOUN
ajlm-991	57	18	producing	produce	VERB
ajlm-991	57	19	gram	gram	NOUN
ajlm-991	57	20	-	-	PUNCT
ajlm-991	57	21	negative	negative	ADJ
ajlm-991	57	22	isolates	isolate	NOUN
ajlm-991	57	23	at	at	ADP
ajlm-991	57	24	a	a	DET
ajlm-991	57	25	hospital	hospital	NOUN
ajlm-991	57	26	in	in	ADP
ajlm-991	57	27	delhi	delhi	PROPN
ajlm-991	57	28	,	,	PUNCT
ajlm-991	57	29	india	india	PROPN
ajlm-991	57	30	,	,	PUNCT
ajlm-991	57	31	february	february	PROPN
ajlm-991	57	32	2017	2017	NUM
ajlm-991	57	33	to	to	ADP
ajlm-991	57	34	june	june	PROPN
ajlm-991	57	35	2017	2017	NUM
ajlm-991	57	36	.	.	PUNCT
ajlm-991	58	1	among	among	ADP
ajlm-991	58	2	the	the	DET
ajlm-991	58	3	identified	identify	VERB
ajlm-991	58	4	esbl	esbl	NOUN
ajlm-991	58	5	-	-	PUNCT
ajlm-991	58	6	producing	produce	VERB
ajlm-991	58	7	gnb	gnb	NOUN
ajlm-991	58	8	,	,	PUNCT
ajlm-991	58	9	44	44	NUM
ajlm-991	58	10	(	(	PUNCT
ajlm-991	58	11	73.3	73.3	NUM
ajlm-991	58	12	%	%	NOUN
ajlm-991	58	13	)	)	PUNCT
ajlm-991	58	14	e.	e.	PROPN
ajlm-991	58	15	coli	coli	PROPN
ajlm-991	58	16	and	and	CCONJ
ajlm-991	58	17	7	7	NUM
ajlm-991	58	18	(	(	PUNCT
ajlm-991	58	19	53.8	53.8	NUM
ajlm-991	58	20	%	%	NOUN
ajlm-991	58	21	)	)	PUNCT
ajlm-991	58	22	k.	k.	PROPN
ajlm-991	58	23	pneumoniae	pneumoniae	NOUN
ajlm-991	58	24	showed	show	VERB
ajlm-991	58	25	sensitivity	sensitivity	NOUN
ajlm-991	58	26	towards	towards	ADP
ajlm-991	58	27	cse	cse	NOUN
ajlm-991	58	28	,	,	PUNCT
ajlm-991	58	29	while	while	SCONJ
ajlm-991	58	30	51	51	NUM
ajlm-991	58	31	(	(	PUNCT
ajlm-991	58	32	85	85	NUM
ajlm-991	58	33	%	%	NOUN
ajlm-991	58	34	)	)	PUNCT
ajlm-991	58	35	e.	e.	PROPN
ajlm-991	58	36	coli	coli	PROPN
ajlm-991	58	37	and	and	CCONJ
ajlm-991	58	38	11	11	NUM
ajlm-991	58	39	(	(	PUNCT
ajlm-991	58	40	84.6	84.6	NUM
ajlm-991	58	41	%	%	NOUN
ajlm-991	58	42	)	)	PUNCT
ajlm-991	59	1	k.	k.	PROPN
ajlm-991	59	2	pneumoniae	pneumoniae	NOUN
ajlm-991	59	3	showed	show	VERB
ajlm-991	59	4	sensitivity	sensitivity	NOUN
ajlm-991	59	5	towards	towards	ADP
ajlm-991	59	6	meropenem	meropenem	PROPN
ajlm-991	59	7	.	.	PUNCT
ajlm-991	60	1	the	the	DET
ajlm-991	60	2	most	most	ADV
ajlm-991	60	3	common	common	ADJ
ajlm-991	60	4	mbl	mbl	NOUN
ajlm-991	60	5	-	-	PUNCT
ajlm-991	60	6	producing	produce	VERB
ajlm-991	60	7	gnbs	gnbs	NOUN
ajlm-991	60	8	,	,	PUNCT
ajlm-991	60	9	k.	k.	PROPN
ajlm-991	60	10	pneumoniae	pneumoniae	PROPN
ajlm-991	60	11	,	,	PUNCT
ajlm-991	60	12	a.	a.	NOUN
ajlm-991	60	13	baumanii	baumanii	PROPN
ajlm-991	60	14	and	and	CCONJ
ajlm-991	60	15	e.	e.	PROPN
ajlm-991	60	16	coli	coli	PROPN
ajlm-991	60	17	,	,	PUNCT
ajlm-991	60	18	showed	show	VERB
ajlm-991	60	19	27.5	27.5	NUM
ajlm-991	60	20	%	%	NOUN
ajlm-991	60	21	(	(	PUNCT
ajlm-991	60	22	n	n	NOUN
ajlm-991	60	23	=	=	NUM
ajlm-991	60	24	11	11	NUM
ajlm-991	60	25	)	)	PUNCT
ajlm-991	60	26	,	,	PUNCT
ajlm-991	60	27	48	48	NUM
ajlm-991	60	28	%	%	NOUN
ajlm-991	60	29	(	(	PUNCT
ajlm-991	60	30	n	n	NOUN
ajlm-991	60	31	=	=	NUM
ajlm-991	60	32	12	12	NUM
ajlm-991	60	33	)	)	PUNCT
ajlm-991	60	34	and	and	CCONJ
ajlm-991	60	35	31.3	31.3	NUM
ajlm-991	60	36	%	%	NOUN
ajlm-991	60	37	(	(	PUNCT
ajlm-991	60	38	n	n	NOUN
ajlm-991	60	39	=	=	SYM
ajlm-991	60	40	5	5	NUM
ajlm-991	60	41	)	)	PUNCT
ajlm-991	60	42	sensitivity	sensitivity	NOUN
ajlm-991	60	43	,	,	PUNCT
ajlm-991	60	44	respectively	respectively	ADV
ajlm-991	60	45	,	,	PUNCT
ajlm-991	60	46	towards	towards	ADP
ajlm-991	60	47	cse	cse	NOUN
ajlm-991	60	48	and	and	CCONJ
ajlm-991	60	49	2.5	2.5	NUM
ajlm-991	60	50	%	%	NOUN
ajlm-991	60	51	(	(	PUNCT
ajlm-991	60	52	n	n	NOUN
ajlm-991	60	53	=	=	SYM
ajlm-991	60	54	1	1	NUM
ajlm-991	60	55	)	)	PUNCT
ajlm-991	60	56	,	,	PUNCT
ajlm-991	60	57	0	0	NUM
ajlm-991	60	58	%	%	NOUN
ajlm-991	60	59	and	and	CCONJ
ajlm-991	60	60	6.3	6.3	NUM
ajlm-991	60	61	%	%	NOUN
ajlm-991	60	62	(	(	PUNCT
ajlm-991	60	63	n	n	NOUN
ajlm-991	60	64	=	=	SYM
ajlm-991	60	65	1	1	NUM
ajlm-991	60	66	)	)	PUNCT
ajlm-991	60	67	sensitivity	sensitivity	NOUN
ajlm-991	60	68	,	,	PUNCT
ajlm-991	60	69	respectively	respectively	ADV
ajlm-991	60	70	,	,	PUNCT
ajlm-991	60	71	towards	towards	ADP
ajlm-991	60	72	meropenem	meropenem	PROPN
ajlm-991	60	73	(	(	PUNCT
ajlm-991	60	74	data	datum	NOUN
ajlm-991	60	75	not	not	PART
ajlm-991	60	76	shown	show	VERB
ajlm-991	60	77	)	)	PUNCT
ajlm-991	60	78	.	.	PUNCT
ajlm-991	61	1	a	a	DET
ajlm-991	61	2	statistically	statistically	ADV
ajlm-991	61	3	significant	significant	ADJ
ajlm-991	61	4	association	association	NOUN
ajlm-991	61	5	was	be	AUX
ajlm-991	61	6	found	find	VERB
ajlm-991	61	7	when	when	SCONJ
ajlm-991	61	8	susceptibility	susceptibility	NOUN
ajlm-991	61	9	to	to	PART
ajlm-991	61	10	meropenem	meropenem	PROPN
ajlm-991	61	11	and	and	CCONJ
ajlm-991	61	12	cse	cse	PROPN
ajlm-991	61	13	were	be	AUX
ajlm-991	61	14	compared	compare	VERB
ajlm-991	61	15	(	(	PUNCT
ajlm-991	61	16	p	p	X
ajlm-991	61	17	<	<	X
ajlm-991	61	18	0.001	0.001	NUM
ajlm-991	61	19	)	)	PUNCT
ajlm-991	61	20	in	in	ADP
ajlm-991	61	21	esbl	esbl	NOUN
ajlm-991	61	22	-	-	PUNCT
ajlm-991	61	23	producing	produce	VERB
ajlm-991	61	24	e.	e.	NOUN
ajlm-991	61	25	coli	coli	NOUN
ajlm-991	61	26	.	.	PUNCT
ajlm-991	62	1	however	however	ADV
ajlm-991	62	2	,	,	PUNCT
ajlm-991	62	3	no	no	DET
ajlm-991	62	4	statistically	statistically	ADV
ajlm-991	62	5	significant	significant	ADJ
ajlm-991	62	6	associations	association	NOUN
ajlm-991	62	7	were	be	AUX
ajlm-991	62	8	seen	see	VERB
ajlm-991	62	9	when	when	SCONJ
ajlm-991	62	10	the	the	DET
ajlm-991	62	11	cse	cse	NOUN
ajlm-991	62	12	susceptibility	susceptibility	NOUN
ajlm-991	62	13	pattern	pattern	NOUN
ajlm-991	62	14	was	be	AUX
ajlm-991	62	15	compared	compare	VERB
ajlm-991	62	16	to	to	PART
ajlm-991	62	17	meropenem	meropenem	VERB
ajlm-991	62	18	susceptibility	susceptibility	NOUN
ajlm-991	62	19	patterns	pattern	NOUN
ajlm-991	62	20	for	for	ADP
ajlm-991	62	21	other	other	ADJ
ajlm-991	62	22	esbland	esbland	NOUN
ajlm-991	62	23	mbl	mbl	NOUN
ajlm-991	62	24	-	-	PUNCT
ajlm-991	62	25	producing	produce	VERB
ajlm-991	62	26	organisms	organism	NOUN
ajlm-991	62	27	.	.	PUNCT
ajlm-991	63	1	twelve	twelve	NUM
ajlm-991	63	2	(	(	PUNCT
ajlm-991	63	3	48	48	NUM
ajlm-991	63	4	%	%	NOUN
ajlm-991	63	5	)	)	PUNCT
ajlm-991	63	6	of	of	ADP
ajlm-991	63	7	the	the	DET
ajlm-991	63	8	mbl	mbl	NOUN
ajlm-991	63	9	-	-	PUNCT
ajlm-991	63	10	producing	produce	VERB
ajlm-991	63	11	a.	a.	NOUN
ajlm-991	63	12	baumanii	baumanii	NOUN
ajlm-991	63	13	isolates	isolate	NOUN
ajlm-991	63	14	which	which	PRON
ajlm-991	63	15	were	be	AUX
ajlm-991	63	16	resistant	resistant	ADJ
ajlm-991	63	17	to	to	PART
ajlm-991	63	18	meropenem	meropenem	PROPN
ajlm-991	63	19	showed	show	VERB
ajlm-991	63	20	susceptibility	susceptibility	NOUN
ajlm-991	63	21	to	to	ADP
ajlm-991	63	22	cse	cse	PROPN
ajlm-991	63	23	(	(	PUNCT
ajlm-991	63	24	data	datum	NOUN
ajlm-991	63	25	not	not	PART
ajlm-991	63	26	shown	show	VERB
ajlm-991	63	27	)	)	PUNCT
ajlm-991	63	28	.	.	PUNCT
ajlm-991	64	1	multi	multi	ADJ
ajlm-991	64	2	-	-	ADJ
ajlm-991	64	3	drug	drug	ADJ
ajlm-991	64	4	resistant	resistant	ADJ
ajlm-991	64	5	e.	e.	PROPN
ajlm-991	64	6	coli	coli	PROPN
ajlm-991	64	7	,	,	PUNCT
ajlm-991	64	8	k.	k.	NOUN
ajlm-991	65	1	pneumoniae	pneumoniae	NOUN
ajlm-991	65	2	and	and	CCONJ
ajlm-991	65	3	a.	a.	NOUN
ajlm-991	65	4	baumanii	baumanii	PROPN
ajlm-991	65	5	showed	show	VERB
ajlm-991	65	6	64.5	64.5	NUM
ajlm-991	65	7	%	%	NOUN
ajlm-991	65	8	(	(	PUNCT
ajlm-991	65	9	n	n	NOUN
ajlm-991	65	10	=	=	SYM
ajlm-991	65	11	49	49	NUM
ajlm-991	65	12	)	)	PUNCT
ajlm-991	65	13	,	,	PUNCT
ajlm-991	65	14	33.9	33.9	NUM
ajlm-991	65	15	%	%	NOUN
ajlm-991	65	16	(	(	PUNCT
ajlm-991	65	17	n	n	NOUN
ajlm-991	65	18	=	=	SYM
ajlm-991	65	19	18	18	NUM
ajlm-991	65	20	)	)	PUNCT
ajlm-991	65	21	and	and	CCONJ
ajlm-991	65	22	48.1	48.1	NUM
ajlm-991	65	23	%	%	NOUN
ajlm-991	65	24	(	(	PUNCT
ajlm-991	65	25	n	n	NOUN
ajlm-991	65	26	=	=	SYM
ajlm-991	65	27	13	13	NUM
ajlm-991	65	28	)	)	PUNCT
ajlm-991	65	29	susceptibility	susceptibility	NOUN
ajlm-991	65	30	,	,	PUNCT
ajlm-991	65	31	respectively	respectively	ADV
ajlm-991	65	32	,	,	PUNCT
ajlm-991	65	33	towards	towards	ADP
ajlm-991	65	34	cse	cse	NOUN
ajlm-991	65	35	and	and	CCONJ
ajlm-991	65	36	71.1	71.1	NUM
ajlm-991	65	37	%	%	NOUN
ajlm-991	65	38	(	(	PUNCT
ajlm-991	65	39	n	n	NOUN
ajlm-991	65	40	=	=	SYM
ajlm-991	65	41	54	54	NUM
ajlm-991	65	42	)	)	PUNCT
ajlm-991	65	43	,	,	PUNCT
ajlm-991	65	44	20.8	20.8	NUM
ajlm-991	65	45	%	%	NOUN
ajlm-991	65	46	(	(	PUNCT
ajlm-991	65	47	n	n	NOUN
ajlm-991	65	48	=	=	SYM
ajlm-991	65	49	11	11	NUM
ajlm-991	65	50	)	)	PUNCT
ajlm-991	65	51	and	and	CCONJ
ajlm-991	65	52	7.4	7.4	NUM
ajlm-991	65	53	%	%	NOUN
ajlm-991	65	54	(	(	PUNCT
ajlm-991	65	55	n	n	NOUN
ajlm-991	65	56	=	=	SYM
ajlm-991	65	57	2	2	NUM
ajlm-991	65	58	)	)	PUNCT
ajlm-991	65	59	,	,	PUNCT
ajlm-991	65	60	respectively	respectively	ADV
ajlm-991	65	61	,	,	PUNCT
ajlm-991	65	62	against	against	ADP
ajlm-991	65	63	meropenem	meropenem	PROPN
ajlm-991	65	64	(	(	PUNCT
ajlm-991	65	65	figure	figure	NOUN
ajlm-991	65	66	3	3	NUM
ajlm-991	65	67	)	)	PUNCT
ajlm-991	65	68	.	.	PUNCT
ajlm-991	66	1	figure	figure	VERB
ajlm-991	66	2	3	3	NUM
ajlm-991	66	3	:	:	PUNCT
ajlm-991	66	4	in	in	ADP
ajlm-991	66	5	vitro	vitro	X
ajlm-991	66	6	antibiotic	antibiotic	ADJ
ajlm-991	66	7	susceptibility	susceptibility	NOUN
ajlm-991	66	8	pattern	pattern	NOUN
ajlm-991	66	9	for	for	ADP
ajlm-991	66	10	most	most	ADJ
ajlm-991	66	11	common	common	ADJ
ajlm-991	66	12	gram	gram	NOUN
ajlm-991	66	13	-	-	PUNCT
ajlm-991	66	14	negative	negative	ADJ
ajlm-991	66	15	isolates	isolate	NOUN
ajlm-991	66	16	against	against	ADP
ajlm-991	66	17	ceftriaxone	ceftriaxone	NOUN
ajlm-991	66	18	-	-	PUNCT
ajlm-991	66	19	sulbactam	sulbactam	NOUN
ajlm-991	66	20	-	-	PUNCT
ajlm-991	66	21	disodium	disodium	NOUN
ajlm-991	66	22	edetate	edetate	NOUN
ajlm-991	66	23	and	and	CCONJ
ajlm-991	66	24	meropenem	meropenem	PROPN
ajlm-991	66	25	(	(	PUNCT
ajlm-991	66	26	n	n	NOUN
ajlm-991	66	27	=	=	SYM
ajlm-991	66	28	156	156	NUM
ajlm-991	66	29	)	)	PUNCT
ajlm-991	66	30	at	at	ADP
ajlm-991	66	31	a	a	DET
ajlm-991	66	32	hospital	hospital	NOUN
ajlm-991	66	33	in	in	ADP
ajlm-991	66	34	delhi	delhi	PROPN
ajlm-991	66	35	,	,	PUNCT
ajlm-991	66	36	india	india	PROPN
ajlm-991	66	37	,	,	PUNCT
ajlm-991	66	38	february	february	PROPN
ajlm-991	66	39	2017	2017	NUM
ajlm-991	66	40	to	to	ADP
ajlm-991	66	41	june	june	PROPN
ajlm-991	66	42	2017	2017	NUM
ajlm-991	66	43	.	.	PUNCT
ajlm-991	67	1	discussion	discussion	NOUN
ajlm-991	67	2	this	this	DET
ajlm-991	67	3	study	study	NOUN
ajlm-991	67	4	included	include	VERB
ajlm-991	67	5	only	only	ADV
ajlm-991	67	6	those	those	DET
ajlm-991	67	7	mdr	mdr	PROPN
ajlm-991	67	8	gnb	gnb	PROPN
ajlm-991	67	9	isolates	isolate	NOUN
ajlm-991	67	10	which	which	PRON
ajlm-991	67	11	were	be	AUX
ajlm-991	67	12	proven	prove	VERB
ajlm-991	67	13	to	to	PART
ajlm-991	67	14	be	be	AUX
ajlm-991	67	15	pathogenic	pathogenic	ADJ
ajlm-991	67	16	,	,	PUNCT
ajlm-991	67	17	obtained	obtain	VERB
ajlm-991	67	18	from	from	ADP
ajlm-991	67	19	clinically	clinically	ADV
ajlm-991	67	20	established	establish	VERB
ajlm-991	67	21	cases	case	NOUN
ajlm-991	67	22	of	of	ADP
ajlm-991	67	23	infection	infection	NOUN
ajlm-991	67	24	.	.	PUNCT
ajlm-991	68	1	the	the	DET
ajlm-991	68	2	majority	majority	NOUN
ajlm-991	68	3	of	of	ADP
ajlm-991	68	4	isolates	isolate	NOUN
ajlm-991	68	5	were	be	AUX
ajlm-991	68	6	from	from	ADP
ajlm-991	68	7	urine	urine	NOUN
ajlm-991	68	8	samples	sample	NOUN
ajlm-991	68	9	(	(	PUNCT
ajlm-991	68	10	n	n	NOUN
ajlm-991	68	11	=	=	SYM
ajlm-991	68	12	84	84	NUM
ajlm-991	68	13	;	;	PUNCT
ajlm-991	68	14	47	47	NUM
ajlm-991	68	15	%	%	NOUN
ajlm-991	68	16	)	)	PUNCT
ajlm-991	68	17	,	,	PUNCT
ajlm-991	68	18	followed	follow	VERB
ajlm-991	68	19	by	by	ADP
ajlm-991	68	20	pus	pus	PROPN
ajlm-991	68	21	(	(	PUNCT
ajlm-991	68	22	n	n	NOUN
ajlm-991	68	23	=	=	SYM
ajlm-991	68	24	34	34	NUM
ajlm-991	68	25	;	;	PUNCT
ajlm-991	68	26	19	19	NUM
ajlm-991	68	27	%	%	NOUN
ajlm-991	68	28	)	)	PUNCT
ajlm-991	68	29	and	and	CCONJ
ajlm-991	68	30	blood	blood	NOUN
ajlm-991	68	31	(	(	PUNCT
ajlm-991	68	32	n	n	NOUN
ajlm-991	68	33	=	=	SYM
ajlm-991	68	34	18	18	NUM
ajlm-991	68	35	;	;	PUNCT
ajlm-991	68	36	10	10	NUM
ajlm-991	68	37	%	%	NOUN
ajlm-991	68	38	)	)	PUNCT
ajlm-991	68	39	.	.	PUNCT
ajlm-991	69	1	the	the	DET
ajlm-991	69	2	identified	identify	VERB
ajlm-991	69	3	pathogens	pathogen	NOUN
ajlm-991	69	4	included	include	VERB
ajlm-991	69	5	e.	e.	PROPN
ajlm-991	69	6	coli	coli	PROPN
ajlm-991	69	7	,	,	PUNCT
ajlm-991	69	8	k.	k.	NOUN
ajlm-991	70	1	pneumoniae	pneumoniae	NOUN
ajlm-991	70	2	and	and	CCONJ
ajlm-991	70	3	a.	a.	NOUN
ajlm-991	70	4	baumanii	baumanii	PROPN
ajlm-991	70	5	,	,	PUNCT
ajlm-991	70	6	in	in	ADP
ajlm-991	70	7	decreasing	decrease	VERB
ajlm-991	70	8	order	order	NOUN
ajlm-991	70	9	of	of	ADP
ajlm-991	70	10	prevalence	prevalence	NOUN
ajlm-991	70	11	.	.	PUNCT
ajlm-991	71	1	similar	similar	ADJ
ajlm-991	71	2	distributions	distribution	NOUN
ajlm-991	71	3	of	of	ADP
ajlm-991	71	4	isolates	isolate	NOUN
ajlm-991	71	5	with	with	ADP
ajlm-991	71	6	similar	similar	ADJ
ajlm-991	71	7	specimen	speciman	NOUN
ajlm-991	71	8	distribution	distribution	NOUN
ajlm-991	71	9	have	have	AUX
ajlm-991	71	10	been	be	AUX
ajlm-991	71	11	reported	report	VERB
ajlm-991	71	12	by	by	ADP
ajlm-991	71	13	other	other	ADJ
ajlm-991	71	14	studies.21,22	studies.21,22	NOUN
ajlm-991	71	15	in	in	ADP
ajlm-991	71	16	the	the	DET
ajlm-991	71	17	present	present	ADJ
ajlm-991	71	18	study	study	NOUN
ajlm-991	71	19	,	,	PUNCT
ajlm-991	71	20	e.	e.	PROPN
ajlm-991	71	21	coli	coli	PROPN
ajlm-991	71	22	(	(	PUNCT
ajlm-991	71	23	n	n	NOUN
ajlm-991	71	24	=	=	SYM
ajlm-991	71	25	49	49	NUM
ajlm-991	71	26	;	;	PUNCT
ajlm-991	71	27	58.3	58.3	NUM
ajlm-991	71	28	%	%	NOUN
ajlm-991	71	29	)	)	PUNCT
ajlm-991	71	30	was	be	AUX
ajlm-991	71	31	highly	highly	ADV
ajlm-991	71	32	prevalent	prevalent	ADJ
ajlm-991	71	33	in	in	ADP
ajlm-991	71	34	urine	urine	NOUN
ajlm-991	71	35	samples	sample	NOUN
ajlm-991	71	36	,	,	PUNCT
ajlm-991	71	37	followed	follow	VERB
ajlm-991	71	38	by	by	ADP
ajlm-991	71	39	k.	k.	PROPN
ajlm-991	71	40	pneumoniae	pneumoniae	PROPN
ajlm-991	71	41	(	(	PUNCT
ajlm-991	71	42	n	n	NOUN
ajlm-991	71	43	=	=	SYM
ajlm-991	71	44	22	22	NUM
ajlm-991	71	45	;	;	PUNCT
ajlm-991	71	46	26.2	26.2	NUM
ajlm-991	71	47	%	%	NOUN
ajlm-991	71	48	)	)	PUNCT
ajlm-991	71	49	,	,	PUNCT
ajlm-991	71	50	indicating	indicate	VERB
ajlm-991	71	51	their	their	PRON
ajlm-991	71	52	significant	significant	ADJ
ajlm-991	71	53	role	role	NOUN
ajlm-991	71	54	in	in	ADP
ajlm-991	71	55	urinary	urinary	ADJ
ajlm-991	71	56	tract	tract	NOUN
ajlm-991	71	57	infections	infection	NOUN
ajlm-991	71	58	.	.	PUNCT
ajlm-991	72	1	similar	similar	ADJ
ajlm-991	72	2	findings	finding	NOUN
ajlm-991	72	3	were	be	AUX
ajlm-991	72	4	also	also	ADV
ajlm-991	72	5	reported	report	VERB
ajlm-991	72	6	by	by	ADP
ajlm-991	72	7	janifer	janifer	NOUN
ajlm-991	72	8	et	et	PROPN
ajlm-991	72	9	al	al	PROPN
ajlm-991	72	10	.	.	PROPN
ajlm-991	73	1	in	in	ADP
ajlm-991	73	2	chennai	chennai	PROPN
ajlm-991	73	3	,	,	PUNCT
ajlm-991	73	4	south	south	ADJ
ajlm-991	73	5	india23	india23	NOUN
ajlm-991	73	6	and	and	CCONJ
ajlm-991	73	7	ruchika	ruchika	PROPN
ajlm-991	73	8	et	et	PROPN
ajlm-991	73	9	al	al	PROPN
ajlm-991	73	10	.	.	PROPN
ajlm-991	74	1	in	in	ADP
ajlm-991	74	2	gurgaon	gurgaon	PROPN
ajlm-991	74	3	,	,	PUNCT
ajlm-991	74	4	haryana	haryana	PROPN
ajlm-991	74	5	,	,	PUNCT
ajlm-991	74	6	north	north	PROPN
ajlm-991	74	7	india.24	india.24	PROPN
ajlm-991	74	8	klebsiella	klebsiella	PROPN
ajlm-991	74	9	spp	spp	PROPN
ajlm-991	74	10	.	.	PROPN
ajlm-991	75	1	and	and	CCONJ
ajlm-991	75	2	e.	e.	PROPN
ajlm-991	75	3	coli	coli	PROPN
ajlm-991	75	4	are	be	AUX
ajlm-991	75	5	known	know	VERB
ajlm-991	75	6	to	to	PART
ajlm-991	75	7	be	be	AUX
ajlm-991	75	8	the	the	DET
ajlm-991	75	9	major	major	ADJ
ajlm-991	75	10	causative	causative	ADJ
ajlm-991	75	11	agents	agent	NOUN
ajlm-991	75	12	for	for	ADP
ajlm-991	75	13	hospital	hospital	NOUN
ajlm-991	75	14	-	-	PUNCT
ajlm-991	75	15	acquired	acquire	VERB
ajlm-991	75	16	infections	infection	NOUN
ajlm-991	75	17	.	.	PUNCT
ajlm-991	76	1	according	accord	VERB
ajlm-991	76	2	to	to	ADP
ajlm-991	76	3	the	the	DET
ajlm-991	76	4	national	national	PROPN
ajlm-991	76	5	health	health	PROPN
ajlm-991	76	6	service	service	NOUN
ajlm-991	76	7	report	report	NOUN
ajlm-991	76	8	of	of	ADP
ajlm-991	76	9	2017	2017	NUM
ajlm-991	76	10	on	on	ADP
ajlm-991	76	11	gram	gram	NOUN
ajlm-991	76	12	-	-	PUNCT
ajlm-991	76	13	negative	negative	ADJ
ajlm-991	76	14	bloodstream	bloodstream	NOUN
ajlm-991	76	15	infections	infection	NOUN
ajlm-991	76	16	,	,	PUNCT
ajlm-991	76	17	e.	e.	PROPN
ajlm-991	76	18	coli	coli	PROPN
ajlm-991	76	19	,	,	PUNCT
ajlm-991	76	20	p.	p.	NOUN
ajlm-991	76	21	aeruginosa	aeruginosa	PROPN
ajlm-991	76	22	and	and	CCONJ
ajlm-991	76	23	klebsiella	klebsiella	PROPN
ajlm-991	76	24	spp	spp	PROPN
ajlm-991	76	25	.	.	PUNCT
ajlm-991	76	26	were	be	AUX
ajlm-991	76	27	responsible	responsible	ADJ
ajlm-991	76	28	for	for	ADP
ajlm-991	76	29	72	72	NUM
ajlm-991	76	30	%	%	NOUN
ajlm-991	76	31	of	of	ADP
ajlm-991	76	32	all	all	DET
ajlm-991	76	33	gram	gram	NOUN
ajlm-991	76	34	-	-	PUNCT
ajlm-991	76	35	negative	negative	ADJ
ajlm-991	76	36	bloodstream	bloodstream	NOUN
ajlm-991	76	37	infections	infection	NOUN
ajlm-991	76	38	,	,	PUNCT
ajlm-991	76	39	with	with	ADP
ajlm-991	76	40	e.coli	e.coli	NOUN
ajlm-991	76	41	accounting	account	VERB
ajlm-991	76	42	for	for	ADP
ajlm-991	76	43	59	59	NUM
ajlm-991	76	44	%	%	NOUN
ajlm-991	76	45	of	of	ADP
ajlm-991	76	46	the	the	DET
ajlm-991	76	47	total	total	ADJ
ajlm-991	76	48	cases.25	cases.25	NOUN
ajlm-991	76	49	however	however	ADV
ajlm-991	76	50	,	,	PUNCT
ajlm-991	76	51	in	in	ADP
ajlm-991	76	52	the	the	DET
ajlm-991	76	53	present	present	ADJ
ajlm-991	76	54	study	study	NOUN
ajlm-991	76	55	,	,	PUNCT
ajlm-991	76	56	e.	e.	PROPN
ajlm-991	76	57	coli	coli	PROPN
ajlm-991	76	58	and	and	CCONJ
ajlm-991	76	59	k.	k.	NOUN
ajlm-991	76	60	pneumoniae	pneumoniae	NOUN
ajlm-991	76	61	were	be	AUX
ajlm-991	76	62	implicated	implicate	VERB
ajlm-991	76	63	in	in	ADP
ajlm-991	76	64	16	16	NUM
ajlm-991	76	65	out	out	ADP
ajlm-991	76	66	of	of	ADP
ajlm-991	76	67	18	18	NUM
ajlm-991	76	68	(	(	PUNCT
ajlm-991	76	69	88.8	88.8	NUM
ajlm-991	76	70	%	%	NOUN
ajlm-991	76	71	)	)	PUNCT
ajlm-991	76	72	gram	gram	NOUN
ajlm-991	76	73	-	-	PUNCT
ajlm-991	76	74	negative	negative	ADJ
ajlm-991	76	75	bloodstream	bloodstream	NOUN
ajlm-991	76	76	infection	infection	NOUN
ajlm-991	76	77	cases	case	NOUN
ajlm-991	76	78	,	,	PUNCT
ajlm-991	76	79	with	with	ADP
ajlm-991	76	80	k.	k.	PROPN
ajlm-991	76	81	pneumoniae	pneumoniae	PROPN
ajlm-991	76	82	identified	identify	VERB
ajlm-991	76	83	in	in	ADP
ajlm-991	76	84	the	the	DET
ajlm-991	76	85	majority	majority	NOUN
ajlm-991	76	86	(	(	PUNCT
ajlm-991	76	87	10/18	10/18	NUM
ajlm-991	76	88	;	;	PUNCT
ajlm-991	76	89	55.5	55.5	NUM
ajlm-991	76	90	%	%	NOUN
ajlm-991	76	91	)	)	PUNCT
ajlm-991	76	92	of	of	ADP
ajlm-991	76	93	cases	case	NOUN
ajlm-991	76	94	as	as	SCONJ
ajlm-991	76	95	compared	compare	VERB
ajlm-991	76	96	to	to	ADP
ajlm-991	76	97	e.	e.	PROPN
ajlm-991	76	98	coli	coli	PROPN
ajlm-991	76	99	(	(	PUNCT
ajlm-991	76	100	6/18	6/18	NUM
ajlm-991	76	101	;	;	PUNCT
ajlm-991	76	102	33.3	33.3	NUM
ajlm-991	76	103	%	%	NOUN
ajlm-991	76	104	)	)	PUNCT
ajlm-991	76	105	,	,	PUNCT
ajlm-991	76	106	which	which	PRON
ajlm-991	76	107	is	be	AUX
ajlm-991	76	108	in	in	ADP
ajlm-991	76	109	contrast	contrast	NOUN
ajlm-991	76	110	to	to	ADP
ajlm-991	76	111	the	the	DET
ajlm-991	76	112	national	national	PROPN
ajlm-991	76	113	health	health	PROPN
ajlm-991	76	114	service	service	PROPN
ajlm-991	76	115	report.25	report.25	NOUN
ajlm-991	76	116	acinetobacter	acinetobacter	ADV
ajlm-991	76	117	baumanii	baumanii	NOUN
ajlm-991	76	118	is	be	AUX
ajlm-991	76	119	known	know	VERB
ajlm-991	76	120	to	to	PART
ajlm-991	76	121	be	be	AUX
ajlm-991	76	122	an	an	DET
ajlm-991	76	123	important	important	ADJ
ajlm-991	76	124	pathogen	pathogen	NOUN
ajlm-991	76	125	in	in	ADP
ajlm-991	76	126	causing	cause	VERB
ajlm-991	76	127	respiratory	respiratory	ADJ
ajlm-991	76	128	infections	infection	NOUN
ajlm-991	76	129	such	such	ADJ
ajlm-991	76	130	as	as	ADP
ajlm-991	76	131	hospital	hospital	NOUN
ajlm-991	76	132	-	-	PUNCT
ajlm-991	76	133	acquired	acquire	VERB
ajlm-991	76	134	pneumonia	pneumonia	NOUN
ajlm-991	76	135	and	and	CCONJ
ajlm-991	76	136	bacteraemia	bacteraemia	NOUN
ajlm-991	76	137	,	,	PUNCT
ajlm-991	76	138	especially	especially	ADV
ajlm-991	76	139	in	in	ADP
ajlm-991	76	140	intensive	intensive	ADJ
ajlm-991	76	141	care	care	NOUN
ajlm-991	76	142	patients	patient	NOUN
ajlm-991	76	143	,	,	PUNCT
ajlm-991	76	144	followed	follow	VERB
ajlm-991	76	145	by	by	ADP
ajlm-991	76	146	skin	skin	NOUN
ajlm-991	76	147	and	and	CCONJ
ajlm-991	76	148	soft	soft	ADJ
ajlm-991	76	149	tissue	tissue	NOUN
ajlm-991	76	150	infections	infection	NOUN
ajlm-991	76	151	and	and	CCONJ
ajlm-991	76	152	urinary	urinary	ADJ
ajlm-991	76	153	tract	tract	NOUN
ajlm-991	76	154	infections.26,27	infections.26,27	NOUN
ajlm-991	76	155	the	the	DET
ajlm-991	76	156	present	present	ADJ
ajlm-991	76	157	study	study	NOUN
ajlm-991	76	158	has	have	VERB
ajlm-991	76	159	dissimilar	dissimilar	ADJ
ajlm-991	76	160	findings	finding	NOUN
ajlm-991	76	161	in	in	ADP
ajlm-991	76	162	terms	term	NOUN
ajlm-991	76	163	of	of	ADP
ajlm-991	76	164	isolation	isolation	NOUN
ajlm-991	76	165	of	of	ADP
ajlm-991	76	166	a.	a.	NOUN
ajlm-991	76	167	baumanii	baumanii	PROPN
ajlm-991	76	168	,	,	PUNCT
ajlm-991	76	169	with	with	ADP
ajlm-991	76	170	maximum	maximum	ADJ
ajlm-991	76	171	isolation	isolation	NOUN
ajlm-991	76	172	from	from	ADP
ajlm-991	76	173	pus	pus	NOUN
ajlm-991	76	174	,	,	PUNCT
ajlm-991	76	175	because	because	SCONJ
ajlm-991	76	176	of	of	ADP
ajlm-991	76	177	skin	skin	NOUN
ajlm-991	76	178	and	and	CCONJ
ajlm-991	76	179	soft	soft	ADJ
ajlm-991	76	180	tissue	tissue	NOUN
ajlm-991	76	181	infection	infection	NOUN
ajlm-991	76	182	cases	case	NOUN
ajlm-991	76	183	(	(	PUNCT
ajlm-991	76	184	50	50	NUM
ajlm-991	76	185	%	%	NOUN
ajlm-991	76	186	)	)	PUNCT
ajlm-991	76	187	;	;	PUNCT
ajlm-991	76	188	followed	follow	VERB
ajlm-991	76	189	by	by	ADP
ajlm-991	76	190	respiratory	respiratory	ADJ
ajlm-991	76	191	samples	sample	NOUN
ajlm-991	76	192	,	,	PUNCT
ajlm-991	76	193	because	because	SCONJ
ajlm-991	76	194	of	of	ADP
ajlm-991	76	195	respiratory	respiratory	ADJ
ajlm-991	76	196	infections	infection	NOUN
ajlm-991	76	197	(	(	PUNCT
ajlm-991	76	198	32.1	32.1	NUM
ajlm-991	76	199	%	%	NOUN
ajlm-991	76	200	)	)	PUNCT
ajlm-991	76	201	;	;	PUNCT
ajlm-991	76	202	and	and	CCONJ
ajlm-991	76	203	blood	blood	NOUN
ajlm-991	76	204	samples	sample	NOUN
ajlm-991	76	205	,	,	PUNCT
ajlm-991	76	206	because	because	SCONJ
ajlm-991	76	207	of	of	ADP
ajlm-991	76	208	bacteraemia	bacteraemia	NOUN
ajlm-991	76	209	(	(	PUNCT
ajlm-991	76	210	7.1	7.1	NUM
ajlm-991	76	211	%	%	NOUN
ajlm-991	76	212	)	)	PUNCT
ajlm-991	76	213	.	.	PUNCT
ajlm-991	77	1	in	in	ADP
ajlm-991	77	2	the	the	DET
ajlm-991	77	3	present	present	ADJ
ajlm-991	77	4	study	study	NOUN
ajlm-991	77	5	,	,	PUNCT
ajlm-991	77	6	95	95	NUM
ajlm-991	77	7	out	out	ADP
ajlm-991	77	8	of	of	ADP
ajlm-991	77	9	179	179	NUM
ajlm-991	77	10	(	(	PUNCT
ajlm-991	77	11	53.1	53.1	NUM
ajlm-991	77	12	%	%	NOUN
ajlm-991	77	13	)	)	PUNCT
ajlm-991	77	14	mdr	mdr	PROPN
ajlm-991	77	15	gnb	gnb	PROPN
ajlm-991	77	16	isolates	isolate	NOUN
ajlm-991	77	17	showed	show	VERB
ajlm-991	77	18	sensitivity	sensitivity	NOUN
ajlm-991	77	19	to	to	ADP
ajlm-991	77	20	cse	cse	NOUN
ajlm-991	77	21	in	in	ADP
ajlm-991	77	22	vitro	vitro	VERB
ajlm-991	77	23	.	.	PUNCT
ajlm-991	78	1	in	in	ADP
ajlm-991	78	2	similar	similar	ADJ
ajlm-991	78	3	studies	study	NOUN
ajlm-991	78	4	conducted	conduct	VERB
ajlm-991	78	5	in	in	ADP
ajlm-991	78	6	the	the	DET
ajlm-991	78	7	northern	northern	ADJ
ajlm-991	78	8	and	and	CCONJ
ajlm-991	78	9	western	western	ADJ
ajlm-991	78	10	parts	part	NOUN
ajlm-991	78	11	of	of	ADP
ajlm-991	78	12	india	india	PROPN
ajlm-991	78	13	,	,	PUNCT
ajlm-991	78	14	higher	high	ADJ
ajlm-991	78	15	susceptibility	susceptibility	NOUN
ajlm-991	78	16	rates	rate	NOUN
ajlm-991	78	17	against	against	ADP
ajlm-991	78	18	cse	cse	PROPN
ajlm-991	78	19	have	have	AUX
ajlm-991	78	20	been	be	AUX
ajlm-991	78	21	reported	report	VERB
ajlm-991	78	22	by	by	ADP
ajlm-991	78	23	bhatia	bhatia	PROPN
ajlm-991	78	24	et	et	PROPN
ajlm-991	78	25	al	al	PROPN
ajlm-991	78	26	.	.	PROPN
ajlm-991	79	1	(	(	PUNCT
ajlm-991	79	2	84	84	NUM
ajlm-991	79	3	%	%	NOUN
ajlm-991	79	4	–	–	PUNCT
ajlm-991	79	5	94	94	NUM
ajlm-991	79	6	%	%	NOUN
ajlm-991	79	7	)	)	PUNCT
ajlm-991	79	8	,	,	PUNCT
ajlm-991	79	9	kumar	kumar	PROPN
ajlm-991	79	10	et	et	PROPN
ajlm-991	79	11	al	al	PROPN
ajlm-991	79	12	.	.	PROPN
ajlm-991	80	1	(	(	PUNCT
ajlm-991	80	2	81.9	81.9	NUM
ajlm-991	80	3	%	%	NOUN
ajlm-991	80	4	–	–	PUNCT
ajlm-991	80	5	94.74	94.74	NUM
ajlm-991	80	6	%	%	NOUN
ajlm-991	80	7	)	)	PUNCT
ajlm-991	80	8	,	,	PUNCT
ajlm-991	80	9	bagga	bagga	PROPN
ajlm-991	80	10	et	et	PROPN
ajlm-991	80	11	al	al	PROPN
ajlm-991	80	12	.	.	PROPN
ajlm-991	81	1	(	(	PUNCT
ajlm-991	81	2	87.5	87.5	NUM
ajlm-991	81	3	%	%	NOUN
ajlm-991	81	4	–	–	PUNCT
ajlm-991	81	5	94.6	94.6	NUM
ajlm-991	81	6	%	%	NOUN
ajlm-991	81	7	)	)	PUNCT
ajlm-991	81	8	and	and	CCONJ
ajlm-991	81	9	sachdeva	sachdeva	VERB
ajlm-991	81	10	et	et	PROPN
ajlm-991	81	11	al	al	PROPN
ajlm-991	81	12	.	.	PUNCT
ajlm-991	82	1	(	(	PUNCT
ajlm-991	82	2	74.2	74.2	NUM
ajlm-991	82	3	%	%	NOUN
ajlm-991	82	4	–	–	PUNCT
ajlm-991	82	5	80.5%).12,24,28,29	80.5%).12,24,28,29	NUM
ajlm-991	82	6	the	the	DET
ajlm-991	82	7	lower	low	ADJ
ajlm-991	82	8	rate	rate	NOUN
ajlm-991	82	9	in	in	ADP
ajlm-991	82	10	our	our	PRON
ajlm-991	82	11	study	study	NOUN
ajlm-991	82	12	compared	compare	VERB
ajlm-991	82	13	to	to	ADP
ajlm-991	82	14	other	other	ADJ
ajlm-991	82	15	studies	study	NOUN
ajlm-991	82	16	could	could	AUX
ajlm-991	82	17	be	be	AUX
ajlm-991	82	18	because	because	SCONJ
ajlm-991	82	19	the	the	DET
ajlm-991	82	20	isolates	isolate	NOUN
ajlm-991	82	21	tested	test	VERB
ajlm-991	82	22	in	in	ADP
ajlm-991	82	23	the	the	DET
ajlm-991	82	24	present	present	ADJ
ajlm-991	82	25	study	study	NOUN
ajlm-991	82	26	have	have	AUX
ajlm-991	82	27	been	be	AUX
ajlm-991	82	28	identified	identify	VERB
ajlm-991	82	29	as	as	ADP
ajlm-991	82	30	esbl	esbl	NOUN
ajlm-991	82	31	or	or	CCONJ
ajlm-991	82	32	mbl	mbl	NOUN
ajlm-991	82	33	producers	producer	NOUN
ajlm-991	82	34	,	,	PUNCT
ajlm-991	82	35	which	which	PRON
ajlm-991	82	36	was	be	AUX
ajlm-991	82	37	not	not	PART
ajlm-991	82	38	specifically	specifically	ADV
ajlm-991	82	39	mentioned	mention	VERB
ajlm-991	82	40	by	by	ADP
ajlm-991	82	41	other	other	ADJ
ajlm-991	82	42	studies	study	NOUN
ajlm-991	82	43	.	.	PUNCT
ajlm-991	83	1	the	the	DET
ajlm-991	83	2	susceptibility	susceptibility	NOUN
ajlm-991	83	3	of	of	ADP
ajlm-991	83	4	esbland	esbland	NOUN
ajlm-991	83	5	mbl	mbl	NOUN
ajlm-991	83	6	-	-	PUNCT
ajlm-991	83	7	producing	produce	VERB
ajlm-991	83	8	isolates	isolate	NOUN
ajlm-991	83	9	to	to	ADP
ajlm-991	83	10	the	the	DET
ajlm-991	83	11	cse	cse	NOUN
ajlm-991	83	12	combination	combination	NOUN
ajlm-991	83	13	in	in	ADP
ajlm-991	83	14	the	the	DET
ajlm-991	83	15	present	present	ADJ
ajlm-991	83	16	study	study	NOUN
ajlm-991	83	17	was	be	AUX
ajlm-991	83	18	from	from	ADP
ajlm-991	83	19	68	68	NUM
ajlm-991	83	20	%	%	NOUN
ajlm-991	83	21	for	for	ADP
ajlm-991	83	22	esbl	esbl	NOUN
ajlm-991	83	23	producers	producer	NOUN
ajlm-991	83	24	and	and	CCONJ
ajlm-991	83	25	39	39	NUM
ajlm-991	83	26	%	%	NOUN
ajlm-991	83	27	for	for	ADP
ajlm-991	83	28	mbl	mbl	NOUN
ajlm-991	83	29	producers	producer	NOUN
ajlm-991	83	30	.	.	PUNCT
ajlm-991	84	1	the	the	DET
ajlm-991	84	2	range	range	NOUN
ajlm-991	84	3	is	be	AUX
ajlm-991	84	4	close	close	ADJ
ajlm-991	84	5	to	to	ADP
ajlm-991	84	6	a	a	DET
ajlm-991	84	7	similar	similar	ADJ
ajlm-991	84	8	study	study	NOUN
ajlm-991	84	9	conducted	conduct	VERB
ajlm-991	84	10	in	in	ADP
ajlm-991	84	11	mumbai	mumbai	PROPN
ajlm-991	84	12	,	,	PUNCT
ajlm-991	84	13	maharashtra	maharashtra	PROPN
ajlm-991	84	14	,	,	PUNCT
ajlm-991	84	15	india	india	PROPN
ajlm-991	84	16	by	by	ADP
ajlm-991	84	17	sahu	sahu	PROPN
ajlm-991	84	18	et	et	PROPN
ajlm-991	84	19	al.30	al.30	PROPN
ajlm-991	84	20	because	because	SCONJ
ajlm-991	84	21	of	of	ADP
ajlm-991	84	22	increased	increase	VERB
ajlm-991	84	23	clinical	clinical	ADJ
ajlm-991	84	24	use	use	NOUN
ajlm-991	84	25	of	of	ADP
ajlm-991	84	26	carbapenems	carbapenem	NOUN
ajlm-991	84	27	against	against	ADP
ajlm-991	84	28	mdr	mdr	PROPN
ajlm-991	84	29	gnb	gnb	PROPN
ajlm-991	84	30	,	,	PUNCT
ajlm-991	84	31	our	our	PRON
ajlm-991	84	32	study	study	NOUN
ajlm-991	84	33	also	also	ADV
ajlm-991	84	34	compared	compare	VERB
ajlm-991	84	35	the	the	DET
ajlm-991	84	36	efficacy	efficacy	NOUN
ajlm-991	84	37	of	of	ADP
ajlm-991	84	38	cse	cse	PROPN
ajlm-991	84	39	against	against	ADP
ajlm-991	84	40	meropenem	meropenem	PROPN
ajlm-991	84	41	on	on	ADP
ajlm-991	84	42	gram	gram	NOUN
ajlm-991	84	43	-	-	PUNCT
ajlm-991	84	44	negative	negative	ADJ
ajlm-991	84	45	isolates	isolate	NOUN
ajlm-991	84	46	to	to	PART
ajlm-991	84	47	use	use	VERB
ajlm-991	84	48	this	this	DET
ajlm-991	84	49	new	new	ADJ
ajlm-991	84	50	combination	combination	NOUN
ajlm-991	84	51	as	as	ADP
ajlm-991	84	52	a	a	DET
ajlm-991	84	53	possible	possible	ADJ
ajlm-991	84	54	carbapenem	carbapenem	NOUN
ajlm-991	84	55	-	-	PUNCT
ajlm-991	84	56	sparing	spare	VERB
ajlm-991	84	57	drug	drug	NOUN
ajlm-991	84	58	.	.	PUNCT
ajlm-991	85	1	carbapenems	carbapenem	NOUN
ajlm-991	85	2	are	be	AUX
ajlm-991	85	3	considered	consider	VERB
ajlm-991	85	4	to	to	PART
ajlm-991	85	5	be	be	AUX
ajlm-991	85	6	the	the	DET
ajlm-991	85	7	drug	drug	NOUN
ajlm-991	85	8	of	of	ADP
ajlm-991	85	9	choice	choice	NOUN
ajlm-991	85	10	for	for	ADP
ajlm-991	85	11	esbl	esbl	NOUN
ajlm-991	85	12	-	-	PUNCT
ajlm-991	85	13	producing	produce	VERB
ajlm-991	85	14	gnb	gnb	NOUN
ajlm-991	85	15	.	.	PUNCT
ajlm-991	86	1	the	the	DET
ajlm-991	86	2	present	present	ADJ
ajlm-991	86	3	study	study	NOUN
ajlm-991	86	4	showed	show	VERB
ajlm-991	86	5	that	that	SCONJ
ajlm-991	86	6	58	58	NUM
ajlm-991	86	7	(	(	PUNCT
ajlm-991	86	8	68.2	68.2	NUM
ajlm-991	86	9	%	%	NOUN
ajlm-991	86	10	)	)	PUNCT
ajlm-991	86	11	of	of	ADP
ajlm-991	86	12	the	the	DET
ajlm-991	86	13	esbl	esbl	NOUN
ajlm-991	86	14	isolates	isolate	NOUN
ajlm-991	86	15	were	be	AUX
ajlm-991	86	16	susceptible	susceptible	ADJ
ajlm-991	86	17	to	to	ADP
ajlm-991	86	18	cse	cse	NOUN
ajlm-991	86	19	,	,	PUNCT
ajlm-991	86	20	of	of	ADP
ajlm-991	86	21	which	which	PRON
ajlm-991	86	22	e.	e.	PROPN
ajlm-991	86	23	coli	coli	NOUN
ajlm-991	86	24	susceptibility	susceptibility	NOUN
ajlm-991	86	25	to	to	ADP
ajlm-991	86	26	cse	cse	PROPN
ajlm-991	86	27	was	be	AUX
ajlm-991	86	28	statistically	statistically	ADV
ajlm-991	86	29	significant	significant	ADJ
ajlm-991	86	30	when	when	SCONJ
ajlm-991	86	31	compared	compare	VERB
ajlm-991	86	32	with	with	ADP
ajlm-991	86	33	its	its	PRON
ajlm-991	86	34	susceptibility	susceptibility	NOUN
ajlm-991	86	35	to	to	PART
ajlm-991	86	36	meropenem	meropenem	PROPN
ajlm-991	86	37	(	(	PUNCT
ajlm-991	86	38	p	p	X
ajlm-991	86	39	<	<	X
ajlm-991	86	40	0.001	0.001	NUM
ajlm-991	86	41	)	)	PUNCT
ajlm-991	86	42	.	.	PUNCT
ajlm-991	87	1	the	the	DET
ajlm-991	87	2	susceptibility	susceptibility	NOUN
ajlm-991	87	3	profile	profile	NOUN
ajlm-991	87	4	to	to	ADP
ajlm-991	87	5	cse	cse	PROPN
ajlm-991	87	6	of	of	ADP
ajlm-991	87	7	the	the	DET
ajlm-991	87	8	three	three	NUM
ajlm-991	87	9	most	most	ADV
ajlm-991	87	10	predominant	predominant	ADJ
ajlm-991	87	11	pathogens	pathogen	NOUN
ajlm-991	87	12	in	in	ADP
ajlm-991	87	13	our	our	PRON
ajlm-991	87	14	study	study	NOUN
ajlm-991	87	15	,	,	PUNCT
ajlm-991	87	16	e.	e.	PROPN
ajlm-991	87	17	coli	coli	PROPN
ajlm-991	87	18	(	(	PUNCT
ajlm-991	87	19	49/76	49/76	NUM
ajlm-991	87	20	,	,	PUNCT
ajlm-991	87	21	64.5	64.5	NUM
ajlm-991	87	22	%	%	NOUN
ajlm-991	87	23	)	)	PUNCT
ajlm-991	87	24	,	,	PUNCT
ajlm-991	87	25	k.	k.	PROPN
ajlm-991	88	1	pneumoniae	pneumoniae	ADJ
ajlm-991	88	2	(	(	PUNCT
ajlm-991	88	3	18/53	18/53	NUM
ajlm-991	88	4	,	,	PUNCT
ajlm-991	88	5	34	34	NUM
ajlm-991	88	6	%	%	NOUN
ajlm-991	88	7	)	)	PUNCT
ajlm-991	88	8	and	and	CCONJ
ajlm-991	88	9	a.	a.	NOUN
ajlm-991	88	10	baumanii	baumanii	PROPN
ajlm-991	88	11	(	(	PUNCT
ajlm-991	88	12	13/27	13/27	NUM
ajlm-991	88	13	,	,	PUNCT
ajlm-991	88	14	48.1	48.1	NUM
ajlm-991	88	15	%	%	NOUN
ajlm-991	88	16	)	)	PUNCT
ajlm-991	88	17	was	be	AUX
ajlm-991	88	18	comparable	comparable	ADJ
ajlm-991	88	19	for	for	ADP
ajlm-991	88	20	e.coli	e.coli	NOUN
ajlm-991	88	21	(	(	PUNCT
ajlm-991	88	22	54/76	54/76	NUM
ajlm-991	88	23	,	,	PUNCT
ajlm-991	88	24	71.1	71.1	NUM
ajlm-991	88	25	%	%	NOUN
ajlm-991	88	26	)	)	PUNCT
ajlm-991	88	27	when	when	SCONJ
ajlm-991	88	28	compared	compare	VERB
ajlm-991	88	29	to	to	ADP
ajlm-991	88	30	meropenem	meropenem	PROPN
ajlm-991	88	31	and	and	CCONJ
ajlm-991	88	32	high	high	ADJ
ajlm-991	88	33	for	for	ADP
ajlm-991	88	34	k.	k.	PROPN
ajlm-991	88	35	pneumoniae	pneumoniae	PROPN
ajlm-991	88	36	(	(	PUNCT
ajlm-991	88	37	11/53	11/53	NUM
ajlm-991	88	38	,	,	PUNCT
ajlm-991	88	39	20.8	20.8	NUM
ajlm-991	88	40	%	%	NOUN
ajlm-991	88	41	)	)	PUNCT
ajlm-991	88	42	and	and	CCONJ
ajlm-991	88	43	a.	a.	NOUN
ajlm-991	88	44	baumanii	baumanii	PROPN
ajlm-991	88	45	(	(	PUNCT
ajlm-991	88	46	2/27	2/27	NUM
ajlm-991	88	47	,	,	PUNCT
ajlm-991	88	48	7.4	7.4	NUM
ajlm-991	88	49	%	%	NOUN
ajlm-991	88	50	)	)	PUNCT
ajlm-991	88	51	.	.	PUNCT
ajlm-991	89	1	however	however	ADV
ajlm-991	89	2	,	,	PUNCT
ajlm-991	89	3	several	several	ADJ
ajlm-991	89	4	authors	author	NOUN
ajlm-991	89	5	from	from	ADP
ajlm-991	89	6	different	different	ADJ
ajlm-991	89	7	parts	part	NOUN
ajlm-991	89	8	of	of	ADP
ajlm-991	89	9	india	india	PROPN
ajlm-991	89	10	(	(	PUNCT
ajlm-991	89	11	haryana	haryana	PROPN
ajlm-991	89	12	,	,	PUNCT
ajlm-991	89	13	western	western	ADJ
ajlm-991	89	14	uttar	uttar	PROPN
ajlm-991	89	15	pradesh	pradesh	PROPN
ajlm-991	89	16	,	,	PUNCT
ajlm-991	89	17	gujarat	gujarat	PROPN
ajlm-991	89	18	)	)	PUNCT
ajlm-991	89	19	have	have	AUX
ajlm-991	89	20	reported	report	VERB
ajlm-991	89	21	significantly	significantly	ADV
ajlm-991	89	22	higher	high	ADJ
ajlm-991	89	23	susceptibility	susceptibility	NOUN
ajlm-991	89	24	to	to	ADP
ajlm-991	89	25	cse	cse	NOUN
ajlm-991	89	26	when	when	SCONJ
ajlm-991	89	27	compared	compare	VERB
ajlm-991	89	28	with	with	ADP
ajlm-991	89	29	meropenem.24,28,31	meropenem.24,28,31	NOUN
ajlm-991	89	30	our	our	PRON
ajlm-991	89	31	study	study	NOUN
ajlm-991	89	32	showed	show	VERB
ajlm-991	89	33	comparable	comparable	ADJ
ajlm-991	89	34	sensitivity	sensitivity	NOUN
ajlm-991	89	35	among	among	ADP
ajlm-991	89	36	esbl	esbl	NOUN
ajlm-991	89	37	organisms	organism	NOUN
ajlm-991	89	38	to	to	ADP
ajlm-991	89	39	cse	cse	PROPN
ajlm-991	89	40	(	(	PUNCT
ajlm-991	89	41	58/85	58/85	NUM
ajlm-991	89	42	,	,	PUNCT
ajlm-991	89	43	68.2	68.2	NUM
ajlm-991	89	44	%	%	NOUN
ajlm-991	89	45	)	)	PUNCT
ajlm-991	89	46	and	and	CCONJ
ajlm-991	89	47	meropenem	meropenem	PROPN
ajlm-991	89	48	(	(	PUNCT
ajlm-991	89	49	64/85	64/85	NUM
ajlm-991	89	50	,	,	PUNCT
ajlm-991	89	51	75.3	75.3	NUM
ajlm-991	89	52	%	%	NOUN
ajlm-991	89	53	)	)	PUNCT
ajlm-991	89	54	,	,	PUNCT
ajlm-991	89	55	which	which	PRON
ajlm-991	89	56	implies	imply	VERB
ajlm-991	89	57	that	that	SCONJ
ajlm-991	89	58	if	if	SCONJ
ajlm-991	89	59	cse	cse	PROPN
ajlm-991	89	60	is	be	AUX
ajlm-991	89	61	tested	test	VERB
ajlm-991	89	62	against	against	ADP
ajlm-991	89	63	all	all	DET
ajlm-991	89	64	esbl	esbl	NOUN
ajlm-991	89	65	isolates	isolate	NOUN
ajlm-991	89	66	and	and	CCONJ
ajlm-991	89	67	they	they	PRON
ajlm-991	89	68	are	be	AUX
ajlm-991	89	69	found	find	VERB
ajlm-991	89	70	to	to	PART
ajlm-991	89	71	be	be	AUX
ajlm-991	89	72	susceptible	susceptible	ADJ
ajlm-991	89	73	,	,	PUNCT
ajlm-991	89	74	cse	cse	NOUN
ajlm-991	89	75	could	could	AUX
ajlm-991	89	76	be	be	AUX
ajlm-991	89	77	used	use	VERB
ajlm-991	89	78	as	as	ADP
ajlm-991	89	79	a	a	DET
ajlm-991	89	80	drug	drug	NOUN
ajlm-991	89	81	of	of	ADP
ajlm-991	89	82	choice	choice	NOUN
ajlm-991	89	83	in	in	ADP
ajlm-991	89	84	place	place	NOUN
ajlm-991	89	85	of	of	ADP
ajlm-991	89	86	carbapenems	carbapenem	NOUN
ajlm-991	89	87	.	.	PUNCT
ajlm-991	90	1	most	most	ADJ
ajlm-991	90	2	of	of	ADP
ajlm-991	90	3	the	the	DET
ajlm-991	90	4	mbl	mbl	NOUN
ajlm-991	90	5	-	-	PUNCT
ajlm-991	90	6	producing	produce	VERB
ajlm-991	90	7	organisms	organism	NOUN
ajlm-991	90	8	are	be	AUX
ajlm-991	90	9	resistant	resistant	ADJ
ajlm-991	90	10	to	to	ADP
ajlm-991	90	11	carbapenems	carbapenem	NOUN
ajlm-991	90	12	and	and	CCONJ
ajlm-991	90	13	the	the	DET
ajlm-991	90	14	drug	drug	NOUN
ajlm-991	90	15	of	of	ADP
ajlm-991	90	16	choice	choice	NOUN
ajlm-991	90	17	for	for	ADP
ajlm-991	90	18	such	such	ADJ
ajlm-991	90	19	isolates	isolate	NOUN
ajlm-991	90	20	is	be	AUX
ajlm-991	90	21	polymixins	polymixin	NOUN
ajlm-991	90	22	.	.	PUNCT
ajlm-991	91	1	in	in	ADP
ajlm-991	91	2	the	the	DET
ajlm-991	91	3	present	present	ADJ
ajlm-991	91	4	study	study	NOUN
ajlm-991	91	5	,	,	PUNCT
ajlm-991	91	6	39.4	39.4	NUM
ajlm-991	91	7	%	%	NOUN
ajlm-991	91	8	(	(	PUNCT
ajlm-991	91	9	34	34	NUM
ajlm-991	91	10	)	)	PUNCT
ajlm-991	91	11	of	of	ADP
ajlm-991	91	12	such	such	ADJ
ajlm-991	91	13	isolates	isolate	NOUN
ajlm-991	91	14	were	be	AUX
ajlm-991	91	15	susceptible	susceptible	ADJ
ajlm-991	91	16	to	to	ADP
ajlm-991	91	17	cse	cse	NOUN
ajlm-991	91	18	;	;	PUNCT
ajlm-991	91	19	thus	thus	ADV
ajlm-991	91	20	,	,	PUNCT
ajlm-991	91	21	cse	cse	NOUN
ajlm-991	91	22	instead	instead	ADV
ajlm-991	91	23	of	of	ADP
ajlm-991	91	24	polymixins	polymixin	NOUN
ajlm-991	91	25	could	could	AUX
ajlm-991	91	26	be	be	AUX
ajlm-991	91	27	considered	consider	VERB
ajlm-991	91	28	as	as	ADP
ajlm-991	91	29	a	a	DET
ajlm-991	91	30	therapeutic	therapeutic	ADJ
ajlm-991	91	31	option	option	NOUN
ajlm-991	91	32	in	in	ADP
ajlm-991	91	33	these	these	DET
ajlm-991	91	34	cases	case	NOUN
ajlm-991	91	35	.	.	PUNCT
ajlm-991	92	1	one	one	NUM
ajlm-991	92	2	major	major	ADJ
ajlm-991	92	3	concern	concern	NOUN
ajlm-991	92	4	is	be	AUX
ajlm-991	92	5	finding	find	VERB
ajlm-991	92	6	effective	effective	ADJ
ajlm-991	92	7	treatments	treatment	NOUN
ajlm-991	92	8	for	for	ADP
ajlm-991	92	9	infection	infection	NOUN
ajlm-991	92	10	with	with	ADP
ajlm-991	92	11	acinetobacter	acinetobacter	PROPN
ajlm-991	92	12	spp	spp	NOUN
ajlm-991	92	13	.	.	PROPN
ajlm-991	92	14	,	,	PUNCT
ajlm-991	92	15	which	which	PRON
ajlm-991	92	16	is	be	AUX
ajlm-991	92	17	now	now	ADV
ajlm-991	92	18	commonly	commonly	ADV
ajlm-991	92	19	isolated	isolate	VERB
ajlm-991	92	20	from	from	ADP
ajlm-991	92	21	critical	critical	ADJ
ajlm-991	92	22	areas	area	NOUN
ajlm-991	92	23	in	in	ADP
ajlm-991	92	24	most	most	ADJ
ajlm-991	92	25	of	of	ADP
ajlm-991	92	26	the	the	DET
ajlm-991	92	27	hospitals	hospital	NOUN
ajlm-991	92	28	worldwide.24	worldwide.24	VERB
ajlm-991	92	29	our	our	PRON
ajlm-991	92	30	study	study	NOUN
ajlm-991	92	31	found	find	VERB
ajlm-991	92	32	cse	cse	PROPN
ajlm-991	92	33	to	to	PART
ajlm-991	92	34	be	be	AUX
ajlm-991	92	35	effective	effective	ADJ
ajlm-991	92	36	in	in	ADP
ajlm-991	92	37	48.1	48.1	NUM
ajlm-991	92	38	%	%	NOUN
ajlm-991	92	39	of	of	ADP
ajlm-991	92	40	mbl	mbl	NOUN
ajlm-991	92	41	-	-	PUNCT
ajlm-991	92	42	producing	produce	VERB
ajlm-991	92	43	a.	a.	NOUN
ajlm-991	92	44	baumanii	baumanii	PROPN
ajlm-991	92	45	infections	infection	NOUN
ajlm-991	92	46	,	,	PUNCT
ajlm-991	92	47	which	which	PRON
ajlm-991	92	48	is	be	AUX
ajlm-991	92	49	a	a	DET
ajlm-991	92	50	fair	fair	ADJ
ajlm-991	92	51	number	number	NOUN
ajlm-991	92	52	,	,	PUNCT
ajlm-991	92	53	and	and	CCONJ
ajlm-991	92	54	use	use	NOUN
ajlm-991	92	55	of	of	ADP
ajlm-991	92	56	cse	cse	NOUN
ajlm-991	92	57	could	could	AUX
ajlm-991	92	58	be	be	AUX
ajlm-991	92	59	beneficial	beneficial	ADJ
ajlm-991	92	60	in	in	ADP
ajlm-991	92	61	such	such	ADJ
ajlm-991	92	62	infections	infection	NOUN
ajlm-991	92	63	.	.	PUNCT
ajlm-991	93	1	a	a	DET
ajlm-991	93	2	similar	similar	ADJ
ajlm-991	93	3	study	study	NOUN
ajlm-991	93	4	conducted	conduct	VERB
ajlm-991	93	5	in	in	ADP
ajlm-991	93	6	pune	pune	NOUN
ajlm-991	93	7	,	,	PUNCT
ajlm-991	93	8	india	india	PROPN
ajlm-991	93	9	found	find	VERB
ajlm-991	93	10	that	that	SCONJ
ajlm-991	93	11	cse	cse	PROPN
ajlm-991	93	12	was	be	AUX
ajlm-991	93	13	a	a	DET
ajlm-991	93	14	superior	superior	ADJ
ajlm-991	93	15	antibiotic	antibiotic	NOUN
ajlm-991	93	16	compared	compare	VERB
ajlm-991	93	17	to	to	ADP
ajlm-991	93	18	other	other	ADJ
ajlm-991	93	19	commonly	commonly	ADV
ajlm-991	93	20	used	use	VERB
ajlm-991	93	21	β	β	NOUN
ajlm-991	93	22	-	-	NOUN
ajlm-991	93	23	lactam	lactam	NOUN
ajlm-991	93	24	antibiotics	antibiotic	NOUN
ajlm-991	93	25	,	,	PUNCT
ajlm-991	93	26	including	include	VERB
ajlm-991	93	27	carbapenems	carbapenem	NOUN
ajlm-991	93	28	,	,	PUNCT
ajlm-991	93	29	when	when	SCONJ
ajlm-991	93	30	tested	test	VERB
ajlm-991	93	31	against	against	ADP
ajlm-991	93	32	mdr	mdr	PROPN
ajlm-991	93	33	gnb.32	gnb.32	PROPN
ajlm-991	93	34	a	a	DET
ajlm-991	93	35	study	study	NOUN
ajlm-991	93	36	conducted	conduct	VERB
ajlm-991	93	37	in	in	ADP
ajlm-991	93	38	faridabad	faridabad	PROPN
ajlm-991	93	39	,	,	PUNCT
ajlm-991	93	40	haryana	haryana	PROPN
ajlm-991	93	41	,	,	PUNCT
ajlm-991	93	42	india	india	PROPN
ajlm-991	93	43	,	,	PUNCT
ajlm-991	93	44	which	which	PRON
ajlm-991	93	45	evaluated	evaluate	VERB
ajlm-991	93	46	the	the	DET
ajlm-991	93	47	clinical	clinical	ADJ
ajlm-991	93	48	use	use	NOUN
ajlm-991	93	49	of	of	ADP
ajlm-991	93	50	cse	cse	NOUN
ajlm-991	93	51	on	on	ADP
ajlm-991	93	52	patients	patient	NOUN
ajlm-991	93	53	,	,	PUNCT
ajlm-991	93	54	concluded	conclude	VERB
ajlm-991	93	55	that	that	SCONJ
ajlm-991	93	56	cse	cse	PROPN
ajlm-991	93	57	should	should	AUX
ajlm-991	93	58	be	be	AUX
ajlm-991	93	59	used	use	VERB
ajlm-991	93	60	as	as	ADP
ajlm-991	93	61	a	a	DET
ajlm-991	93	62	carbapenem	carbapenem	NOUN
ajlm-991	93	63	-	-	PUNCT
ajlm-991	93	64	sparing	spare	VERB
ajlm-991	93	65	drug	drug	NOUN
ajlm-991	93	66	and	and	CCONJ
ajlm-991	93	67	its	its	PRON
ajlm-991	93	68	combination	combination	NOUN
ajlm-991	93	69	with	with	ADP
ajlm-991	93	70	polymyxins	polymyxin	NOUN
ajlm-991	93	71	can	can	AUX
ajlm-991	93	72	help	help	VERB
ajlm-991	93	73	to	to	PART
ajlm-991	93	74	reduce	reduce	VERB
ajlm-991	93	75	mortality	mortality	NOUN
ajlm-991	93	76	rates	rate	NOUN
ajlm-991	93	77	by	by	ADP
ajlm-991	93	78	successfully	successfully	ADV
ajlm-991	93	79	treating	treat	VERB
ajlm-991	93	80	complicated	complicated	ADJ
ajlm-991	93	81	mdr	mdr	NOUN
ajlm-991	93	82	cases	case	NOUN
ajlm-991	93	83	of	of	ADP
ajlm-991	93	84	intraabdominal	intraabdominal	ADJ
ajlm-991	93	85	,	,	PUNCT
ajlm-991	93	86	lower	low	ADJ
ajlm-991	93	87	respiratory	respiratory	ADJ
ajlm-991	93	88	tract	tract	NOUN
ajlm-991	93	89	and	and	CCONJ
ajlm-991	93	90	urinary	urinary	ADJ
ajlm-991	93	91	tract	tract	NOUN
ajlm-991	93	92	infections.12	infections.12	NOUN
ajlm-991	93	93	limitations	limitation	VERB
ajlm-991	93	94	the	the	DET
ajlm-991	93	95	limitation	limitation	NOUN
ajlm-991	93	96	of	of	ADP
ajlm-991	93	97	our	our	PRON
ajlm-991	93	98	study	study	NOUN
ajlm-991	93	99	was	be	AUX
ajlm-991	93	100	the	the	DET
ajlm-991	93	101	relatively	relatively	ADV
ajlm-991	93	102	small	small	ADJ
ajlm-991	93	103	number	number	NOUN
ajlm-991	93	104	of	of	ADP
ajlm-991	93	105	isolates	isolate	NOUN
ajlm-991	93	106	tested	test	VERB
ajlm-991	93	107	.	.	PUNCT
ajlm-991	94	1	larger	large	ADJ
ajlm-991	94	2	sample	sample	NOUN
ajlm-991	94	3	size	size	NOUN
ajlm-991	94	4	and	and	CCONJ
ajlm-991	94	5	diverse	diverse	ADJ
ajlm-991	94	6	health	health	NOUN
ajlm-991	94	7	facility	facility	NOUN
ajlm-991	94	8	level	level	NOUN
ajlm-991	94	9	(	(	PUNCT
ajlm-991	94	10	primary	primary	ADJ
ajlm-991	94	11	to	to	ADP
ajlm-991	94	12	tertiary	tertiary	ADJ
ajlm-991	94	13	)	)	PUNCT
ajlm-991	94	14	studies	study	NOUN
ajlm-991	94	15	would	would	AUX
ajlm-991	94	16	be	be	AUX
ajlm-991	94	17	required	require	VERB
ajlm-991	94	18	to	to	PART
ajlm-991	94	19	rule	rule	VERB
ajlm-991	94	20	out	out	ADP
ajlm-991	94	21	any	any	DET
ajlm-991	94	22	referral	referral	ADJ
ajlm-991	94	23	bias	bias	NOUN
ajlm-991	94	24	that	that	PRON
ajlm-991	94	25	is	be	AUX
ajlm-991	94	26	expected	expect	VERB
ajlm-991	94	27	in	in	ADP
ajlm-991	94	28	a	a	DET
ajlm-991	94	29	tertiary	tertiary	ADJ
ajlm-991	94	30	-	-	PUNCT
ajlm-991	94	31	care	care	NOUN
ajlm-991	94	32	hospital	hospital	NOUN
ajlm-991	94	33	.	.	PUNCT
ajlm-991	95	1	further	far	ADV
ajlm-991	95	2	,	,	PUNCT
ajlm-991	95	3	this	this	DET
ajlm-991	95	4	study	study	NOUN
ajlm-991	95	5	can	can	AUX
ajlm-991	95	6	be	be	AUX
ajlm-991	95	7	extended	extend	VERB
ajlm-991	95	8	with	with	ADP
ajlm-991	95	9	application	application	NOUN
ajlm-991	95	10	to	to	ADP
ajlm-991	95	11	clinical	clinical	ADJ
ajlm-991	95	12	situations	situation	NOUN
ajlm-991	95	13	to	to	PART
ajlm-991	95	14	have	have	VERB
ajlm-991	95	15	a	a	DET
ajlm-991	95	16	clinico	clinico	NOUN
ajlm-991	95	17	-	-	PUNCT
ajlm-991	95	18	microbiological	microbiological	ADJ
ajlm-991	95	19	correlation	correlation	NOUN
ajlm-991	95	20	to	to	PART
ajlm-991	95	21	guide	guide	VERB
ajlm-991	95	22	clinicians	clinician	NOUN
ajlm-991	95	23	for	for	ADP
ajlm-991	95	24	the	the	DET
ajlm-991	95	25	judicious	judicious	ADJ
ajlm-991	95	26	use	use	NOUN
ajlm-991	95	27	of	of	ADP
ajlm-991	95	28	cse	cse	NOUN
ajlm-991	95	29	against	against	ADP
ajlm-991	95	30	mdr	mdr	PROPN
ajlm-991	95	31	pathogens	pathogen	NOUN
ajlm-991	95	32	.	.	PUNCT
ajlm-991	96	1	conclusion	conclusion	VERB
ajlm-991	96	2	the	the	DET
ajlm-991	96	3	results	result	NOUN
ajlm-991	96	4	of	of	ADP
ajlm-991	96	5	this	this	DET
ajlm-991	96	6	study	study	NOUN
ajlm-991	96	7	show	show	VERB
ajlm-991	96	8	that	that	SCONJ
ajlm-991	96	9	cse	cse	NOUN
ajlm-991	96	10	can	can	AUX
ajlm-991	96	11	potentially	potentially	ADV
ajlm-991	96	12	be	be	AUX
ajlm-991	96	13	effective	effective	ADJ
ajlm-991	96	14	among	among	ADP
ajlm-991	96	15	esbl	esbl	NOUN
ajlm-991	96	16	-	-	PUNCT
ajlm-991	96	17	producing	produce	VERB
ajlm-991	96	18	bacteria	bacteria	NOUN
ajlm-991	96	19	,	,	PUNCT
ajlm-991	96	20	especially	especially	ADV
ajlm-991	96	21	e.	e.	PROPN
ajlm-991	96	22	coli	coli	PROPN
ajlm-991	96	23	.	.	PUNCT
ajlm-991	97	1	the	the	DET
ajlm-991	97	2	susceptibility	susceptibility	NOUN
ajlm-991	97	3	of	of	ADP
ajlm-991	97	4	multi	multi	ADJ
ajlm-991	97	5	-	-	ADJ
ajlm-991	97	6	drug	drug	ADJ
ajlm-991	97	7	resistant	resistant	ADJ
ajlm-991	97	8	gram	gram	NOUN
ajlm-991	97	9	-	-	PUNCT
ajlm-991	97	10	negative	negative	ADJ
ajlm-991	97	11	microorganisms	microorganism	NOUN
ajlm-991	97	12	to	to	ADP
ajlm-991	97	13	cse	cse	NOUN
ajlm-991	97	14	suggests	suggest	VERB
ajlm-991	97	15	that	that	SCONJ
ajlm-991	97	16	cse	cse	NOUN
ajlm-991	97	17	could	could	AUX
ajlm-991	97	18	be	be	AUX
ajlm-991	97	19	a	a	DET
ajlm-991	97	20	good	good	ADJ
ajlm-991	97	21	option	option	NOUN
ajlm-991	97	22	as	as	ADP
ajlm-991	97	23	a	a	DET
ajlm-991	97	24	carbapenem	carbapenem	NOUN
ajlm-991	97	25	-	-	PUNCT
ajlm-991	97	26	sparing	spare	VERB
ajlm-991	97	27	drug	drug	NOUN
ajlm-991	97	28	and	and	CCONJ
ajlm-991	97	29	also	also	ADV
ajlm-991	97	30	against	against	ADP
ajlm-991	97	31	some	some	PRON
ajlm-991	97	32	of	of	ADP
ajlm-991	97	33	the	the	DET
ajlm-991	97	34	mbl	mbl	NOUN
ajlm-991	97	35	-	-	PUNCT
ajlm-991	97	36	producing	produce	VERB
ajlm-991	97	37	organisms	organism	NOUN
ajlm-991	97	38	.	.	PUNCT
ajlm-991	98	1	acknowledgements	acknowledgement	NOUN
ajlm-991	98	2	we	we	PRON
ajlm-991	98	3	wish	wish	VERB
ajlm-991	98	4	to	to	PART
ajlm-991	98	5	thank	thank	VERB
ajlm-991	98	6	venus	venus	PROPN
ajlm-991	98	7	remedies	remedy	NOUN
ajlm-991	98	8	(	(	PUNCT
ajlm-991	98	9	india	india	PROPN
ajlm-991	98	10	)	)	PUNCT
ajlm-991	98	11	for	for	ADP
ajlm-991	98	12	providing	provide	VERB
ajlm-991	98	13	antibiotic	antibiotic	ADJ
ajlm-991	98	14	discs	disc	NOUN
ajlm-991	98	15	of	of	ADP
ajlm-991	98	16	ceftriaxone	ceftriaxone	NOUN
ajlm-991	98	17	-	-	PUNCT
ajlm-991	98	18	sulbactam	sulbactam	NOUN
ajlm-991	98	19	-	-	PUNCT
ajlm-991	98	20	disodium	disodium	NOUN
ajlm-991	98	21	edetate	edetate	NOUN
ajlm-991	98	22	for	for	ADP
ajlm-991	98	23	testing	testing	NOUN
ajlm-991	98	24	.	.	PUNCT
ajlm-991	99	1	competing	compete	VERB
ajlm-991	99	2	interests	interest	NOUN
ajlm-991	99	3	there	there	PRON
ajlm-991	99	4	are	be	VERB
ajlm-991	99	5	no	no	DET
ajlm-991	99	6	competing	compete	VERB
ajlm-991	99	7	interests	interest	NOUN
ajlm-991	99	8	,	,	PUNCT
ajlm-991	99	9	financial	financial	ADJ
ajlm-991	99	10	interests	interest	NOUN
ajlm-991	99	11	,	,	PUNCT
ajlm-991	99	12	relationships	relationship	NOUN
ajlm-991	99	13	and	and	CCONJ
ajlm-991	99	14	affiliations	affiliation	NOUN
ajlm-991	99	15	relevant	relevant	ADJ
ajlm-991	99	16	to	to	ADP
ajlm-991	99	17	the	the	DET
ajlm-991	99	18	subject	subject	ADJ
ajlm-991	99	19	matter	matter	NOUN
ajlm-991	99	20	or	or	CCONJ
ajlm-991	99	21	materials	material	NOUN
ajlm-991	99	22	discussed	discuss	VERB
ajlm-991	99	23	in	in	ADP
ajlm-991	99	24	the	the	DET
ajlm-991	99	25	manuscript	manuscript	NOUN
ajlm-991	99	26	.	.	PUNCT
ajlm-991	100	1	authors	author	NOUN
ajlm-991	100	2	’	'	PUNCT
ajlm-991	100	3	contributions	contribution	NOUN
ajlm-991	100	4	all	all	DET
ajlm-991	100	5	authors	author	NOUN
ajlm-991	100	6	contributed	contribute	VERB
ajlm-991	100	7	intellectually	intellectually	ADV
ajlm-991	100	8	to	to	ADP
ajlm-991	100	9	the	the	DET
ajlm-991	100	10	work	work	NOUN
ajlm-991	100	11	.	.	PUNCT
ajlm-991	101	1	s.g	s.g	PROPN
ajlm-991	101	2	.	.	PROPN
ajlm-991	101	3	was	be	AUX
ajlm-991	101	4	involved	involve	VERB
ajlm-991	101	5	in	in	ADP
ajlm-991	101	6	bench	bench	NOUN
ajlm-991	101	7	work	work	NOUN
ajlm-991	101	8	and	and	CCONJ
ajlm-991	101	9	manuscript	manuscript	NOUN
ajlm-991	101	10	writing	writing	NOUN
ajlm-991	101	11	;	;	PUNCT
ajlm-991	101	12	m.k	m.k	X
ajlm-991	101	13	.	.	PROPN
ajlm-991	101	14	was	be	AUX
ajlm-991	101	15	involved	involve	VERB
ajlm-991	101	16	in	in	ADP
ajlm-991	101	17	the	the	DET
ajlm-991	101	18	study	study	NOUN
ajlm-991	101	19	concept	concept	NOUN
ajlm-991	101	20	and	and	CCONJ
ajlm-991	101	21	supervision	supervision	NOUN
ajlm-991	101	22	,	,	PUNCT
ajlm-991	101	23	manuscript	manuscript	NOUN
ajlm-991	101	24	writing	writing	NOUN
ajlm-991	101	25	and	and	CCONJ
ajlm-991	101	26	final	final	ADJ
ajlm-991	101	27	approval	approval	NOUN
ajlm-991	101	28	;	;	PUNCT
ajlm-991	101	29	s.p.s.s	s.p.s.s	PROPN
ajlm-991	101	30	.	.	PROPN
ajlm-991	101	31	was	be	AUX
ajlm-991	101	32	involved	involve	VERB
ajlm-991	101	33	in	in	ADP
ajlm-991	101	34	the	the	DET
ajlm-991	101	35	study	study	NOUN
ajlm-991	101	36	concept	concept	NOUN
ajlm-991	101	37	and	and	CCONJ
ajlm-991	101	38	supervision	supervision	NOUN
ajlm-991	101	39	;	;	PUNCT
ajlm-991	101	40	and	and	CCONJ
ajlm-991	101	41	k.t	k.t	PROPN
ajlm-991	101	42	.	.	PROPN
ajlm-991	101	43	was	be	AUX
ajlm-991	101	44	responsible	responsible	ADJ
ajlm-991	101	45	for	for	ADP
ajlm-991	101	46	collection	collection	NOUN
ajlm-991	101	47	of	of	ADP
ajlm-991	101	48	mdr	mdr	PROPN
ajlm-991	101	49	strains	strain	NOUN
ajlm-991	101	50	,	,	PUNCT
ajlm-991	101	51	and	and	CCONJ
ajlm-991	101	52	contributed	contribute	VERB
ajlm-991	101	53	to	to	ADP
ajlm-991	101	54	the	the	DET
ajlm-991	101	55	bench	bench	NOUN
ajlm-991	101	56	work	work	NOUN
ajlm-991	101	57	.	.	PUNCT
ajlm-991	102	1	sources	source	NOUN
ajlm-991	102	2	of	of	ADP
ajlm-991	102	3	support	support	NOUN
ajlm-991	102	4	this	this	DET
ajlm-991	102	5	research	research	NOUN
ajlm-991	102	6	received	receive	VERB
ajlm-991	102	7	no	no	DET
ajlm-991	102	8	specific	specific	ADJ
ajlm-991	102	9	grant	grant	NOUN
ajlm-991	102	10	from	from	ADP
ajlm-991	102	11	any	any	DET
ajlm-991	102	12	funding	funding	NOUN
ajlm-991	102	13	agency	agency	NOUN
ajlm-991	102	14	in	in	ADP
ajlm-991	102	15	the	the	DET
ajlm-991	102	16	public	public	ADJ
ajlm-991	102	17	,	,	PUNCT
ajlm-991	102	18	commercial	commercial	ADJ
ajlm-991	102	19	,	,	PUNCT
ajlm-991	102	20	or	or	CCONJ
ajlm-991	102	21	not	not	PART
ajlm-991	102	22	-	-	PUNCT
ajlm-991	102	23	for	for	ADP
ajlm-991	102	24	-	-	PUNCT
ajlm-991	102	25	profit	profit	NOUN
ajlm-991	102	26	sectors	sector	NOUN
ajlm-991	102	27	.	.	PUNCT
ajlm-991	103	1	data	datum	NOUN
ajlm-991	103	2	availability	availability	NOUN
ajlm-991	103	3	statement	statement	NOUN
ajlm-991	103	4	data	datum	NOUN
ajlm-991	103	5	sharing	sharing	NOUN
ajlm-991	103	6	is	be	AUX
ajlm-991	103	7	not	not	PART
ajlm-991	103	8	applicable	applicable	ADJ
ajlm-991	103	9	to	to	ADP
ajlm-991	103	10	this	this	DET
ajlm-991	103	11	article	article	NOUN
ajlm-991	103	12	as	as	SCONJ
ajlm-991	103	13	no	no	DET
ajlm-991	103	14	new	new	ADJ
ajlm-991	103	15	data	datum	NOUN
ajlm-991	103	16	were	be	AUX
ajlm-991	103	17	created	create	VERB
ajlm-991	103	18	or	or	CCONJ
ajlm-991	103	19	analysed	analyse	VERB
ajlm-991	103	20	in	in	ADP
ajlm-991	103	21	this	this	DET
ajlm-991	103	22	study	study	NOUN
ajlm-991	103	23	disclaimer	disclaimer	NOUN
ajlm-991	103	24	the	the	DET
ajlm-991	103	25	views	view	NOUN
ajlm-991	103	26	and	and	CCONJ
ajlm-991	103	27	opinions	opinion	NOUN
ajlm-991	103	28	expressed	express	VERB
ajlm-991	103	29	in	in	ADP
ajlm-991	103	30	this	this	DET
ajlm-991	103	31	article	article	NOUN
ajlm-991	103	32	are	be	AUX
ajlm-991	103	33	those	those	PRON
ajlm-991	103	34	of	of	ADP
ajlm-991	103	35	the	the	DET
ajlm-991	103	36	authors	author	NOUN
ajlm-991	103	37	and	and	CCONJ
ajlm-991	103	38	do	do	AUX
ajlm-991	103	39	not	not	PART
ajlm-991	103	40	necessarily	necessarily	ADV
ajlm-991	103	41	reflect	reflect	VERB
ajlm-991	103	42	the	the	DET
ajlm-991	103	43	official	official	ADJ
ajlm-991	103	44	policy	policy	NOUN
ajlm-991	103	45	or	or	CCONJ
ajlm-991	103	46	position	position	NOUN
ajlm-991	103	47	of	of	ADP
ajlm-991	103	48	any	any	DET
ajlm-991	103	49	affiliated	affiliated	ADJ
ajlm-991	103	50	agency	agency	NOUN
ajlm-991	103	51	of	of	ADP
ajlm-991	103	52	the	the	DET
ajlm-991	103	53	authors	author	NOUN
ajlm-991	103	54	.	.	PUNCT
ajlm-991	104	1	references	reference	NOUN
ajlm-991	104	2	kumar	kumar	PROPN
ajlm-991	104	3	d	d	PROPN
ajlm-991	104	4	,	,	PUNCT
ajlm-991	104	5	singh	singh	PROPN
ajlm-991	104	6	ak	ak	PROPN
ajlm-991	104	7	,	,	PUNCT
ajlm-991	104	8	ali	ali	PROPN
ajlm-991	104	9	mr	mr	PROPN
ajlm-991	104	10	,	,	PUNCT
ajlm-991	104	11	chander	chander	PROPN
ajlm-991	104	12	y.	y.	PROPN
ajlm-991	104	13	antimicrobial	antimicrobial	ADJ
ajlm-991	104	14	susceptibility	susceptibility	NOUN
ajlm-991	104	15	profile	profile	NOUN
ajlm-991	104	16	of	of	ADP
ajlm-991	104	17	extended	extended	ADJ
ajlm-991	104	18	spectrum	spectrum	NOUN
ajlm-991	104	19	ß	ß	NOUN
ajlm-991	104	20	-	-	NOUN
ajlm-991	104	21	lactamase	lactamase	ADJ
ajlm-991	104	22	(	(	PUNCT
ajlm-991	104	23	esbl	esbl	NOUN
ajlm-991	104	24	)	)	PUNCT
ajlm-991	104	25	producing	produce	VERB
ajlm-991	104	26	escherichia	escherichia	NOUN
ajlm-991	104	27	coli	coli	NOUN
ajlm-991	104	28	from	from	ADP
ajlm-991	104	29	various	various	ADJ
ajlm-991	104	30	clinical	clinical	ADJ
ajlm-991	104	31	samples	sample	NOUN
ajlm-991	104	32	.	.	PUNCT
ajlm-991	105	1	infect	infect	VERB
ajlm-991	105	2	dis	dis	PROPN
ajlm-991	105	3	(	(	PUNCT
ajlm-991	105	4	auckl	auckl	PROPN
ajlm-991	105	5	)	)	PUNCT
ajlm-991	105	6	.	.	PUNCT
ajlm-991	106	1	2014;7:1–8	2014;7:1–8	NOUN
ajlm-991	106	2	.	.	PUNCT
ajlm-991	107	1	https://doi.org/10.4137/idrt.s13820	https://doi.org/10.4137/idrt.s13820	PROPN
ajlm-991	107	2	global	global	ADJ
ajlm-991	107	3	antibiotic	antibiotic	ADJ
ajlm-991	107	4	resistance	resistance	NOUN
ajlm-991	107	5	partnership	partnership	NOUN
ajlm-991	107	6	(	(	PUNCT
ajlm-991	107	7	garp	garp	NOUN
ajlm-991	107	8	)	)	PUNCT
ajlm-991	107	9	–	–	PUNCT
ajlm-991	107	10	india	india	PROPN
ajlm-991	107	11	working	working	PROPN
ajlm-991	107	12	group	group	NOUN
ajlm-991	107	13	.	.	PUNCT
ajlm-991	108	1	rationalizing	rationalize	VERB
ajlm-991	108	2	antibiotic	antibiotic	ADJ
ajlm-991	108	3	use	use	NOUN
ajlm-991	108	4	to	to	PART
ajlm-991	108	5	limit	limit	VERB
ajlm-991	108	6	antibiotic	antibiotic	ADJ
ajlm-991	108	7	resistance	resistance	NOUN
ajlm-991	108	8	in	in	ADP
ajlm-991	108	9	india	india	PROPN
ajlm-991	108	10	.	.	PUNCT
ajlm-991	109	1	indian	indian	PROPN
ajlm-991	109	2	j	j	PROPN
ajlm-991	109	3	med	med	PROPN
ajlm-991	109	4	res	re	NOUN
ajlm-991	109	5	.	.	PUNCT
ajlm-991	110	1	2011;134(3):281–294	2011;134(3):281–294	NUM
ajlm-991	110	2	.	.	PUNCT
ajlm-991	110	3	national	national	ADJ
ajlm-991	110	4	action	action	NOUN
ajlm-991	110	5	plan	plan	NOUN
ajlm-991	110	6	on	on	ADP
ajlm-991	110	7	antimicrobial	antimicrobial	ADJ
ajlm-991	110	8	resistance	resistance	NOUN
ajlm-991	110	9	(	(	PUNCT
ajlm-991	110	10	nap	nap	NOUN
ajlm-991	110	11	-	-	PUNCT
ajlm-991	110	12	amr	amr	NOUN
ajlm-991	110	13	)	)	PUNCT
ajlm-991	110	14	2017–2021	2017–2021	NUM
ajlm-991	110	15	.	.	PUNCT
ajlm-991	111	1	april	april	PROPN
ajlm-991	111	2	2017	2017	NUM
ajlm-991	112	1	|	|	ADV
ajlm-991	112	2	ministry	ministry	PROPN
ajlm-991	112	3	of	of	ADP
ajlm-991	112	4	health	health	PROPN
ajlm-991	112	5	&	&	CCONJ
ajlm-991	112	6	family	family	PROPN
ajlm-991	112	7	welfare	welfare	NOUN
ajlm-991	112	8	-	-	PUNCT
ajlm-991	112	9	government	government	NOUN
ajlm-991	112	10	of	of	ADP
ajlm-991	112	11	india	india	PROPN
ajlm-991	112	12	.	.	PUNCT
ajlm-991	113	1	bush	bush	PROPN
ajlm-991	113	2	k.	k.	PROPN
ajlm-991	113	3	bench	bench	PROPN
ajlm-991	113	4	-	-	PUNCT
ajlm-991	113	5	to	to	ADP
ajlm-991	113	6	-	-	PUNCT
ajlm-991	113	7	bedside	bedside	NOUN
ajlm-991	113	8	review	review	NOUN
ajlm-991	113	9	:	:	PUNCT
ajlm-991	113	10	the	the	DET
ajlm-991	113	11	role	role	NOUN
ajlm-991	113	12	of	of	ADP
ajlm-991	113	13	β	β	NOUN
ajlm-991	113	14	-	-	NOUN
ajlm-991	113	15	lactamases	lactamase	NOUN
ajlm-991	113	16	in	in	ADP
ajlm-991	113	17	antibiotic	antibiotic	ADJ
ajlm-991	113	18	-	-	PUNCT
ajlm-991	113	19	resistant	resistant	ADJ
ajlm-991	113	20	gram	gram	NOUN
ajlm-991	113	21	-	-	PUNCT
ajlm-991	113	22	negative	negative	ADJ
ajlm-991	113	23	infections	infection	NOUN
ajlm-991	113	24	.	.	PUNCT
ajlm-991	114	1	bush	bush	PROPN
ajlm-991	114	2	crit	crit	PROPN
ajlm-991	114	3	care	care	NOUN
ajlm-991	114	4	.	.	PUNCT
ajlm-991	115	1	2010;14:224	2010;14:224	NUM
ajlm-991	115	2	.	.	PUNCT
ajlm-991	116	1	https://doi.org/10.1186/cc8892	https://doi.org/10.1186/cc8892	PROPN
ajlm-991	116	2	bush	bush	PROPN
ajlm-991	116	3	k	k	PROPN
ajlm-991	116	4	,	,	PUNCT
ajlm-991	116	5	jacoby	jacoby	PROPN
ajlm-991	116	6	ga	ga	PROPN
ajlm-991	116	7	,	,	PUNCT
ajlm-991	116	8	medeiros	medeiros	PROPN
ajlm-991	116	9	aa	aa	PROPN
ajlm-991	116	10	.	.	PUNCT
ajlm-991	117	1	a	a	DET
ajlm-991	117	2	functional	functional	ADJ
ajlm-991	117	3	classification	classification	NOUN
ajlm-991	117	4	scheme	scheme	NOUN
ajlm-991	117	5	for	for	ADP
ajlm-991	117	6	βlactamases	βlactamase	NOUN
ajlm-991	117	7	and	and	CCONJ
ajlm-991	117	8	its	its	PRON
ajlm-991	117	9	correlation	correlation	NOUN
ajlm-991	117	10	with	with	ADP
ajlm-991	117	11	molecular	molecular	ADJ
ajlm-991	117	12	structure	structure	NOUN
ajlm-991	117	13	.	.	PUNCT
ajlm-991	118	1	antimicrob	antimicrob	PROPN
ajlm-991	118	2	agents	agents	PROPN
ajlm-991	118	3	chemother	chemother	PROPN
ajlm-991	118	4	.	.	PUNCT
ajlm-991	119	1	1995;39(6):1211–1233	1995;39(6):1211–1233	NUM
ajlm-991	119	2	.	.	PUNCT
ajlm-991	120	1	https://doi.org/10.1128/aac.39.6.1211	https://doi.org/10.1128/aac.39.6.1211	PROPN
ajlm-991	120	2	bush	bush	PROPN
ajlm-991	120	3	k	k	PROPN
ajlm-991	120	4	,	,	PUNCT
ajlm-991	120	5	jacoby	jacoby	PROPN
ajlm-991	120	6	ga	ga	PROPN
ajlm-991	120	7	.	.	PROPN
ajlm-991	120	8	updated	update	VERB
ajlm-991	120	9	functional	functional	ADJ
ajlm-991	120	10	classification	classification	NOUN
ajlm-991	120	11	of	of	ADP
ajlm-991	120	12	beta	beta	NOUN
ajlm-991	120	13	-	-	PUNCT
ajlm-991	120	14	lactamases	lactamase	NOUN
ajlm-991	120	15	.	.	PUNCT
ajlm-991	121	1	antimicrobial	antimicrobial	ADJ
ajlm-991	121	2	agents	agents	PROPN
ajlm-991	121	3	chemother	chemother	PROPN
ajlm-991	121	4	.	.	PUNCT
ajlm-991	122	1	2010;54(3):969–976	2010;54(3):969–976	X
ajlm-991	122	2	.	.	PUNCT
ajlm-991	123	1	https://doi.org/10.1128/aac.01009-09	https://doi.org/10.1128/aac.01009-09	PROPN
ajlm-991	123	2	bradford	bradford	PROPN
ajlm-991	123	3	pa	pa	PROPN
ajlm-991	123	4	.	.	PROPN
ajlm-991	123	5	extended	extend	VERB
ajlm-991	123	6	-	-	PUNCT
ajlm-991	123	7	spectrum	spectrum	NOUN
ajlm-991	123	8	β	β	NOUN
ajlm-991	123	9	-	-	NOUN
ajlm-991	123	10	lactamases	lactamase	NOUN
ajlm-991	123	11	in	in	ADP
ajlm-991	123	12	the	the	DET
ajlm-991	123	13	21st	21st	ADJ
ajlm-991	123	14	century	century	NOUN
ajlm-991	123	15	:	:	PUNCT
ajlm-991	123	16	characterization	characterization	NOUN
ajlm-991	123	17	,	,	PUNCT
ajlm-991	123	18	epidemiology	epidemiology	NOUN
ajlm-991	123	19	,	,	PUNCT
ajlm-991	123	20	and	and	CCONJ
ajlm-991	123	21	detection	detection	NOUN
ajlm-991	123	22	of	of	ADP
ajlm-991	123	23	this	this	DET
ajlm-991	123	24	important	important	ADJ
ajlm-991	123	25	resistance	resistance	NOUN
ajlm-991	123	26	threat	threat	NOUN
ajlm-991	123	27	.	.	PUNCT
ajlm-991	124	1	clin	clin	PROPN
ajlm-991	124	2	microbiol	microbiol	PROPN
ajlm-991	124	3	rev	rev	VERB
ajlm-991	124	4	.	.	PROPN
ajlm-991	125	1	2001;14(4):933–951	2001;14(4):933–951	NUM
ajlm-991	125	2	.	.	PUNCT
ajlm-991	126	1	https://doi.org/10.1128/cmr.14.4.933-951.2001	https://doi.org/10.1128/cmr.14.4.933-951.2001	VERB
ajlm-991	126	2	drawz	drawz	PROPN
ajlm-991	126	3	sm	sm	PROPN
ajlm-991	126	4	,	,	PUNCT
ajlm-991	126	5	bonomo	bonomo	PROPN
ajlm-991	126	6	ra	ra	PROPN
ajlm-991	126	7	.	.	PUNCT
ajlm-991	127	1	three	three	NUM
ajlm-991	127	2	decades	decade	NOUN
ajlm-991	127	3	of	of	ADP
ajlm-991	127	4	β	β	NOUN
ajlm-991	127	5	-	-	PUNCT
ajlm-991	127	6	lactamase	lactamase	ADJ
ajlm-991	127	7	inhibitors	inhibitor	NOUN
ajlm-991	127	8	.	.	PUNCT
ajlm-991	128	1	clin	clin	PROPN
ajlm-991	128	2	microbiol	microbiol	PROPN
ajlm-991	128	3	rev	rev	VERB
ajlm-991	128	4	.	.	PROPN
ajlm-991	128	5	2010;23(4):160–201	2010;23(4):160–201	X
ajlm-991	128	6	.	.	PUNCT
ajlm-991	129	1	https://doi.org/10.1128/cmr.00037-09	https://doi.org/10.1128/cmr.00037-09	PROPN
ajlm-991	129	2	chopra	chopra	PROPN
ajlm-991	129	3	i	i	PROPN
ajlm-991	129	4	,	,	PUNCT
ajlm-991	129	5	schofield	schofield	PROPN
ajlm-991	129	6	c	c	PROPN
ajlm-991	129	7	,	,	PUNCT
ajlm-991	129	8	everett	everett	PROPN
ajlm-991	129	9	m	m	PROPN
ajlm-991	129	10	,	,	PUNCT
ajlm-991	129	11	et	et	PROPN
ajlm-991	129	12	al	al	PROPN
ajlm-991	129	13	.	.	PUNCT
ajlm-991	129	14	treatment	treatment	NOUN
ajlm-991	129	15	of	of	ADP
ajlm-991	129	16	health	health	NOUN
ajlm-991	129	17	-	-	PUNCT
ajlm-991	129	18	care	care	NOUN
ajlm-991	129	19	associated	associate	VERB
ajlm-991	129	20	infections	infection	NOUN
ajlm-991	129	21	caused	cause	VERB
ajlm-991	129	22	by	by	ADP
ajlm-991	129	23	gram	gram	NOUN
ajlm-991	129	24	-	-	PUNCT
ajlm-991	129	25	negative	negative	ADJ
ajlm-991	129	26	bacteria	bacteria	NOUN
ajlm-991	129	27	:	:	PUNCT
ajlm-991	129	28	a	a	DET
ajlm-991	129	29	consensus	consensus	NOUN
ajlm-991	129	30	statement	statement	NOUN
ajlm-991	129	31	.	.	PUNCT
ajlm-991	130	1	lancet	lancet	PROPN
ajlm-991	130	2	infect	infect	PROPN
ajlm-991	130	3	dis	dis	PROPN
ajlm-991	130	4	.	.	PUNCT
ajlm-991	131	1	2008;8(2):133–139	2008;8(2):133–139	X
ajlm-991	131	2	.	.	PUNCT
ajlm-991	131	3	https://doi.org/10.1016/s1473-3099(08)70018-5	https://doi.org/10.1016/s1473-3099(08)70018-5	PROPN
ajlm-991	131	4	pravin	pravin	PROPN
ajlm-991	131	5	kn	kn	PROPN
ajlm-991	131	6	and	and	CCONJ
ajlm-991	131	7	michelle	michelle	PROPN
ajlm-991	131	8	sv	sv	PROPN
ajlm-991	131	9	.	.	PUNCT
ajlm-991	132	1	prevalence	prevalence	NOUN
ajlm-991	132	2	of	of	ADP
ajlm-991	132	3	carbapenem	carbapenem	PROPN
ajlm-991	132	4	resistant	resistant	ADJ
ajlm-991	132	5	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-991	132	6	from	from	ADP
ajlm-991	132	7	a	a	DET
ajlm-991	132	8	tertiary	tertiary	ADJ
ajlm-991	132	9	care	care	NOUN
ajlm-991	132	10	hospital	hospital	NOUN
ajlm-991	132	11	in	in	ADP
ajlm-991	132	12	mumbai	mumbai	PROPN
ajlm-991	132	13	,	,	PUNCT
ajlm-991	132	14	india	india	PROPN
ajlm-991	132	15	.	.	PUNCT
ajlm-991	133	1	j	j	PROPN
ajlm-991	133	2	microbiol	microbiol	PROPN
ajlm-991	133	3	infect	infect	VERB
ajlm-991	133	4	dis	dis	PROPN
ajlm-991	133	5	.	.	PUNCT
ajlm-991	134	1	2013;3(04):207–210	2013;3(04):207–210	X
ajlm-991	134	2	.	.	PUNCT
ajlm-991	135	1	https://doi.org/10.5799/ahinjs.02.2013.04.0110	https://doi.org/10.5799/ahinjs.02.2013.04.0110	PROPN
ajlm-991	135	2	rodrigues	rodrigues	PROPN
ajlm-991	135	3	c.	c.	PROPN
ajlm-991	135	4	carbapenem	carbapenem	PROPN
ajlm-991	135	5	-	-	PUNCT
ajlm-991	135	6	resistant	resistant	ADJ
ajlm-991	135	7	enterobacteriaceae	enterobacteriaceae	NOUN
ajlm-991	135	8	:	:	PUNCT
ajlm-991	135	9	a	a	DET
ajlm-991	135	10	reality	reality	NOUN
ajlm-991	135	11	check	check	NOUN
ajlm-991	135	12	.	.	PUNCT
ajlm-991	136	1	reg	reg	PROPN
ajlm-991	136	2	health	health	PROPN
ajlm-991	136	3	forum	forum	PROPN
ajlm-991	136	4	.	.	PUNCT
ajlm-991	137	1	2011;15(1):83–86	2011;15(1):83–86	NUM
ajlm-991	137	2	.	.	PUNCT
ajlm-991	137	3	bhatia	bhatia	PROPN
ajlm-991	137	4	p.	p.	PROPN
ajlm-991	137	5	alternative	alternative	ADJ
ajlm-991	137	6	empiric	empiric	ADJ
ajlm-991	137	7	therapy	therapy	NOUN
ajlm-991	137	8	to	to	ADP
ajlm-991	137	9	carbapenems	carbapenem	NOUN
ajlm-991	137	10	in	in	ADP
ajlm-991	137	11	management	management	NOUN
ajlm-991	137	12	of	of	ADP
ajlm-991	137	13	drug	drug	NOUN
ajlm-991	137	14	resistant	resistant	ADJ
ajlm-991	137	15	gram	gram	NOUN
ajlm-991	137	16	negative	negative	ADJ
ajlm-991	137	17	pathogens	pathogen	NOUN
ajlm-991	137	18	:	:	PUNCT
ajlm-991	137	19	a	a	DET
ajlm-991	137	20	new	new	ADJ
ajlm-991	137	21	way	way	NOUN
ajlm-991	137	22	to	to	ADP
ajlm-991	137	23	spare	spare	ADJ
ajlm-991	137	24	carbapenems	carbapenem	NOUN
ajlm-991	137	25	.	.	PUNCT
ajlm-991	138	1	res	re	NOUN
ajlm-991	138	2	j	j	PROPN
ajlm-991	138	3	infect	infect	VERB
ajlm-991	138	4	dis	dis	PROPN
ajlm-991	138	5	.	.	PUNCT
ajlm-991	139	1	2015;3:2	2015;3:2	X
ajlm-991	139	2	.	.	PUNCT
ajlm-991	140	1	http://doi.org/10.7243/2052-5958-3-2	http://doi.org/10.7243/2052-5958-3-2	PROPN
ajlm-991	140	2	basavaraj	basavaraj	VERB
ajlm-991	140	3	cm	cm	PROPN
ajlm-991	140	4	,	,	PUNCT
ajlm-991	140	5	jyothi	jyothi	PROPN
ajlm-991	140	6	p	p	PROPN
ajlm-991	140	7	,	,	PUNCT
ajlm-991	140	8	peerapur	peerapur	NOUN
ajlm-991	140	9	basavaraj	basavaraj	NOUN
ajlm-991	140	10	v.	v.	ADP
ajlm-991	140	11	the	the	DET
ajlm-991	140	12	prevalence	prevalence	NOUN
ajlm-991	140	13	of	of	ADP
ajlm-991	140	14	esbl	esbl	NOUN
ajlm-991	140	15	among	among	ADP
ajlm-991	140	16	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-991	140	17	in	in	ADP
ajlm-991	140	18	a	a	DET
ajlm-991	140	19	tertiary	tertiary	ADJ
ajlm-991	140	20	care	care	NOUN
ajlm-991	140	21	hospital	hospital	NOUN
ajlm-991	140	22	of	of	ADP
ajlm-991	140	23	north	north	PROPN
ajlm-991	140	24	karnataka	karnataka	PROPN
ajlm-991	140	25	,	,	PUNCT
ajlm-991	140	26	india	india	PROPN
ajlm-991	140	27	.	.	PUNCT
ajlm-991	141	1	j	j	PROPN
ajlm-991	141	2	clin	clin	PROPN
ajlm-991	141	3	diagn	diagn	PROPN
ajlm-991	141	4	res	re	NOUN
ajlm-991	141	5	.	.	PUNCT
ajlm-991	142	1	2011;5(3):470–475	2011;5(3):470–475	X
ajlm-991	142	2	.	.	PUNCT
ajlm-991	142	3	chaudhuri	chaudhuri	PROPN
ajlm-991	142	4	bn	bn	PROPN
ajlm-991	142	5	,	,	PUNCT
ajlm-991	142	6	rodrigues	rodrigues	PROPN
ajlm-991	142	7	c	c	PROPN
ajlm-991	142	8	,	,	PUNCT
ajlm-991	142	9	balaji	balaji	PROPN
ajlm-991	142	10	v	v	PROPN
ajlm-991	142	11	,	,	PUNCT
ajlm-991	142	12	et	et	PROPN
ajlm-991	142	13	al	al	PROPN
ajlm-991	143	1	.	.	PROPN
ajlm-991	143	2	incidence	incidence	NOUN
ajlm-991	143	3	of	of	ADP
ajlm-991	143	4	esbl	esbl	NOUN
ajlm-991	143	5	producers	producer	NOUN
ajlm-991	143	6	amongst	amongst	ADP
ajlm-991	143	7	gram	gram	NOUN
ajlm-991	143	8	-	-	PUNCT
ajlm-991	143	9	negative	negative	ADJ
ajlm-991	143	10	bacilli	bacilli	NOUN
ajlm-991	143	11	isolated	isolate	VERB
ajlm-991	143	12	from	from	ADP
ajlm-991	143	13	intra	intra	ADJ
ajlm-991	143	14	-	-	ADJ
ajlm-991	143	15	abdominal	abdominal	ADJ
ajlm-991	143	16	infections	infection	NOUN
ajlm-991	143	17	across	across	ADP
ajlm-991	143	18	india	india	PROPN
ajlm-991	143	19	(	(	PUNCT
ajlm-991	143	20	based	base	VERB
ajlm-991	143	21	on	on	ADP
ajlm-991	143	22	smart	smart	ADJ
ajlm-991	143	23	study	study	NOUN
ajlm-991	143	24	,	,	PUNCT
ajlm-991	143	25	2007	2007	NUM
ajlm-991	143	26	data	datum	NOUN
ajlm-991	143	27	)	)	PUNCT
ajlm-991	143	28	.	.	PUNCT
ajlm-991	144	1	j	j	PROPN
ajlm-991	144	2	assoc	assoc	PROPN
ajlm-991	144	3	physicians	physicians	PROPN
ajlm-991	144	4	ind	ind	PROPN
ajlm-991	144	5	.	.	PUNCT
ajlm-991	145	1	2011;59(5):287–292	2011;59(5):287–292	X
ajlm-991	145	2	.	.	X
ajlm-991	145	3	de	de	ADP
ajlm-991	145	4	as	as	ADP
ajlm-991	145	5	,	,	PUNCT
ajlm-991	145	6	kumar	kumar	PROPN
ajlm-991	145	7	sh	sh	PROPN
ajlm-991	145	8	,	,	PUNCT
ajlm-991	145	9	baveja	baveja	PROPN
ajlm-991	145	10	sm	sm	PROPN
ajlm-991	145	11	.	.	PUNCT
ajlm-991	146	1	prevalence	prevalence	NOUN
ajlm-991	146	2	of	of	ADP
ajlm-991	146	3	metallo	metallo	PROPN
ajlm-991	146	4	-	-	PUNCT
ajlm-991	146	5	β	β	NOUN
ajlm-991	146	6	-	-	PUNCT
ajlm-991	146	7	lactamase	lactamase	ADJ
ajlm-991	146	8	producing	produce	VERB
ajlm-991	146	9	pseudomonas	pseudomona	NOUN
ajlm-991	146	10	aeruginosa	aeruginosa	NOUN
ajlm-991	146	11	and	and	CCONJ
ajlm-991	146	12	acinetobacter	acinetobacter	ADJ
ajlm-991	146	13	species	specie	NOUN
ajlm-991	146	14	in	in	ADP
ajlm-991	146	15	intensive	intensive	ADJ
ajlm-991	146	16	care	care	NOUN
ajlm-991	146	17	areas	area	NOUN
ajlm-991	146	18	in	in	ADP
ajlm-991	146	19	a	a	DET
ajlm-991	146	20	tertiary	tertiary	ADJ
ajlm-991	146	21	care	care	NOUN
ajlm-991	146	22	hospital	hospital	NOUN
ajlm-991	146	23	.	.	PUNCT
ajlm-991	147	1	indian	indian	PROPN
ajlm-991	147	2	j	j	PROPN
ajlm-991	147	3	crit	crit	PROPN
ajlm-991	147	4	care	care	PROPN
ajlm-991	147	5	med	me	VERB
ajlm-991	147	6	.	.	PUNCT
ajlm-991	148	1	2010;4(1):217–219	2010;4(1):217–219	X
ajlm-991	148	2	.	.	PUNCT
ajlm-991	149	1	https://doi.org/10.4103/0972-5229.76089	https://doi.org/10.4103/0972-5229.76089	PROPN
ajlm-991	149	2	chaudhary	chaudhary	PROPN
ajlm-991	149	3	m	m	PROPN
ajlm-991	149	4	,	,	PUNCT
ajlm-991	149	5	payasi	payasi	PROPN
ajlm-991	149	6	a.	a.	NOUN
ajlm-991	149	7	clinical	clinical	PROPN
ajlm-991	149	8	,	,	PUNCT
ajlm-991	149	9	microbial	microbial	ADJ
ajlm-991	149	10	efficacy	efficacy	NOUN
ajlm-991	149	11	and	and	CCONJ
ajlm-991	149	12	tolerability	tolerability	NOUN
ajlm-991	149	13	of	of	ADP
ajlm-991	149	14	elores	elore	NOUN
ajlm-991	149	15	,	,	PUNCT
ajlm-991	149	16	a	a	DET
ajlm-991	149	17	novel	novel	ADJ
ajlm-991	149	18	antibiotic	antibiotic	ADJ
ajlm-991	149	19	adjuvant	adjuvant	ADJ
ajlm-991	149	20	entity	entity	NOUN
ajlm-991	149	21	in	in	ADP
ajlm-991	149	22	esbl	esbl	NOUN
ajlm-991	149	23	producing	produce	VERB
ajlm-991	149	24	pathogens	pathogen	NOUN
ajlm-991	149	25	:	:	PUNCT
ajlm-991	149	26	prospective	prospective	ADJ
ajlm-991	149	27	randomized	randomize	VERB
ajlm-991	149	28	controlled	control	VERB
ajlm-991	149	29	clinical	clinical	ADJ
ajlm-991	149	30	trial	trial	NOUN
ajlm-991	149	31	.	.	PUNCT
ajlm-991	150	1	j	j	PROPN
ajlm-991	150	2	pharmacy	pharmacy	NOUN
ajlm-991	150	3	res	re	NOUN
ajlm-991	150	4	.	.	PUNCT
ajlm-991	151	1	2013;7(4):275–280	2013;7(4):275–280	NUM
ajlm-991	151	2	.	.	X
ajlm-991	152	1	https://doi.org/10.1016/j.jopr.2013.04.017	https://doi.org/10.1016/j.jopr.2013.04.017	NUM
ajlm-991	152	2	chaudhary	chaudhary	PROPN
ajlm-991	152	3	m	m	PROPN
ajlm-991	152	4	,	,	PUNCT
ajlm-991	152	5	payasi	payasi	PROPN
ajlm-991	152	6	a.	a.	PROPN
ajlm-991	152	7	a	a	DET
ajlm-991	152	8	randomized	randomized	ADJ
ajlm-991	152	9	,	,	PUNCT
ajlm-991	152	10	open	open	ADJ
ajlm-991	152	11	label	label	NOUN
ajlm-991	152	12	prospective	prospective	ADJ
ajlm-991	152	13	,	,	PUNCT
ajlm-991	152	14	multicenter	multicenter	ADJ
ajlm-991	152	15	phase	phase	NOUN
ajlm-991	152	16	-	-	PUNCT
ajlm-991	152	17	iii	iii	NOUN
ajlm-991	152	18	clinical	clinical	ADJ
ajlm-991	152	19	trial	trial	NOUN
ajlm-991	152	20	of	of	ADP
ajlm-991	152	21	elores	elore	NOUN
ajlm-991	152	22	in	in	ADP
ajlm-991	152	23	lower	low	ADJ
ajlm-991	152	24	respiratory	respiratory	ADJ
ajlm-991	152	25	tract	tract	NOUN
ajlm-991	152	26	and	and	CCONJ
ajlm-991	152	27	urinary	urinary	ADJ
ajlm-991	152	28	tract	tract	NOUN
ajlm-991	152	29	infections	infection	NOUN
ajlm-991	152	30	.	.	PUNCT
ajlm-991	153	1	j	j	PROPN
ajlm-991	153	2	pharmacy	pharmacy	NOUN
ajlm-991	153	3	res	re	NOUN
ajlm-991	153	4	.	.	PUNCT
ajlm-991	154	1	2013;6(4):409–414	2013;6(4):409–414	NUM
ajlm-991	154	2	.	.	X
ajlm-991	155	1	https://doi.org/10.1016/j.jopr.2013.04.011	https://doi.org/10.1016/j.jopr.2013.04.011	PROPN
ajlm-991	155	2	magiorakos	magiorakos	PROPN
ajlm-991	155	3	ap	ap	PROPN
ajlm-991	155	4	,	,	PUNCT
ajlm-991	155	5	srinivasan	srinivasan	PROPN
ajlm-991	155	6	a	a	PROPN
ajlm-991	155	7	,	,	PUNCT
ajlm-991	155	8	carey	carey	PROPN
ajlm-991	155	9	rb	rb	PROPN
ajlm-991	155	10	,	,	PUNCT
ajlm-991	155	11	et	et	PROPN
ajlm-991	155	12	al	al	PROPN
ajlm-991	155	13	.	.	PROPN
ajlm-991	156	1	multidrug	multidrug	NOUN
ajlm-991	156	2	-	-	PUNCT
ajlm-991	156	3	resistant	resistant	ADJ
ajlm-991	156	4	,	,	PUNCT
ajlm-991	156	5	extensively	extensively	ADV
ajlm-991	156	6	drug	drug	NOUN
ajlm-991	156	7	resistant	resistant	ADJ
ajlm-991	156	8	and	and	CCONJ
ajlm-991	156	9	pandrug	pandrug	ADJ
ajlm-991	156	10	-	-	PUNCT
ajlm-991	156	11	resistant	resistant	ADJ
ajlm-991	156	12	bacteria	bacteria	NOUN
ajlm-991	156	13	:	:	PUNCT
ajlm-991	156	14	an	an	DET
ajlm-991	156	15	international	international	ADJ
ajlm-991	156	16	expert	expert	NOUN
ajlm-991	156	17	proposal	proposal	NOUN
ajlm-991	156	18	for	for	ADP
ajlm-991	156	19	interim	interim	ADJ
ajlm-991	156	20	standard	standard	ADJ
ajlm-991	156	21	definitions	definition	NOUN
ajlm-991	156	22	for	for	ADP
ajlm-991	156	23	acquired	acquire	VERB
ajlm-991	156	24	resistance	resistance	NOUN
ajlm-991	156	25	.	.	PUNCT
ajlm-991	157	1	clin	clin	PROPN
ajlm-991	157	2	microbiol	microbiol	PROPN
ajlm-991	157	3	infect	infect	VERB
ajlm-991	157	4	.	.	PUNCT
ajlm-991	158	1	2012;18(3):268–281	2012;18(3):268–281	NUM
ajlm-991	158	2	.	.	NUM
ajlm-991	158	3	https://doi.org/10.1111/j.1469–0691.2011.03570.x	https://doi.org/10.1111/j.1469–0691.2011.03570.x	VERB
ajlm-991	158	4	clinical	clinical	ADJ
ajlm-991	158	5	laboratory	laboratory	PROPN
ajlm-991	158	6	standard	standard	PROPN
ajlm-991	158	7	institute	institute	PROPN
ajlm-991	158	8	(	(	PUNCT
ajlm-991	158	9	clsi	clsi	PROPN
ajlm-991	158	10	)	)	PUNCT
ajlm-991	158	11	.	.	PUNCT
ajlm-991	159	1	performance	performance	NOUN
ajlm-991	159	2	standards	standard	NOUN
ajlm-991	159	3	for	for	ADP
ajlm-991	159	4	antimicrobial	antimicrobial	ADJ
ajlm-991	159	5	susceptibility	susceptibility	NOUN
ajlm-991	159	6	testing	testing	NOUN
ajlm-991	159	7	(	(	PUNCT
ajlm-991	159	8	2017	2017	NUM
ajlm-991	159	9	)	)	PUNCT
ajlm-991	159	10	clsi	clsi	NOUN
ajlm-991	159	11	approved	approve	VERB
ajlm-991	159	12	standards	standard	NOUN
ajlm-991	159	13	clsi	clsi	VERB
ajlm-991	159	14	m100	m100	PROPN
ajlm-991	159	15	-	-	PUNCT
ajlm-991	159	16	s23	s23	NOUN
ajlm-991	159	17	.	.	PUNCT
ajlm-991	160	1	wayne	wayne	PROPN
ajlm-991	160	2	,	,	PUNCT
ajlm-991	160	3	pa	pa	PROPN
ajlm-991	160	4	:	:	PUNCT
ajlm-991	160	5	clsi	clsi	ADJ
ajlm-991	160	6	;	;	PUNCT
ajlm-991	160	7	2017	2017	NUM
ajlm-991	160	8	.	.	PUNCT
ajlm-991	161	1	clinical	clinical	ADJ
ajlm-991	161	2	laboratory	laboratory	PROPN
ajlm-991	161	3	standard	standard	PROPN
ajlm-991	161	4	institute	institute	PROPN
ajlm-991	161	5	.	.	PUNCT
ajlm-991	162	1	performance	performance	NOUN
ajlm-991	162	2	standards	standard	NOUN
ajlm-991	162	3	for	for	ADP
ajlm-991	162	4	antimicrobial	antimicrobial	ADJ
ajlm-991	162	5	susceptibility	susceptibility	NOUN
ajlm-991	162	6	testing	testing	NOUN
ajlm-991	162	7	;	;	PUNCT
ajlm-991	162	8	twenty	twenty	NUM
ajlm-991	162	9	-	-	PUNCT
ajlm-991	162	10	second	second	ADJ
ajlm-991	162	11	informational	informational	ADJ
ajlm-991	162	12	supplement	supplement	NOUN
ajlm-991	162	13	.	.	PUNCT
ajlm-991	163	1	wayne	wayne	PROPN
ajlm-991	163	2	,	,	PUNCT
ajlm-991	163	3	pa	pa	PROPN
ajlm-991	163	4	:	:	PUNCT
ajlm-991	163	5	clinical	clinical	ADJ
ajlm-991	163	6	laboratory	laboratory	PROPN
ajlm-991	163	7	standard	standard	PROPN
ajlm-991	163	8	institute	institute	PROPN
ajlm-991	163	9	;	;	PUNCT
ajlm-991	163	10	2013	2013	NUM
ajlm-991	163	11	,	,	PUNCT
ajlm-991	163	12	p.	p.	NOUN
ajlm-991	163	13	32	32	NUM
ajlm-991	163	14	.	.	PUNCT
ajlm-991	164	1	pop	pop	VERB
ajlm-991	164	2	-	-	PUNCT
ajlm-991	164	3	vicas	vicas	ADJ
ajlm-991	164	4	ae	ae	PROPN
ajlm-991	164	5	,	,	PUNCT
ajlm-991	164	6	d’agata	d’agata	PROPN
ajlm-991	164	7	em	em	PRON
ajlm-991	164	8	.	.	PUNCT
ajlm-991	165	1	the	the	DET
ajlm-991	165	2	rising	rise	VERB
ajlm-991	165	3	influx	influx	NOUN
ajlm-991	165	4	of	of	ADP
ajlm-991	165	5	multidrug	multidrug	NOUN
ajlm-991	165	6	-	-	PUNCT
ajlm-991	165	7	resistant	resistant	ADJ
ajlm-991	165	8	gram	gram	NOUN
ajlm-991	165	9	-	-	PUNCT
ajlm-991	165	10	negative	negative	ADJ
ajlm-991	165	11	bacilli	bacilli	NOUN
ajlm-991	165	12	into	into	ADP
ajlm-991	165	13	a	a	DET
ajlm-991	165	14	tertiary	tertiary	ADJ
ajlm-991	165	15	care	care	NOUN
ajlm-991	165	16	hospital	hospital	NOUN
ajlm-991	165	17	.	.	PUNCT
ajlm-991	166	1	clin	clin	PROPN
ajlm-991	166	2	infect	infect	PROPN
ajlm-991	166	3	dis	dis	PROPN
ajlm-991	166	4	.	.	PUNCT
ajlm-991	167	1	2005;40(12):1792–1798	2005;40(12):1792–1798	X
ajlm-991	167	2	.	.	PUNCT
ajlm-991	168	1	https://doi.org/10.1086/430314	https://doi.org/10.1086/430314	PROPN
ajlm-991	169	1	subhedar	subhedar	PROPN
ajlm-991	169	2	v	v	ADP
ajlm-991	169	3	,	,	PUNCT
ajlm-991	169	4	jain	jain	PROPN
ajlm-991	169	5	sk	sk	PROPN
ajlm-991	169	6	.	.	PUNCT
ajlm-991	169	7	gram	gram	PROPN
ajlm-991	169	8	negative	negative	ADJ
ajlm-991	169	9	super	super	ADJ
ajlm-991	169	10	bugs	bug	NOUN
ajlm-991	169	11	:	:	PUNCT
ajlm-991	169	12	a	a	DET
ajlm-991	169	13	new	new	ADJ
ajlm-991	169	14	generation	generation	NOUN
ajlm-991	169	15	of	of	ADP
ajlm-991	169	16	icu	icu	PROPN
ajlm-991	169	17	infections	infection	NOUN
ajlm-991	169	18	,	,	PUNCT
ajlm-991	169	19	an	an	DET
ajlm-991	169	20	emerging	emerge	VERB
ajlm-991	169	21	challenge	challenge	NOUN
ajlm-991	169	22	for	for	ADP
ajlm-991	169	23	health	health	NOUN
ajlm-991	169	24	care	care	NOUN
ajlm-991	169	25	settings	setting	NOUN
ajlm-991	169	26	.	.	PUNCT
ajlm-991	170	1	am	be	AUX
ajlm-991	170	2	j	j	PROPN
ajlm-991	170	3	microbiol	microbiol	PROPN
ajlm-991	170	4	res	re	NOUN
ajlm-991	170	5	.	.	PUNCT
ajlm-991	170	6	2016;4(1):47–50	2016;4(1):47–50	NUM
ajlm-991	170	7	.	.	PUNCT
ajlm-991	171	1	janifer	janifer	PROPN
ajlm-991	171	2	j	j	PROPN
ajlm-991	171	3	,	,	PUNCT
ajlm-991	171	4	geethalaksmi	geethalaksmi	VERB
ajlm-991	171	5	s	s	PROPN
ajlm-991	171	6	,	,	PUNCT
ajlm-991	171	7	satyavani	satyavani	PROPN
ajlm-991	171	8	k	k	PROPN
ajlm-991	171	9	,	,	PUNCT
ajlm-991	171	10	et	et	PROPN
ajlm-991	171	11	al	al	PROPN
ajlm-991	171	12	.	.	PUNCT
ajlm-991	172	1	prevalence	prevalence	NOUN
ajlm-991	172	2	of	of	ADP
ajlm-991	172	3	lower	low	ADJ
ajlm-991	172	4	urinary	urinary	ADJ
ajlm-991	172	5	tract	tract	NOUN
ajlm-991	172	6	infection	infection	NOUN
ajlm-991	172	7	in	in	ADP
ajlm-991	172	8	south	south	PROPN
ajlm-991	172	9	indian	indian	ADJ
ajlm-991	172	10	type	type	NOUN
ajlm-991	172	11	2	2	NUM
ajlm-991	172	12	diabetic	diabetic	ADJ
ajlm-991	172	13	subjects	subject	NOUN
ajlm-991	172	14	.	.	PUNCT
ajlm-991	173	1	indian	indian	ADJ
ajlm-991	173	2	j	j	PROPN
ajlm-991	173	3	nephrol	nephrol	NOUN
ajlm-991	173	4	.	.	PUNCT
ajlm-991	174	1	2009;19(3):107–111	2009;19(3):107–111	NUM
ajlm-991	174	2	.	.	PUNCT
ajlm-991	175	1	https://doi.org/10.4103/0971-4065.57107	https://doi.org/10.4103/0971-4065.57107	PROPN
ajlm-991	175	2	bagga	bagga	PROPN
ajlm-991	175	3	r.	r.	PROPN
ajlm-991	175	4	retrospective	retrospective	ADJ
ajlm-991	175	5	analysis	analysis	NOUN
ajlm-991	175	6	of	of	ADP
ajlm-991	175	7	antibiotic	antibiotic	ADJ
ajlm-991	175	8	susceptibility	susceptibility	NOUN
ajlm-991	175	9	and	and	CCONJ
ajlm-991	175	10	resistance	resistance	NOUN
ajlm-991	175	11	patterns	pattern	NOUN
ajlm-991	175	12	against	against	ADP
ajlm-991	175	13	nosocomial	nosocomial	ADJ
ajlm-991	175	14	gram	gram	NOUN
ajlm-991	175	15	negative	negative	ADJ
ajlm-991	175	16	pathogens	pathogen	NOUN
ajlm-991	175	17	in	in	ADP
ajlm-991	175	18	fortis	fortis	PROPN
ajlm-991	175	19	memorial	memorial	ADJ
ajlm-991	175	20	research	research	PROPN
ajlm-991	175	21	institute	institute	PROPN
ajlm-991	175	22	gurgaon	gurgaon	PROPN
ajlm-991	175	23	.	.	PUNCT
ajlm-991	176	1	int	int	PROPN
ajlm-991	177	1	j	j	PROPN
ajlm-991	177	2	curr	curr	PROPN
ajlm-991	177	3	adv	adv	PROPN
ajlm-991	177	4	res	re	NOUN
ajlm-991	177	5	,	,	PUNCT
ajlm-991	177	6	2015;4(9):347–351	2015;4(9):347–351	PROPN
ajlm-991	177	7	.	.	PUNCT
ajlm-991	178	1	nhs_improvement	nhs_improvement	NOUN
ajlm-991	178	2	.	.	PUNCT
ajlm-991	179	1	guidance	guidance	NOUN
ajlm-991	179	2	on	on	ADP
ajlm-991	179	3	the	the	DET
ajlm-991	179	4	definition	definition	NOUN
ajlm-991	179	5	of	of	ADP
ajlm-991	179	6	healthcare	healthcare	PROPN
ajlm-991	179	7	associated	associate	VERB
ajlm-991	179	8	gram	gram	NOUN
ajlm-991	179	9	-	-	PUNCT
ajlm-991	179	10	negative	negative	ADJ
ajlm-991	179	11	bloodstream	bloodstream	NOUN
ajlm-991	179	12	infections	infection	NOUN
ajlm-991	179	13	.	.	PUNCT
ajlm-991	180	1	in	in	ADP
ajlm-991	180	2	:	:	PUNCT
ajlm-991	180	3	nhs	nhs	NOUN
ajlm-991	180	4	improvement	improvement	NOUN
ajlm-991	180	5	,	,	PUNCT
ajlm-991	180	6	editor	editor	NOUN
ajlm-991	180	7	.	.	PUNCT
ajlm-991	181	1	public	public	PROPN
ajlm-991	181	2	health	health	PROPN
ajlm-991	181	3	england	england	PROPN
ajlm-991	181	4	;	;	PUNCT
ajlm-991	181	5	2017	2017	NUM
ajlm-991	181	6	.	.	PUNCT
ajlm-991	182	1	gaynes	gayne	NOUN
ajlm-991	182	2	r	r	PROPN
ajlm-991	182	3	,	,	PUNCT
ajlm-991	182	4	edwards	edwards	PROPN
ajlm-991	182	5	jr	jr	PROPN
ajlm-991	182	6	.	.	PROPN
ajlm-991	182	7	overview	overview	NOUN
ajlm-991	182	8	of	of	ADP
ajlm-991	182	9	nosocomial	nosocomial	ADJ
ajlm-991	182	10	infections	infection	NOUN
ajlm-991	182	11	caused	cause	VERB
ajlm-991	182	12	by	by	ADP
ajlm-991	182	13	gram	gram	NOUN
ajlm-991	182	14	-	-	PUNCT
ajlm-991	182	15	negative	negative	ADJ
ajlm-991	182	16	bacilli	bacilli	NOUN
ajlm-991	182	17	.	.	PUNCT
ajlm-991	183	1	clin	clin	PROPN
ajlm-991	183	2	infect	infect	PROPN
ajlm-991	183	3	dis	dis	PROPN
ajlm-991	183	4	.	.	PUNCT
ajlm-991	184	1	2005;41(6):848–854	2005;41(6):848–854	X
ajlm-991	184	2	.	.	PUNCT
ajlm-991	184	3	https://doi.org/10.1086/432803	https://doi.org/10.1086/432803	DET
ajlm-991	184	4	paul	paul	PROPN
ajlm-991	184	5	m	m	PROPN
ajlm-991	184	6	,	,	PUNCT
ajlm-991	184	7	weinberger	weinberger	PROPN
ajlm-991	184	8	m	m	PROPN
ajlm-991	184	9	,	,	PUNCT
ajlm-991	184	10	siegman	siegman	NOUN
ajlm-991	184	11	-	-	PUNCT
ajlm-991	184	12	igra	igra	PROPN
ajlm-991	184	13	y	y	PROPN
ajlm-991	184	14	,	,	PUNCT
ajlm-991	184	15	et	et	PROPN
ajlm-991	184	16	al	al	PROPN
ajlm-991	184	17	.	.	PROPN
ajlm-991	185	1	acinetobacter	acinetobacter	PROPN
ajlm-991	185	2	baumannii	baumannii	PROPN
ajlm-991	185	3	:	:	PUNCT
ajlm-991	185	4	emergence	emergence	NOUN
ajlm-991	185	5	and	and	CCONJ
ajlm-991	185	6	spread	spread	VERB
ajlm-991	185	7	in	in	ADP
ajlm-991	185	8	israeli	israeli	ADJ
ajlm-991	185	9	hospitals	hospital	NOUN
ajlm-991	185	10	1997–2002	1997–2002	NUM
ajlm-991	185	11	.	.	PUNCT
ajlm-991	186	1	j	j	PROPN
ajlm-991	186	2	hosp	hosp	PROPN
ajlm-991	186	3	infect	infect	PROPN
ajlm-991	186	4	.	.	PUNCT
ajlm-991	187	1	2005;60(3):256–260	2005;60(3):256–260	NUM
ajlm-991	187	2	.	.	X
ajlm-991	187	3	https://doi.org/10.1016/j.jhin.2005.01.007	https://doi.org/10.1016/j.jhin.2005.01.007	VERB
ajlm-991	187	4	kumar	kumar	PROPN
ajlm-991	187	5	m	m	PROPN
ajlm-991	187	6	,	,	PUNCT
ajlm-991	187	7	chaudhary	chaudhary	PROPN
ajlm-991	187	8	s	s	PROPN
ajlm-991	187	9	,	,	PUNCT
ajlm-991	187	10	makkar	makkar	PROPN
ajlm-991	187	11	dk	dk	PROPN
ajlm-991	187	12	,	,	PUNCT
ajlm-991	187	13	garg	garg	PROPN
ajlm-991	187	14	n	n	CCONJ
ajlm-991	187	15	,	,	PUNCT
ajlm-991	187	16	chugh	chugh	NOUN
ajlm-991	187	17	sk	sk	PROPN
ajlm-991	187	18	.	.	PROPN
ajlm-991	187	19	comparative	comparative	ADJ
ajlm-991	187	20	antimicrobial	antimicrobial	ADJ
ajlm-991	187	21	efficacy	efficacy	NOUN
ajlm-991	187	22	evaluation	evaluation	NOUN
ajlm-991	187	23	of	of	ADP
ajlm-991	187	24	a	a	DET
ajlm-991	187	25	new	new	ADJ
ajlm-991	187	26	product	product	NOUN
ajlm-991	187	27	elores	elore	NOUN
ajlm-991	187	28	against	against	ADP
ajlm-991	187	29	meropenem	meropenem	NOUN
ajlm-991	187	30	on	on	ADP
ajlm-991	187	31	gram	gram	NOUN
ajlm-991	187	32	-	-	PUNCT
ajlm-991	187	33	negative	negative	ADJ
ajlm-991	187	34	isolates	isolate	NOUN
ajlm-991	187	35	.	.	PUNCT
ajlm-991	188	1	asian	asian	PROPN
ajlm-991	188	2	j	j	PROPN
ajlm-991	188	3	pharm	pharm	PROPN
ajlm-991	188	4	clin	clin	PROPN
ajlm-991	188	5	res	re	NOUN
ajlm-991	188	6	.	.	PUNCT
ajlm-991	189	1	2015;8:251–254	2015;8:251–254	NUM
ajlm-991	189	2	.	.	PUNCT
ajlm-991	190	1	neelam	neelam	PROPN
ajlm-991	190	2	sachdeva	sachdeva	PROPN
ajlm-991	190	3	.	.	PUNCT
ajlm-991	191	1	antibiotic	antibiotic	ADJ
ajlm-991	191	2	sensitivity	sensitivity	NOUN
ajlm-991	191	3	pattern	pattern	NOUN
ajlm-991	191	4	of	of	ADP
ajlm-991	191	5	bacterial	bacterial	ADJ
ajlm-991	191	6	pathogens	pathogen	NOUN
ajlm-991	191	7	in	in	ADP
ajlm-991	191	8	rajeev	rajeev	PROPN
ajlm-991	191	9	gandhi	gandhi	PROPN
ajlm-991	191	10	cancer	cancer	PROPN
ajlm-991	191	11	hospital	hospital	PROPN
ajlm-991	191	12	,	,	PUNCT
ajlm-991	191	13	delhi	delhi	PROPN
ajlm-991	191	14	.	.	PUNCT
ajlm-991	192	1	int	int	PROPN
ajlm-991	192	2	j	j	PROPN
ajlm-991	192	3	recent	recent	ADJ
ajlm-991	192	4	sci	sci	PROPN
ajlm-991	192	5	res	re	NOUN
ajlm-991	192	6	.	.	PUNCT
ajlm-991	193	1	2016;7(1):8480–8485	2016;7(1):8480–8485	NUM
ajlm-991	193	2	.	.	PUNCT
ajlm-991	194	1	sahu	sahu	PROPN
ajlm-991	194	2	m	m	PROPN
ajlm-991	194	3	,	,	PUNCT
ajlm-991	194	4	sanjith	sanjith	PROPN
ajlm-991	194	5	s	s	PROPN
ajlm-991	194	6	,	,	PUNCT
ajlm-991	194	7	bhalekar	bhalekar	X
ajlm-991	194	8	p	p	X
ajlm-991	194	9	,	,	PUNCT
ajlm-991	194	10	keny	keny	PROPN
ajlm-991	194	11	d.	d.	PROPN
ajlm-991	194	12	waging	wage	VERB
ajlm-991	194	13	war	war	NOUN
ajlm-991	194	14	against	against	ADP
ajlm-991	194	15	extended	extended	ADJ
ajlm-991	194	16	spectrum	spectrum	NOUN
ajlm-991	194	17	beta	beta	NOUN
ajlm-991	194	18	lactamase	lactamase	NOUN
ajlm-991	194	19	and	and	CCONJ
ajlm-991	194	20	metallobetalactamase	metallobetalactamase	NOUN
ajlm-991	194	21	producing	produce	VERB
ajlm-991	194	22	pathogens	pathogen	NOUN
ajlm-991	194	23	–	–	PUNCT
ajlm-991	194	24	novel	novel	ADJ
ajlm-991	194	25	adjuvant	adjuvant	ADJ
ajlm-991	194	26	antimicrobial	antimicrobial	ADJ
ajlm-991	194	27	agent	agent	NOUN
ajlm-991	194	28	cse1034an	cse1034an	NOUN
ajlm-991	194	29	extended	extend	VERB
ajlm-991	194	30	hope	hope	NOUN
ajlm-991	194	31	.	.	PUNCT
ajlm-991	195	1	j	j	PROPN
ajlm-991	195	2	clin	clin	PROPN
ajlm-991	195	3	diagn	diagn	PROPN
ajlm-991	195	4	res	re	NOUN
ajlm-991	195	5	.	.	PUNCT
ajlm-991	196	1	2014;8(6):dc20	2014;8(6):dc20	X
ajlm-991	196	2	–	–	PUNCT
ajlm-991	196	3	dc23	dc23	PROPN
ajlm-991	196	4	.	.	PUNCT
ajlm-991	197	1	https://doi.org/10.7860/jcdr/2014/8802.4504	https://doi.org/10.7860/jcdr/2014/8802.4504	PRON
ajlm-991	197	2	makkar	makkar	PROPN
ajlm-991	197	3	dk	dk	PROPN
ajlm-991	197	4	,	,	PUNCT
ajlm-991	197	5	kumar	kumar	PROPN
ajlm-991	197	6	m	m	PROPN
ajlm-991	197	7	,	,	PUNCT
ajlm-991	197	8	chaudhary	chaudhary	PROPN
ajlm-991	197	9	s	s	PROPN
ajlm-991	197	10	,	,	PUNCT
ajlm-991	197	11	goyal	goyal	PROPN
ajlm-991	197	12	s	s	PROPN
ajlm-991	197	13	,	,	PUNCT
ajlm-991	197	14	aggarwal	aggarwal	PROPN
ajlm-991	197	15	p	p	NOUN
ajlm-991	197	16	,	,	PUNCT
ajlm-991	197	17	garg	garg	PROPN
ajlm-991	197	18	n.	n.	PROPN
ajlm-991	197	19	comparative	comparative	ADJ
ajlm-991	197	20	antimicrobial	antimicrobial	ADJ
ajlm-991	197	21	efficacy	efficacy	NOUN
ajlm-991	197	22	evaluation	evaluation	NOUN
ajlm-991	197	23	of	of	ADP
ajlm-991	197	24	a	a	DET
ajlm-991	197	25	new	new	ADJ
ajlm-991	197	26	product	product	NOUN
ajlm-991	197	27	elores	elore	NOUN
ajlm-991	197	28	against	against	ADP
ajlm-991	197	29	meropenem	meropenem	PROPN
ajlm-991	197	30	on	on	ADP
ajlm-991	197	31	gramnegative	gramnegative	ADJ
ajlm-991	197	32	isolates	isolate	NOUN
ajlm-991	197	33	.	.	PUNCT
ajlm-991	198	1	asian	asian	PROPN
ajlm-991	198	2	j	j	PROPN
ajlm-991	198	3	pharm	pharm	PROPN
ajlm-991	198	4	clin	clin	PROPN
ajlm-991	198	5	res	re	NOUN
ajlm-991	198	6	.	.	PUNCT
ajlm-991	199	1	2015;8:1–4	2015;8:1–4	NOUN
ajlm-991	199	2	.	.	PUNCT
ajlm-991	200	1	arora	arora	PROPN
ajlm-991	200	2	s	s	PROPN
ajlm-991	200	3	,	,	PUNCT
ajlm-991	200	4	munshi	munshi	PROPN
ajlm-991	200	5	n.	n.	PROPN
ajlm-991	200	6	comparative	comparative	ADJ
ajlm-991	200	7	assessment	assessment	NOUN
ajlm-991	200	8	of	of	ADP
ajlm-991	200	9	antibiotic	antibiotic	ADJ
ajlm-991	200	10	susceptibility	susceptibility	NOUN
ajlm-991	200	11	pattern	pattern	NOUN
ajlm-991	200	12	of	of	ADP
ajlm-991	200	13	gram	gram	NOUN
ajlm-991	200	14	negative	negative	ADJ
ajlm-991	200	15	pathogens	pathogen	NOUN
ajlm-991	200	16	isolated	isolate	VERB
ajlm-991	200	17	from	from	ADP
ajlm-991	200	18	intensive	intensive	ADJ
ajlm-991	200	19	care	care	NOUN
ajlm-991	200	20	unit	unit	NOUN
ajlm-991	200	21	patients	patient	NOUN
ajlm-991	200	22	in	in	ADP
ajlm-991	200	23	pune	pune	NOUN
ajlm-991	200	24	.	.	PUNCT
ajlm-991	201	1	bmrj	bmrj	NOUN
ajlm-991	201	2	.	.	PUNCT
ajlm-991	202	1	2015;10(2):1–9	2015;10(2):1–9	NUM
ajlm-991	202	2	.	.	PUNCT
ajlm-991	202	3	https://doi.org/10.9734/bmrj/2015/18199	https://doi.org/10.9734/bmrj/2015/18199	VERB